Radius Care Announces First FY Results as a Listed Company
Radius Residential Care Limited
Full Year
Results
31 March 2021
Radius Care
2
Importance
Notice and
Disclaimer
ThispresentationhasbeenpreparedbyRadiusResidentialCareLimited(“RadiusCare”),forinformationalpurposes.Thisdisclaimer
appliestothisdocumentandtheverbalorwrittencommentsofanypersonpresentingit.
ThispresentationsetsoutinformationrelatingtoRadiusCare’sfullyearresultfortheperiodto31March2021.Assuch,itshould
bereadinconjunctionwiththeauditedconsolidatedfinancialstatementsforRadiusCareanditssubsidiariesfortheperiodended
31March2021(“FinancialStatements”)andothermaterialthatRadiusCarehasreleasedtoNZXalongwiththispresentation.That
materialisalsoavailableatwww.radiuscare.co.nz.
Incertainsectionsofthispresentation,RadiusCare haschosentopresentcertain financialinformationexclusiveofthe impactof
significantitems.Anumberofnon-GAAPfinancialmeasuresareusedinthispresentationwhichareusedbymanagementtoassess
the performance of the business and have been derived from the Financial Statements. You should not consider any of these
financialmeasuresinisolationfrom,orasasubstitutefortheinformationprovidedintheFinancialStatements.
Thispresentationmaycontainforward-lookingstatementsandprojections.Suchforward-lookingstatementsarebasedoncurrent
expectations,estimatesandassumptionsandaresubjecttoanumberofrisksanduncertainties,includingmaterialadverseevents,
significant one-off expenses and other unforeseeable circumstances. There is no assurance that results contemplated in any of
theseprojectionsandforward-lookingstatementswillberealised.Actualresultsmaydiffermateriallyfromthoseprojected.Except
as required by law, or the NZX Listing Rules, no person is under any obligation to update this presentation at any time after its
releaseortoprovidefurtherinformationaboutRadiusCare.
TheinformationinthispresentationhasbeenpreparedingoodfaithbyRadiusCare.NeitherRadiusCarenoranyofitsdirectors,
employees, shareholders nor any other person given any representations or warranties (either express or implied) as to the
accuracy or completeness of the information in this presentation and to the maximum extent permitted by law, no such person
shall have any liability whatsoever to any person for any loss (including, without limitation, arising from any fault or negligence)
arisingfromthispresentationoranyinformationsuppliedinconnectionwithit.
Thispresentationisnotaproductdisclosurestatementorotherdisclosuredocument,oranofferofsharesforsubscription,orsale,
inanyjurisdiction.Theinformationinthispresentationdoesnotconstitutefinancialproduct,legal,financial,investment,taxorany
otheradviceorarecommendation.
Radius Care
3
Radius Care
4
Presenting Today
Brien Cree
Executive Chairman / Managing Director
•Founded Radius Care in 2003, then part of
Radius Health Group
•Moved into Executive Chairman role in
June 2020 focusing on growth
opportunities through development and
acquisition
•Majority shareholder since undertaking
management buy out in 2010 and currently
holds 54.0% through Wave Rider Trust
•Board member of the New Zealand Aged
Care Association for more than 10 years
•Over 30 years’ experience in the Aged Care
sector
Stuart Bilbrough
Chief Executive Officer
•Appointed Chief Executive Officer in
June 2020
•Formerly Radius Care Chief Financial
Officer from 2010 to 2017
•Over 30 years’ experience in finance
roles in industries including
healthcare, FMCG, logistics, telecoms
and financial services
•New Zealand Chartered Accountant
and holds an MBA with distinction
from Massey University.
•Joined Radius Care in 2016
•Has nearly 25 years’ experience in
finance roles in various
•Industries worked in include
healthcare and financial services
•Michelle trained with
PricewaterhouseCoopers in South
Africa
•She is a New Zealand Chartered
Accountant.
Michelle Slabber
General Manager, Finance
Radius Care
5
Radius Care
at a Glance
HIGH ACUITY AND
SPECIALIST AGED
CARE PROVIDER
Radius Care operates 22 aged
care facilities nationally,
comprising more than 1,700
aged care beds.
We own three of these facilities
and lease 19 from 3rd party
property investors.
We also own two retirement
villages comprising of 76 units.
Radius Care OwnedLeased from 3
rd
Parties*
Total
Existing Portfolio
Sites51924
Aged Care Beds1781,5371,715
Retirement Village Units
1
76-76
Total Places2541,5371,791
Existing Facility - Landbank
Aged Care Beds4460104
Retirement Village Units202040
Belfast, Christchurch194-194
Total Existing + Landbank5121,6172,129
* All leases are triple net lease and long term in nature -with an average term to next renewal of 9.1 years but 27.7 years after
accounting for all renewals.
Portfolio summary as at 31 March 2021Portfolio summary as at 31 March 2021
Radius Care
announced on 7 April
2021 the exercise of
its option to acquire
4.3 hectares of
development land in
Christchurch
Note: As part of its December 2020 listing Radius Care prepared:
•A Listing Profile (which contains similar information to a Product Disclosure Statement) providing an overview of the business, the industry, risks and financial performance.
•Supplementary Financial Information providing more granular financial and operational information.
This information is contained on the Radius Care website https://www.radiuscare.co.nz/investors-centre/listing-documents
Radius Care
6
4.2% 95.8%
UnitsCare Beds
Radius Care
at a Glance
National aged care focused portfolio with strong regional presenceNational aged care focused portfolio with strong regional presence
Residents and EmployeesResidents and Employees
1,500+
employees
1,700+
beds
Denotes leasehold sitesDenotes freehold sites
A U C K L A N D
Sites Beds ILUs Total
Leased 3 248 -248
W A I K A T O
Sites Beds ILUs Total
Leased 4 334-334
Owned 1-2222
N E W P L Y M O U T H
Sites Beds ILUs Total
Leased 155-55
Owned 163-63
N O R T H L A N D
Sites Beds ILUs Total
Leased 3 155 -155
B A Y O F P L E N T Y
Sites Beds ILUs Total
Leased 2 266 -266
Owned 163-63
N A P I E R
Sites Beds ILUs Total
Leased 145-45
PALMERSTON NORTH
Sites Beds ILUs Total
Leased 162-62
CANTERBURY
Sites Beds ILUs Total
Leased 3 279 -279
Owned 252 54106
Units vs Care BedsUnits vs Care Beds
OTAGO
Sites Beds ILUs Total
Leased
193-93
Radius Care
7
Agenda
Appendix
— Key operational and
financial metrics
— Summary P&L, Balance
Sheet, Cash Flow
44
Overview
of FY21 financial
performance
First year as a listed
company
22
Analysis of result
Continuation of strong track
record
33
Positioning Radius Care
for Growth phase,
strategy update and
FY22 guidance
11
Radius Care
8
Overview of
FY21 Financial
Performance
FIRST YEAR AS A LISTED
COMPANY
Radius Care
9
FY21 Highlights
and Key Events
FY21 Guidance provided at
the time of listing met or
exceeded across all metrics.
Progress on Strategy
- Option exercised to purchase 4.3 hectares of Greenfield
Development land in Belfast, Christchurch post balance date
1
- Increases Greenfield Development pipeline by 70 Care Beds,
30 Care Suites and 94 Retirement Village Units
- Work progressing on final design, building consents and
construction discussions
- Multi-stage development approach provides funding
flexibility
Progress on Strategy
- Option exercised to purchase 4.3 hectares of Greenfield
Development land in Belfast, Christchurch post balance date
1
- Increases Greenfield Development pipeline by 70 Care Beds,
30 Care Suites and 94 Retirement Village Units
- Work progressing on final design, building consents and
construction discussions
- Multi-stage development approach provides funding
flexibility
Financial Performance
- Record result -all guidance metrics met or exceeded
- Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m
to $23.8m)
- Underlying EBITDA per bed up 13% to $19.5k
- Continued strong occupancy, private accommodation
supplements and cost control
Financial Performance
- Record result -all guidance metrics met or exceeded
- Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m
to $23.8m)
- Underlying EBITDA per bed up 13% to $19.5k
- Continued strong occupancy, private accommodation
supplements and cost control
1
See NZX release dated 7 April 2021
Radius Care
10
Enhanced management
and governance for listing
- Brien Cree transitioned in
Executive Chairman role focused
on growth opportunities through
development and acquisition
- Stuart Bilbrough returned as CEO
- Hamish Stevens and Mary
Gardiner appointed as
independent directors
- Direct listing undertaken on 10
December 2020
Enhanced management
and governance for listing
- Brien Cree transitioned in
Executive Chairman role focused
on growth opportunities through
development and acquisition
- Stuart Bilbrough returned as CEO
- Hamish Stevens and Mary
Gardiner appointed as
independent directors
- Direct listing undertaken on 10
December 2020
COVID-19 resilience
- Processes and procedures
introduced in mid-2000s for
Bird Flu performed well
through COVID-19 period
- Locked down facilities early
with industry following
- No COVID-19 cases amongst
residents or staff
1
COVID-19 resilience
- Processes and procedures
introduced in mid-2000s for
Bird Flu performed well
through COVID-19 period
- Locked down facilities early
with industry following
- No COVID-19 cases amongst
residents or staff
1
Balance Sheet Position
- Net debt of $24.5m down $4.7m
from pcp (31 March 20)
- Lease liabilities of $184.3m down
from $185.3m for pcp
Balance Sheet Position
- Net debt of $24.5m down $4.7m
from pcp (31 March 20)
- Lease liabilities of $184.3m down
from $185.3m for pcp
Balance Sheet Position
- Net debt of $24.5m down $4.7m
from pcp (31 March 20)
- Lease liabilities of $184.3m down
from $185.3m for pcp
FY21 highlights
and key events
FY21 Guidance provided at
the time of listing met or
exceeded across all metrics.
1
As at the date of this presentation
Radius Care
11
7.7
8.0
5.8
10.5
0.0
2.0
4.0
6.0
8.0
10.0
12.0
$m
FY18 FY19 FY20 FY21
Financial performance overview
FY21 Underlying EBITDA and Pre-NZ IFRS 16 Underlying EBITDA within Guidance range provided at time of listing
Pre-NZ IFRS 16 Underlying EBITDA
- FY21 Pre-NZ IFRS 16 Underlying EBITDA
of $10.5m up 82%
FY21 guidance range $10.2m –11.0m
Underlying EBITDA
- FY21 Underlying EBITDA of $23.4m up
28%
FY21 guidance range $23.0 -$23.8m
FY21 Guidance achievedFY21 Guidance achieved
19.7
20.4
18.2
23.4
0.0
5.0
10.0
15.0
20.0
25.0
$m
FY19FY18FY20
FY21
Total Revenue
- FY21 Revenue of $126m up 11%
$m
100.2
110.1
113.7
126.0
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
FY19
FY20 FY21FY18
Radius Care
12
Cash Flow and Dividends
AFFO
- FY21 AFFO of $3.7m
- Outperformance partly due to lower maintenance capex
Achieved AFFO in excess of FY21 Guidance
Dividends
FY21 Final Dividend
- Gross fully imputed FY21 final dividend declared of
0.89 cents per share (which includes 0.25 cents per
share of attaching imputation credits)
- Ex Dividend date Friday 11 June 2021
- Record date Monday 14 June 2021
- Payment date Monday 21 June 2021
FY21 Total Dividends
- Including February dividend of 0.58 cents per share
gives a total gross dividend in relation to the FY21
financial year of 1.46 cents per share (which includes
attaching imputation credits of 0.41cents per share)
- The total FY21 cash dividend of 1.05 cents per share is
above the FY21 cash dividend guidance of 0.83 to 1.00
cents per share
FY21 Guidance exceeded
FY21 guidance range $2.9m to $3.5m
1.3
2.0
(0.5)
3.7
(1.0)
0.0
1.0
2.0
3.0
4.0
$m
FY18 FY19 FY20 FY21
Radius Care’s dividend policy is target to pay 50% to 70% of AFFO
Radius Care
13
Summary of Key Drivers of FY21 Financial Performance
Strong growth in Underlying EBITDA driven primary by (1) improving care occupancy (2) increasing
accommodation supplements (3) cost control containment and (4) contributions from new developments
Aged Care: $4.3m
-Bureau: $1.6 million improvement
through strong cost control focus
-Brownfield and Greenfield
Developments contribution: $0.8
million from Windsor Court
Brownfield development ($0.6m)
and Glaisdale (Hamilton)
Greenfield development ($0.2m)
-Other aged care: $1.9 million.
Primarily driven by the increase in
occupancy $0.7m,
accommodation supplements
$0.7m and other $0.4m
Retirement Village: $0.7m
- Compounding impact of DMF and
additional unit sales
Group Support: $0.2m
- Reduced travel as a result of
COVID-19 disruptions
$1.6
$0.8
$0.7
$0.7
$0.4
$0.4
$0.4
$0.2
$(0.1)
$18.2
$23.4
17.0
19.0
21.0
23.0
25.0
FY20 Underlying
EBITDA
Bureau costs Brownfield &
Greenfield
Developments
Occupancy Accommodation
supplements
Other aged care
operations
DMF and weekly
service fees
Realised Gains on
Resales and
Development
Margin
Other village
operations
Support office
expenses
FY21 Underlying
EBITDA
NZ$m
Aged care
Retirementvillage
Group
support
Radius Care
14
Analysis of result
CONTINUATION OF STRONG
TRACK RECORD
Radius Care
15
Strong revenue growth continues with an increasing proportion from direct private (non-Government) revenue streams
Revenue Growth and Diversification
65.4
70.3
70.0
76.1
87.0
100.2
110.1
113.7
126.0
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Total revenueAged careRetirement villageGroup support
End of Financial
period
FY13FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
No. of Beds
1,3071,382 1,371 1,379 1,525 1,682 1,701 1,704 1,715
No. of Units
222222 36 48 55 63 73 76
Total revenue Total revenue Direct private (non-Government) revenue
1
Direct private (non-Government) revenue
1
1
Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues
2.2
3.0
3.0
4.5
6.2
7.1
10.1
9.2
13.8
3.4%
11.0%
0.0%
2.5%
5.0%
7.5%
10.0%
12.5%
0.0
2.5
5.0
7.5
10.0
12.5
15.0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Proportion of total revenue (%)
Direct Private Revenue (NZ$m)
Direct private revenue (LHS)
Direct private proportion of total revenue (RHS)
Radius Care
16
Bed Mix Oriented to High Acuity and Specialist Care
Over FY21, beds certified for high acuity and specialist care have increased from 82% to 86% of the portfolio. Radius Care
continues to provide more care offerings and in particular more specialist care offerings per facility than peers.
Care Beds by use and typeCare Beds by use and type
1 Source: CBRE analysis, September 2020
2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your-health/certified-providers/aged-care/based on data as at 4 May 2021
3 Dementia and Specialist offerings include Dementia, Psychogeriatric, Physical and Intellectual but does not include Rest Home or Hospital –Geriatric or Hospital –Medical care. Average based on simple average of all certified facilities
3.9
3.2
3.2
3.0
3.6
Radius Oceania Arvida Summerset Ryman
0.9
0.5
0.5
0.2
0.8
Radius Oceania Arvida Summerset Ryman
Total and specialist offerings
2
Total and specialist offerings
2
Total offerings aged care
(per Aged Care facility)
Dementia and Specialist offerings
3
(per Aged Care facility)
Care bed
type
Care bed
use
47.1%38.1%11.1%3.6%
Industry
average
1
17.9%
14.4%
34.1%
41.4%
30.3%
26.5%
10.3%
11.1%
6.6%
5.7%
0.8%
0.9%
FY20
FY21
85.6% high acuity and specialist
52.9% high acuity and specialist
34.4%
32.8%
47.9%
49.6%
10.2%
10.8%
6.3%
5.8%
1.2%
1.0%
FY20
FY21
Rest homeSwingHospitalDementiaPsychogeriatricPhysical and intellectual
65.6% high acuity and specialist
67.2% high acuity and specialist
82.1% high acuity and specialist
Radius Care
17
Strong Occupancy Growth
1.
Aging New Zealand population
1
1.
Aging New Zealand population
1
Growing Occupancy v.s. industry
3
Growing Occupancy v.s. industry
3
3. Increasing years in dependency3. Increasing years in dependency
•Life expectancy is increasing but more years are being spent in dependency
90.1%
89.2%
89.1%
90.4%
90.9%
91.3%
91.0%
92.1%
93.0%
93.7%
93.4% as
at 31
March
2021
87.2%
87.2%
86.9%
86.5%
86.9%
87.0%
86.8%
87.6%
87.9%
87.8%
85.0%
86.0%
87.0%
88.0%
89.0%
90.0%
91.0%
92.0%
93.0%
94.0%
95.0%
Jun-19 Sep-19 Dec-19 Mar-20 Jun-20 Sep-20 Dec-20 Mar-21
Occupancy rate %
Radius Care (monthly)Industry average (quarterly)
0.0%
2.0%
4.0%
6.0%
8.0%
Jan-03 Jan-08 Jan-13 Jan-18 Jan-23 Jan-28 Jan-33 Jan-38 Jan-43 Jan-48 Jan-53 Jan-58
Rolling 5-year pop. CAGR
(%)
65 - 85 5-yr CAGR85+ 5-yr CAGR
Aged care demand peak growth
from 2023 -2043
Occupancy growth underpinned by supportive industry backdrop of (1) aging population (2) increasing bed demand
particularly for high acuity and specialist care and (3) rising years in spent in dependency
Increasing number of high occupancy facilitiesIncreasing number of high occupancy facilities
88
7
11
9
3
7
7
5
4
2
5
6
4
2
0
5
10
15
20
25
FY18FY19FY20FY21
Number of Facilities
95.0% to 100%90.0% to 94.9%85.0% to 89.9%<85%
1 Source: Statistics New Zealand
2 Source: EY Aged Residential Care Funding Model Review analysis using ARC model, August 2019. Historical information based on actual demand data per the ARC demand model which EY have extended using the past 5 year trend over the projection period
3 Source: Industry Information based on NZACA Occupancy –TAS Aged Residential Care Quarterly Reporting Survey as at 31 December2020. Includes ORA ARRC-certified beds and residents
2. Increasing high acuity bed demand
2
2. Increasing high acuity bed demand
2
-
2,000
4,000
6,000
8,000
20062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031
ActualProjection
Bed days (000s of days)
DementiaHospitalPsychogeriatricResthome
Radius Care
18
Growing Underlying EBITDA per Care Bed
Underlying EBITDA per Care Bed ($000)
Strong Occupancy
(see previous page)
Increasing Underlying EBITDA per care bed
1
Increasing Underlying EBITDA per care bed
1
Growing accommodation supplementsGrowing accommodation supplements
Strong wage controlStrong wage control
18.3
17.9
17.2
19.5
0.0
5.0
10.0
15.0
20.0
FY18FY19FY20FY21
51.9
57.6
62.8
64.4
52.9%
54.1%
56.1%
53.9%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
FY18FY19FY20FY21
$m
Direct Employee Costs% of Direct Revenue
$3.03
$4.07
$4.92
$5.61
$1,819
$2,400
$2,902
$3,300
0
500
1,000
1,500
2,000
2,500
3,000
3,500
0.0
1.0
2.0
3.0
4.0
5.0
6.0
FY18FY19FY20FY21Accommodation supplement per
Care Bed NZ$
Accommodation supplements
NZ$m
Accommodation supplements (LHS)Accommodation supplements per available Care Bed (RHS)
1 Underlying EBITDA for aged care segment divided by the average number of care beds occupied during the period
Radius Care
19
Positioning Radius
Care for Growth
Phase, Strategy
Update and FY22
Guidance
Radius Care
20
Senior management and board strengthened
and sized for next phase of growth.
Positioning
Radius Care for
Growth Phase
- Brien Cree transitioned to Executive Chairman role
focused on growth opportunities through
development and acquisition
- Stuart Bilbrough returned as CEO (previously CFO
from 2010 to 2017)
- Hamish Stevens and Mary Gardiner appointed as
independent directors
- Employee turnover reduced vs. FY20
- A focus on employees continuing professional
development and ongoing property investments
that enhances accommodation supplement
revenue is a focus for the coming year
Radius Care
21
GO FORWARD STATERGYHISTORICAL TRACK RECORDCURRENT STATUS
1. Brownfield development
•Windsor Court (FY18) –15 Care Beds
•Waipuna (FY17) –28 Care Beds
•Elloughton Gardens (FY17) –27 Care Beds
Brownfield potential identified at owned sites at:
- Lexham Park (Katikati)
- Thornleigh (New Plymouth)
Detailed feasibility studies underway
2. Purchase of strategically
important facilities already
operated by Radius
•Lexham Park (FY20) –63 Care Beds
•Thornleigh Park (FY14) –63 Care Beds
•St Helenas (FY14) –52 Care Beds
Continuing work to identify strategically important facilities
3. Greenfield development
Greenfield Development on owned facilities undertaken and funded by
Radius Care:
•Elloughton Grange Village (FY21) –54 Units
Greenfield Development on leased facilities undertaken with and funded
by landlords:
•Glaisdale (FY18) –80 Care Beds
•Millstream (FY18) –80 Care Beds
Purchase of Belfast, Christchurch Greenfield development land
•As announced in April 2021, Radius Care has exercised its right
to acquire c. 4.3 hectares of land
•Settlement of the land ($5.5m) is expected to take place
between December 2021 and March 2022
•Work progressing on final design, building consents and
construction discussions
•Multi-stage programprovides funding flexibility
4. Opportunistic value accretive
acquisition
•Acquired the operations of 26 aged care facilities and retirement
villages comprising 1,998 Residences since 2003
•Continuing to seek and evaluate potential acquisition
opportunities
Strategy Update
Focus continues on the execution of Radius Care’s growth strategy, with the exercise of Radius Care’s option to acquire the
4.3 hectare Belfast, Christchurch site being a key milestone since Listing
-
Execution of strategy
-
Growth Strategy as outlined in the Listing Profile
Radius Care
22
Radius Care
23
Aged Care
•Average occupancy expected to increase further in FY22 given current run
rate
•Continued accommodation supplements growth in FY22 expected
•Additional funding from the Government as part of the Equal Pay claim
for Health Care Assistants
•Operating costs will increase with staffing wage growth but wages to
revenue expected to remain stable
•Conversion of Dementia rooms at Arran Court
Retirement village
•Sale of final 4 units at Elloughton Grange Village expected
•Resale of 5 units expected
Guidance for the
12 months to 31 March 2022
demonstrates expected
continued earnings uplift.
FY22 Outlook
and Guidance
Guidance
FY21Listing Profile FY21FY22
Actual ($m) Guidance($m) Guidance ($m)
Underlying EBITDA 23.423.0 -23.823.5 –25.5
Pre-NZ IFRS 16Underlying
EBITDA
10.510.2 -11.010.5 –12.5
AFFO3.72.9 -3.53.7 –4.7
Radius Care
24
Radius Care provides unique exposure to a high acuity, specialised care provider that remains committed to and
focused on delivering compassionate and outstanding clinical care outcomes
1. Demand
2. Portfolio
3.
Systematic
Approach
4. Growing
Non-
Government
Revenues
5. Growth
Pathway
6. Strong
Founder
Backed
Team
KeyInvestmentHighlights
0.0%
2.0%
4.0%
6.0%
8.0%
2003 2008 2013 2018 2023 2028 2033 2038 2043 2048 2053 2058
Rolling 5-year pop. CAGR (%)
65 - 85 5-yr CAGR85+ 5-yr CAGR
1
Demand underpinned by population demographics
1
3.9
3.2 3.2
3.0
3.6
Radius Oceania Arvida Summerset Ryman
2
Portfolio oriented to high acuity and specialist care
2
Systematic approach to provision of care
1) Centralised head-office systems and support
2) Leading IT systems
3) Immigration accreditation
4) Early engagement through Radius Online Shop
3
3.4%
11.0%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
FY13FY14FY15FY16FY17FY18FY19FY20FY21
Direct private portion
of total revenue (%)
Growing direct non-Government revenues
4
5
Clear growth pathway via
1) Purchase of strategically important
facilities’ land and buildings
2) Brownfield and greenfield development
with ownership of land and buildings
3) Opportunistic acquisitions
Strong founder backed team
Brien Cree
Founder and Executive Chairman
Stuart Bilbrough
Chief Executive Officer
6
1 Source: Statistics New Zealand
2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your-health/certified-providers/aged-care/based on data as at 4 May 2021
3 Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues
Radius Care
25
Appendix
Radius Care
26
Financial periodFY18 FY19 FY20 FY21
$m
Aged Care
27.2 27.2 26.3 30.6
Retirement Village
0.3 0.80.81.4
Group support
(7.8) (7.6) (8.9) (8.7)
Underlying EBITDA
19.7 20.4 18.2 23.4
Key operational and financial metrics
Financial periodFY18FY19FY20FY21
Number of Care Beds (period end)
1
1,682 1,701 1,704 1,715
Average Care Bed Occupancy
2
89.1% 89.5%90.092.4%
Underlying EBITDA per Care Bed
3
(000s)$18.3 $17.9 $17.2 $19.5
Number of Units (period end)
4
55637376
Number of new Unit sales 91186
Number of existing Unit resales23-7
Realised gains on resales (m)$0.2$0.1-$0.5
Realiseddevelopment margins (m)$0.2$0.5$0.4$0.3
Cash DMF realised uponresale (000s)$67$66-$525
Average resale price (000s)$323$355-$407
Average new unit saleprice (000s)$395$377$403$408
Operating metricsOperating metrics
1 Comprises Care Beds occupied, available to be occupied or unavailable due to refurbishment
2 Total occupied Care Bed days divided by total Care Bed days available during the period
3 Underlying EBITDA for aged care (as set out in the lower right table) divided by the average number of Care Beds occupied during the period
4 Comprises Units occupied, available to be occupied or unavailable due to refurbishment
Financial periodFY18 FY19 FY20 FY21
Accommodation Supplements Revenue
$3.0m $4.1m $4.9m $5.6m
Number of Care Beds
1,682 1,701 1,704 1,715
Number of Available Care Beds with Accommodation Supplements
1,005 1,134 1,138 1,146
Percentage of Care Beds with Accommodation Supplements
59.8% 66.7% 66.8% 66.8%
Accommodation supplementsAccommodation supplements
Financial periodFY18 FY19 FY20 FY21
$m
Aged Care
98.8 107.3 112.6 120.3
Retirement Village
1.3 2.30.54.4
Group support
0.1 0.50.61.3
Total revenue
100.2 110.1 113.7 126.0
Revenue by segmentRevenue by segment
DMF terms for Retirement Village unitsDMF terms for Retirement Village units
•30% over three years
•FY20 –21 average resident tenure: 4 years
Underlying EBITDA by segmentUnderlying EBITDA by segment
Corporate function growth from FY19 to FY20 and FY21 reflects strengthening of senior management and board for
next phase of growth.
Radius Care
27
Underlying EBITDA to AFFO Reconciliation
($m)FY18 FY19 FY20 FY21
Underlying EBITDA19.720.418.223.4
Include: Pre-NZ IFRS 16 operating rental lease expense(12.0) (12.4) (12.4) (12.9)
Pre-NZ IFRS 16 Underlying EBITDA7.78.05.810.5
Include: Depreciation and amortisation (Pre-NZ IFRS 16)(3.0)(3.6)(3.7)(4.3)
Include: Net interest expense (Pre-NZ IFRS 16)(0.6)(0.9)(1.2)(0.8)
Include: Current tax expense(0.9)(0.7)(1.0)(2.1)
Include: Income tax impact from Pro forma adjustments0.20.20.3(0.3)
Pre-NZ IFRS 16 Underlying NPAT3.43.00.23.0
Remove: Depreciation and amortisation (excl. NZ IFRS 16
related)
3.03.63.74.2
Include: Maintenance capital expenditure(5.1)(4.6)(4.4)(3.5)
AFFO1.32.0 (0.5)
1
3.7
AFFO outperformance in part due to maintenance capex below historical levels
Refer to Note 2.1 in the 31 March 2021 Annual Report for reconciliation of Underlying profit to Reported net profit after tax–see Appendix attached
1
The +$4.2m change in AFFO in FY2021 is calculated on AFFO for FY2020 of $(0.5)m, which has been revised from the FY2020 AFFO of $0.8m shown in the 10 December 2020 NZX Listing Profile due to a reclassification of the deferred tax on
the FY2020 revaluation of the three owned properties. The impact of this reclassification was an increase of $1.339m in FY2020 current tax and a corresponding decrease of $1.339m in FY2020 deferred tax. There is no impact on AFFO in
any other period and there is no impact going forward.
Capex
maintenance
guidance is
$4.0m
Radius Care
28
Statement of Comprehensive Income
($000)FY20FY21
Revenue
Revenue from contracts with customers113,359121,217
Deferred management fees6711,081
Total revenue114,030122,298
Fair value movement of investment properties(649)2,879
Government subsidy received353794
Interest income4971
Total revenue and other income113,783126,042
Expenses
Employee costs(70,852)(74,457)
Depreciation expense(10,911)(11,552)
Finance costs(10,583)(9,706)
Other expenses(24,770)(28,298)
Total expenses(117,116)(124,013)
Profit / (loss) before income tax(3,333)2,029
Income tax (expense) / benefit 500(324)
Profit / (loss) for the year(2,833)1,705
Other comprehensive income
Items that will not be reclassified subsequently to profit and loss
Revaluation of property, plant and equipment, net of tax5,7081,104
Other comprehensive income for the year5,7081,104
Total comprehensive income 2,8752,809
Radius Care
29
Statement of Financial Position
($000)FY20FY21
Assets
Cash and cash equivalents2,3172,761
Trade and other receivables7,6487,744
Inventories308548
Property, plant and equipment32,30332,896
Right-of-use assets181,431177,170
Investment properties27,83131,675
Deferred tax assets2,0063,635
Intangible assets16,99616,996
Total assets270,840273,425
Liabilities
Trade and other payables14,08614,911
Current tax liabilities7231,135
Borrowings31,42727,212
Deferred management fee9621,178
Refundable occupation right agreements17,51820,591
Lease liabilities185,304184,305
Total liabilities250,020249,332
Net assets20,82024,093
Equity
Share capital4,7365,932
Asset revaluation5,7086,812
Retained earnings10,37611,349
Total equity20,82024,093
Radius Care
30
Statement of Cash flows
($000)FY20FY21
Cash flow from operating activities
Receipts from residents for care fees and village fees113,282122,337
Receipts of government subsidy-1,210
Payments to suppliers and employees(95,436)(101,724)
Proceeds from the sale of Refundable occupation right agreements3,7053,927
Payments for the repurchase of Refundable occupation right agreements-(464)
Interest received4971
Interest paid –borrowings(1,183)(883)
Interest paid –lease liabilities(9,400)(8,823)
Income tax paid (814)(1,744)
Net cash provided by operating activities10,20313,907
Cash flow from investing activities
Proceeds from the sale of property, plant and equipment11454
Payments for the purchase of plant and equipment(11,305)(3,577)
Payments for village developments(3,723)(965)
Net cash used in investing activities(14,914)(4,488)
Cash flows from financing activities
Proceeds from bank borrowings15,120-
Repayments of bank borrowings4,038(4,215)
Repayments of shareholder loans(5,030)-
Principal repayment of lease liabilities(3,035)(4,028)
Dividends paid(225)(732)
Net cash (used in) / provided by financing activities2,792(8,975)
Reconciliation of cash and cash equivalents
Cash and cash equivalents at beginning of the year4,2362,317
Net increase / (decrease) in cash held(1,919)444
Cash and cash equivalents at end of year2,3172,761
Radius Care
31
Reconciliation of NZ GAAP financial measures to non-GAAP financial measures
($000)FY20FY21
Profit/(loss)for the year(2,833)1,705
Adjustments
Non-recurring or infrequent items
Remove: COVID-19 related expenses34653
Remove: Government COVID-19 Subsidy(353)(857)
Remove: One-off listing costs-1,227
Remove: Share based payments-1,464
Structural changes and other
Include: Listed & other company costs(1,084)(714)
Remove: Historical governance costs350417
Include: Income tax impact from adjustments295(270)
Underlying adjustments
Remove: Change in fair value of investment properties649(2,879)
Include: Realised development margins512343
Include: Realised gains on resales-480
Remove: Deferred tax expense(1,533)(1,831)
Underlying Net profit before tax(3,963)(262)
Remove: Depreciation10,91111,552
Remove: Net interest expense10,5349,636
Remove: Current tax expense1,0332,155
Remove: Income tax impact from adjustments(295)270
Underlying EBITDA18,22023,351
Include: Pre-NZ IFRS 16 operating lease expense(12,435)(12,850)
Pre-NZ IFRS 16 Underlying EBITDA5,78510,501
Include: Depreciation (Pre-NZ IFRS 16)(3,700)(4,262)
Include: Net interest expense (Pre-NZ IFRS 16)(1,134)(812)
Include: Current tax expense(1,033)(2,155)
Include: Income tax impact from adjustments295(270)
Pre-NZ IFRS 16 Underlying Net profit after tax2133,002
Remove: Depreciation (excl. NZ IFRS 16 related)3,7004,262
Include: Maintenance capital expenditure(4,400)(3,543)
AFFO(487)3,721
Radius Care
32
$0.1
$0.1
$(0.8)
$(0.2)
$(0.1)
$(0.6)
$(0.7)
$20.4
$18.2
17.0
19.0
21.0
FY19 Pro forma
Underlying EBITDA
Brownfield &
Greenfield
Developments
Bureau Other aged care
operations
DMF and weekly
service fees
Realised Gains on
Resales and
Development
Margin
Support office
personnel costs
Support office
other expenses
FY20 Pro forma
Underlying EBITDA
NZ$m
Aged careRetirement villageGroup support
Historical Pro forma Underlying EBITDA –FY19 to FY20
Note: Extract from the NZX Listing Profile of 10 December 2020
Radius Care
33
Leased facilityLocationCare Beds Units Current lease term Time to next renewal Rights of renewal Time to final expiry Landlord
HeatherleaNew Plymouth55-12 yrs5 yrs3 x 12 yrs41.1 yrsA
Taupaki GablesKumeu60-12 yrs5 yrs3 x 12 yrs41.1 yrsA
Windsor CourtOhaupo76-12 yrs5 yrs3 x 12 yrs41.1 yrsA
Elloughton GardensTimaru86-12 yrs5 yrs3 x 12 yrs41.1 yrsA
KensingtonHamilton96-10 yrs3.2 yrs2 x 10 yrs13.2 yrsB
PeppertreePalmerston North62-10 yrs3.7 yrs2 x 10 yrs13.7 yrsB
St JoansHamilton82-10 yrs4.1 yrs2 x 10 yrs14.1 yrsB
Fulton HomeDunedin93-10 yrs4.6 yrs2 x 10 yrs14.6 yrsB
Arran CourtAuckland102-10 yrs8.3 yrs1 x 10 yrs18.3 yrsB
Potter HomeWhangarei55-20 yrs8.6 yrs2x 15 yrs38.6 yrsC
Rimu ParkWhangarei55-20 yrs8.6 yrs2x 15 yrs38.6 yrsC
WaipunaAuckland86-30 yrs25.9 yrs-25.9 yrsD
Hampton CourtNapier45-10 yrs7.9 yrs-7.9 yrsE
BaycareNorthland45-12 yrs5 yrs3x 12 yrs41.1 yrsF
MatuaTauranga149-30 yrs21.7 yrs-21.7 yrsG
AlthorpTauranga117-15 yrs7.5 yrs3x 10 yrs37.5 yrsH
MillstreamAshburton80-35 yrs30.3 yrs-30.3 yrsI
Millstream ApartmentsAshburton19-5 yrs3.5 yrs2x 5 yrs13.5 yrsI
GlaisdaleHamilton80-15 yrs11.2 yrs2x 15 yrs41.2 yrsJ
HawthorneChristchurch94-10 yrs9.1 yrs2x 10 yrs19.1 yrsK
Total leased1537-n/an/an/an/a
Simple average leased77-15 yrs9.1 yrsn/a27.7 yrs
Owned facility/village
St HelenasChristchurch52-n/an/an/an/an/a
Thornleigh ParkNew Plymouth63-n/an/an/an/an/a
Lexham ParkKatikati63-n/an/an/an/an/a
Windsor Court VillageOhaupo-22n/an/an/an/an/a
Elloughton Grange Village Timaru-54n/an/an/an/an/a
Total owned17876
Total171576
Directory of facilities
Radius Care
34
---
Annual Report
2021
RADIUS RESIDENTIAL
CARE LIMITED
Welcome
We operate 22 aged care facilities across the country with more than
1,700 care beds. We own three of these facilities and lease 19. Radius
Care also owns and operates two retirement villages comprising 76
units. Our core aged care offering is focused on the high acuity and
specialist care segment of the market - being hospital, dementia,
psychogeriatric, physical and intellectual care. In addition, Radius Care
also provides lower acuity rest home level care and as such covers the
full continuum of care across the aged care segment.
Radius Care listed on NZX on 10 December 2020. Whether you were
one of our investors who was a shareholder at that time or have
joined us since, we warmly welcome you. Thank you for putting your
trust in us and joining our journey. Radius Care is focused on offering
exceptional quality services to our residents. By doing this we will
create sustainable long-term value based on a focused strategy and
supported by strong governance.
This is our first Annual Report as an NZX listed company. We have set
out in this report an overview of the key drivers of the Radius Care
business. Updating you on the financial and operational performance
and outlook, you’ll be well placed to assess our performance and our
future.
Radius Residential Care Limited is a specialist health and
aged care provider for elderly and disabled New Zealanders.
We are a New Zealand owned and operated company
committed to providing high-quality clinical care outcomes
for people who require help in their daily lives.
Annual Report 2021
1
This report covers the financial year ended 31 March 2021 and is dated 28 May 2021. The report
has been approved by the Board and is signed on behalf of Radius Residential Care Limited by
Brien Cree, Executive Chairman and Hamish Stevens, Director.
Brien Cree Hamish Stevens
A Day at a Radius Care Facility 2
2021 Highlights and Key Events 4
Our Values 5
Operating and Financial Highlights 6
Executive Chairman’s Letter 8
Interview with the Executive Chairman 12
Chief Executive’s Report 14
Case study: Florence Kiosk 20
Case study: Vaccine Rollout 21
Case study: Caring is Our Calling 22
Directors and Senior Management 23
Consolidated Financial Statements 27
Corporate Governance Statement 74
Other Disclosures 86
Shareholder Information 91
Directory 94
Contents
Radius Residential Care Limited
2
A day
at a Radius
Care facility
Radius Care’s daily activity programmes use a range of
touchpoints to support, challenge and enhance residents’
psychological, spiritual, social, emotional and physical
wellbeing. Sensory enrichment activities such as education
sessions, outings, discussion groups, cooking, beauty
therapy, exercise, gardening and music are standard
offerings at all facilities.
Annual Report 2021
3
During the nationwide Level 4 lockdown enabling residents to keep in touch with
their families was a priority. Radius Care staff taught residents to use Skype, Zoom,
Whatsapp and Facetime on their own and the company’s hardware. When physical
visits were simply not possible, residents’ use of social media platforms for contact
with family and friends became an important and every day activity.
Appointment
of Mary Gardiner and
Hamish Stevens as
independent directors
December
2020
Stuart Bilbrough
returns to Radius Care
as CEO
June
2020
All Radius sites locked
down as a result of
COVID-19 threat
17 March
2020
New Zealand entered
nationwide Level 4
lockdown
26 March
2020
Board approves
decision to undertake
NZX listing
September
2020
NZX Listing
10 December
2020
Payment of FY21
interim dividend
February
2021
Announcement of
exercise of option to
purchase 4.3ha site at
Belfast, Christchurch
April
2021
2021 Highlights
and Key Events
Radius Residential Care Limited
4
Annual Report 2021
5
Caring is our calling
Exceptional People, Exceptional Care
The foundation that every Radius Care facility is built on.
COMMITMENT
Leaders in care
COURAGE
Do the right thing
COMPASSION
Act with empathy
Annual Report 2021
5
Radius Residential Care Limited
6
Financial Highlights
FY2021 Change
Underlying EBITDA
6
$23.4m +$5.1m
Pre-NZ IFRS 16 Underlying EBITDA
6
$10.5m +$4.7m
AFFO
6
$3.7m +$4.2m
Total assets $273.4m +$2.6m
Net interest bearing bank debt $24.5m -$4.7m
Total gross fully imputed dividend declared for year 1.46 cps
Operating Highlights
FY2021 Change
Overall beds (period end)
1
1,715 +11
Bed occupancy (March 21 month)
2
93.4% +1.8%
Underlying EBITDA per Care Bed
3
$19,505 +13.3%
Retirement village units (period end) 76 +3
Staff (period end) 1,560 +58
Revenue composition
Government funded aged care 63.8% -2.0%
Direct private revenue
4
11.0% +2.9%
Indirect private revenue
5
25.2% -0.9%
Operating
and Financial
Highlights
1. Comprises Care Beds occupied, available to be occupied or unavailable due to refurbishment
2. Total occupied Care Bed days divided by total Care Bed days available during the period
3. Underlying EBITDA for aged care divided by average number of Care Beds occupied during the period
4. Reflects full or partial private aged care payments where the resident exceeds means testing threshold
5. Includes accommodation supplements, retirement village revenues, Radius Online Shop revenue and other privately paid
6. These measures are non-GAAP measures. The definitions and calculations of these measures in this report can be found on pages 37 – 39 of this report. The +$4.2m change in
AFFO in FY2021 is calculated on AFFO for FY2020 of $(0.5)m, which has been revised from the FY2020 AFFO of $0.8m shown in the 10 December 2020 NZX Listing Profile due to a
reclassification of the deferred tax on the FY2020 revaluation of the three owned properties. The impact of this reclassification was an increase of $1.339m in FY2020 current tax and a
corresponding decrease of $1.339m in FY2020 deferred tax.
Radius Residential Care Limited
6
Annual Report 2021
7
NEW PLYMOUTH
SitesBedsILUsTotal
Leased155-55
Owned163-63
WAIKATO
SitesBedsILUsTotal
Leased4334-334
Owned1-2222
CANTERBURY
SitesBedsILUsTotal
Leased3279-279
Owned25254106
BAY OF PLENTY
SitesBedsILUsTotal
Leased2266-266
Owned163-63
AUCKLAND
SitesBedsILUsTotal
Leased3248-248
NORTHLAND
SitesBedsILUsTotal
Leased3155-155
NAPIER
SitesBedsILUsTotal
Leased145-45
PALMERSTON NORTH
SitesBedsILUsTotal
Leased162-62
OTAGO
SitesBedsILUsTotal
Leased193-93
Radius Care
at a Glance
SitesAged Care BedsRetirement Villages
aged care
facilities
nationally
comprising
76 units
owned
22
3 owned 19 leased
1,700+2
Denotes leasehold sites
Denotes freehold sites
Employees & Residents
1,700+1,500+
EmployeesBeds
National portfolio with strong
regional performance
Radius Residential Care Limited
8
Letter from
the Chairman
This is the first report for Radius Care as a listed company.
The 2021 financial year will be memorable for two significant
events – the company’s listing on NZX and for the global impact
of COVID-19.
NZX listing
Radius Care listed on NZX on 10 December 2020. The listing
was one of the first direct listings on NZX for some time. Whilst
Radius Care has a clear strategic growth focus around (1) the
purchase of the land and buildings of strategically important
facilities it currently operates, (2) leveraging its existing
Brownfield and Greenfield acquisition capabilities and (3)
undertaking opportunistic value accretive acquisitions of aged
care focused facilities the timing of opportunities is inherently
uncertain. As such, the direct listing allowed Radius Care to
firstly, achieve an NZX listing, and subsequently, focus on its
strategic growth objectives. Our listing documents (being our
Listing Profile and Supplementary Financial Information) are
available in the investor section of the Radius Care website (see
www.radiuscare.co.nz/investors-centre/listing-documents.
Trading on NZX to date has been relatively light, with an
average of about 50,000 shares a day trading between 1
January and 31 March 2021. While our existing shareholders
have been able to enjoy the benefits of a more liquid market
for their shares, most have chosen not to sell at this point.
I am delighted to present the annual report for the year ended 31 March 2021 for Radius
Residential Care Limited.
Annual Report 2021
9
Radius Care
offers high acuity,
specialised care in
New Zealand with a
commitment to and
focus on delivering
compassionate and
outstanding clinical
care outcomes.
COVID-19 response
The start of the 2021 financial year saw New Zealand in
lockdown and unprecedented operating procedures in place
across all of our facilities. Scenario planning and testing
is a regular feature of our operating procedures and risk
mitigation. A pandemic plan had been thoroughly tested and
was activated prior to New Zealand moving to Alert Level 4 on
26 March 2020. We would like to thank our residents, their
families and our suppliers for their complete co-operation with
the procedures that were required to be put in place to keep
all of our residents safe. Our utmost thanks must also go to
our dedicated staff for their professionalism, resilience and
the level of care that was shown for all of those around them
throughout the lockdown periods.
Our market positioning and care strategy
Radius Care offers high acuity, specialised care across New
Zealand with a commitment to and focus on outstanding
clinical care outcomes, delivered with compassion.
We provide a full range of accommodation and care options
from retirement village to rest home care through to high
acuity and specialist care. Services under the latter category
means hospital, dementia, psychogeriatric, physical and
intellectual care. Radius Care provides a broad offering allowing
residents the confidence that they can “age in place” as their
care needs change, however our key focus is on providing
high acuity and specialist care. This greater focus on aged care
and in particular high acuity and specialist care differentiates
Radius Care from other NZX listed aged care and retirement
village operators.
Radius Care is New Zealand’s leading provider in the high
acuity and specialist care segments of the aged care market.
Its strong care reputation has created a clear and defendable
competitive advantage. The high acuity and specialist care
segment is expected to see the greatest increase in Care Bed
demand with an aging population and increased dependency
levels being the key drivers. This is expected to see it continue
to generate the industry’s highest margins per Care Bed.
Strong regulatory and operational requirements create high
barriers to entry for companies that choose to compete
against Radius Care.
Our growth strategy
Whilst historically Radius Care has predominantly leased its
facilities it has a strategic focus of increasing the proportion of
facilities it owns, where it makes strategic sense to do so. For
Radius Residential Care Limited
10
example, Radius Care would consider acquisitions of sites it
operates but does not own if:
• development potential may be constrained by the
landlord;
• to enhance its legal position allowing a Care Suite
(Occupation Right Agreement (ORA) over a Care Bed)
product to be offered;
• where it provides greater control over its cost base; or
• where there are funding benefits
Radius Care currently owns three of the aged care facilities and
both retirement villages that it operates. We lease 19 aged care
facilities. Where the opportunity to purchase any strategically
important leased facilities at an attractive price arises, we will
look to purchase.
We have identified the opportunity to, in time, develop
an additional 144 Care Beds on existing owned facilities.
Brownfield developments provide strong value accretion to
Radius Care as there is nil land cost associated with them
and, as extensions to existing facilities with known catchment
demand, they are generally low risk in nature. Our property
development team is currently undertaking more detailed work
on the Brownfield Development pipeline.
In future developments high acuity and specialist care will
continue to be the core offering at each property. The optimal
Greenfields Development will comprise a boutique integrated
aged care and retirement village in regional or main centres,
accommodating a facility of 100 Care Beds/Care Suites and
100 Retirement Units or more. We will however consider
other value accretive Greenfield Developments that present
themselves but don’t exactly fit this model.
In addition, the aged care market in which Radius Care
operates remains highly fragmented with approximately
50% of the market still owned by small operators. Over its
history Radius Care has acquired 26
7
facilities with 22 of
Letter from the Chairman continued
7. Radius Care sold facilities at Glenbrae, Lester and Seaview and closed
a facility at St Ives following the Christchurch earthquakes.
these retained. We are frequently contacted by smaller
operators seeking to sell their facilities. We will continue to
make acquisitions where opportunities arise that fit with our
strategy and are value accretive.
In order to accelerate the execution of this strategy to drive
our next phase of growth, I became Executive Chairman in
June 2020 and Stuart Bilbrough, who had been Radius Care’s
Chief Financial Officer between 2010 and 2017, returned
as CEO. In his report to you Stuart talks about our next
Greenfields property development which is an example of our
strategy in action.
Dividends
Radius Care’s dividend policy is to target a pay-out ratio
of 50% to 70% of full financial year available funds from
operations (AFFO) with an interim dividend to be paid in
December and a final dividend to be paid in June of each
year. Each dividend will comprise approximately half of the
expected full year dividend. A number of factors will be
considered, including Radius Care’s financial performance,
financial position, market conditions, future funding
requirements and any contractual, legal or regulatory
restrictions on the payment of dividends by Radius Care.
Guidance was provided of a total cash dividend (net of
imputation credits) of between 0.83 and 1.00 cent per share
to be paid for the 2021 financial year, comprising dividends to
be paid in February and June.
A gross fully imputed interim dividend of 0.58 cents per share
was paid on 26 February (being a cash dividend of 0.41 cents
per share with 0.17 cents per share of attaching imputation
credits). A gross fully imputed full year dividend of 1.46 cents
per share (being a cash dividend of 1.05 cents per share with
Annual Report 2021
11
Brien Cree
Executive Chairman and
Managing Director
0.41 cents per share of attaching imputation credits). The
record date is 14 June 2021 and the payment date is the 21
June 2021 for the final dividend.
Our people
I would like to thank my fellow Directors, the Chief Executive
and the management team for their exemplary contribution to
the Company.
On behalf of the Board, I want to acknowledge our 1,500+
employees who have gone above and beyond through this
year, especially in response to the enormous challenges
presented by COVID-19. Continuing to provide high quality
care for our residents through such challenging times,
recognising that our residents include some of New Zealand’s
highest needs patients, was exceptional and showed huge
levels of commitment. Thank you.
Outlook
The Board and management of Radius Care are firmly focused
on continuing our strong performance in FY2022 and remain
focused on our growth strategy. We will continue to ensure
our residents receive exceptional care and ensure day to
day operations are run efficiently and in line with contract
requirements. Where opportunities to expand the business
present themselves, they will be carefully assessed.
Radius Residential Care Limited
12
with Executive Chairman
Brien Cree
Q&A
What brought you into the industry?
I’ve long had a desire to be involved in an industry that adds
value. My path into aged care started when my mother had a
severe stroke and we immediately needed to find care for her.
The care homes we looked at left me thinking there was an
opportunity to offer something considerably better. My first
purchase was a 54 bed aged care facility, Heatherlea, that I
bought in 2003 and Radius still owns it.
And what were you doing before that?
I was involved in property in the 80s and early 90s in
Wellington. I then worked in business broking and specialised
in aged care. Pretty quickly I moved into owning aged care
facilities and it was when my mother became unwell that I
seriously looked at the clear opportunities to offer really good
care. The opportunity to start Radius came next and here I
can combine all my interests – property development and
management, care and interacting with the elderly.
2021 was a year like no other. What are your
standout memories?
A couple of things – the difficulty and stress in making
decisions without any knowledge of what the outcome of
COVID-19 was going to be. I took the decision to lock down our
facilities ahead of other operators. That created a media frenzy
that was a distraction. Looking back now it was clearly the right
thing to do but it was heavily challenged at the time. A week
later everyone else was doing what Radius had already done
and the Prime Minister announced New Zealand was going to
Lockdown Level 4.
Another thing that is still very clear in my mind is the
tremendous support we had from staff. Radius was declared
early on to be offering an Essential Service and that meant
some of the head office team were still coming in to work every
day. We’d have a call with the facilities at the start of every day,
decide the day’s priorities and then start working on them to
ensure our residents continued to receive superb levels of care
and our staff at all of our facilities were as well supported as
possible. I made videos for the staff to keep them in the loop
on what we were doing. The staff that run the facilities and the
staff at the Parnell head office are a fairly close knit team but it
brought us even closer together. I’m so proud of them and the
lengths they went to to uphold the Radius values and put the
residents first.
The NZX listing was also a significant milestone. Fortunately, it
came after the COVID-19 situation had been stabilised and we
had more line of sight as to what was happening and where
New Zealand was going. Listing on NZX is an experience that
happens to very few companies in New Zealand. It was a really
positive way to sign off 2020. While we’re a mature business
we’ve lifted to another level as we prepped for the listing. We’re
structured and ready to grow again.
And even with everything else that was going on we were
able to exercise an option for the new 4.3 ha site in Belfast,
Christchurch. We’re planning for a new integrated aged care
and retirement development with 70 Care Beds, 30 Care Suites
and 94 Units to be constructed.
Annual Report 2021
13
Are there any new areas of business or
extensions of current services that are
appealing?
I’ve been running Radius for 17 years and I know we lead the
sector in new technologies and new processes. Over the next
10 years I think we’ll see Radius being clearly recognised as
the leading aged care provider in New Zealand and setting
the standard by which the industry is judged. Having said that,
we are developing a good model in care suites and boutique
village developments and that’s where we’re going to continue
to operate. Our competitive advantage is in the combination
of care and bricks and mortar. It’s just a matter of finding
appropriate sites. The ideal is a site of 4 to 5 hectares or
more. That gives us enough land to build a large care facility
and boutique village development. The Belfast Christchurch
property will be the second of this model.
What trends are you seeing that might
influence uptake of Radius Care beds?
Care is becoming more complex. Radius Care’s focus on care
has us at the forefront of new initiatives in an industry where
the barriers to entry are continuing to steadily grow. I see more
and more demand for our services, and we’ll be growing to
cater for that.
How do you think 2022 will look different to
an “average” year for Radius Care?
The recent announcement of the removal of DHBs will mean
the start of a simplification of our processes. We currently
work with all of the DHBs and there’s no consistency between
them in their purchasing of services. I think we’ll also see a
continuation of the increase in demand for our services. And
there’s a steady stream of expansion opportunities presenting
themselves. I’m very focussed on our strategic growth pathway
and hope to demonstrate strong progress this year.
What are some of the new technologies
you’ve seen recently that you might
introduce to benefit patients?
Where we decide to adopt new technologies, we’ll do it because
it frees up time for our staff to spend more time with residents.
As an example, we’ve introduced a check-in kiosk for visitors at
all of our sites. You enter your details, your temperature is taken
and you’re sent a QR code to use for the next time you go to
that facility. We’re the first aged care provider to introduce this
system. It makes for an easy and pleasant check-in experience
that doesn’t require staff support.
What’s different about your role as Executive
Chairman from Chief Executive?
As Chairman I look after the strategic direction and long term
growth of the business. Stuart, as CEO, looks after the day to
day operations of Radius Care. We’re a strong team and this
builds on the strengths we each bring to the business.
If you weren’t Chair of Radius Care, what
would you be doing?
I’d be running an aged care business with development
opportunities. I love it and know a lot about it so why would I
do anything else? Keeping on top of making sure our residents
and staff were safe from COVID-19 and listing Radius on NZX
was a major focus in the 2021 financial year. Strategic progress
is a high priority for me alongside indulging in my passion for
fishing, surfing and boating.
Radius Residential Care Limited
14
Chief
Executive’s Report
The 12 months to 31 March 2021 proved to be an incredibly
challenging year. While the NZX listing of Radius Care was a
project that required considerable input from the executive
team, it did not shift the priority that we place on care for our
residents. Their wellbeing is our complete focus 24 hours a day
7 days a week.
COVID-19
Ensuring our facilities run smoothly and safely is always our
top priority and highest commitment. The safety aspect of
that commitment took on an added dimension of importance
during the Government-mandated lockdowns of the past 12
months. Before I rejoined Radius Care in June, the aged care
Stuart Bilbrough
This is the first Radius Care annual report as a listed company and my first annual report as
the Radius Care Chief Executive. I was the company’s Chief Financial Officer from 2010 until
2017 and rejoined in June 2020 as Chief Executive, giving me responsibility for the Company’s
day to day activities. I know the company well and am delighted to be able to guide its journey
on your behalf.
Annual Report 2021
15
industry, all of New Zealand and the whole world was taking
action to combat the COVID-19 pandemic. As Brien highlighted
in his report, it was all hands to the pump and must have been
a crazy time which would successfully result in no cases of
COVID-19 in our facilities.
On Tuesday 17 March 2020, a few days prior to New Zealand
going to Alert Level 4, all of Radius Care’s facilities moved to
“restricted access” mode due to the risk Covid-19 posed to
older adults. This limited visits from anyone who was not a staff
member or resident. As the first aged care provider to restrict
access to their facilities, this initially caused concerns however
with our peers following suit within a day or two, it quickly
became standard across the industry in New Zealand.
It was all hands to
the pump and it must
have been a crazy
time which would
successfully result in no
cases of COVID-19 in our
facilities.
Our aged care operations were deemed to be an essential
service. That enabled management to continue to come to
work at our Auckland-based office to provide support to our
staff working at our facilities. Our operating procedures quickly
moved to daily calls between the executive office and all of our
facilities across New Zealand, rapid responses to the variety
of issues that arose and underpinned by a strong combined
sense of “we’re going to get through this”. The Radius Care
team worked as one and without external support, as we
navigated a rapidly changing environment.
Financial performance
We are pleased to have delivered a strong first result with:
• Underlying EBITDA of $23.4 million, in line with our
guidance of $23.0 million to $23.8 million;
• Pre-NZ IFRS Underlying EBITDA of $10.5 million in line
with our guidance of $10.2 million to $11.0 million; and
• AFFO of $3.7 million, slightly ahead of our guidance of
$2.9 million to $3.5 million
A Financial Report has been included at pages 27 to 73 of this
report and provides an analysis of the financial performance
for the 12 months to 31 March 2021.
At 31 March 2021, Radius Care had net interest bearing bank
debt of $24.5 million, down $0.3 million from $24.8 million as
at 30 November 2020.
Funding mix and occupancy
Radius Care’s revenues have a high proportion of Government
funding. In recent years we have been increasing the
proportion of revenues derived from non-Government
sources, most notably through a material increase in direct
private payments from a combination of accommodation
supplements, and retirement village revenues.
Direct private revenue
Indirect private revenue
Government funded revenue
11.0
%
8.1
%
25.2
%
26.1
%
63.8
%
65.8
%
Radius Care revenue composition over time
Aged care bed monthly average occupancy as at 31 March
2021 was 93.4%, the highest level we have seen at Radius Care.
This was up from 92.7% as at 30 September 2020 and 90.6%
in May 2020. Several of our facilities operated at close to 100%
for a number of months during the year.
Radius Residential Care Limited
16
We manage our bed mix in order to be able to quickly redeploy
beds as specific situations arise that require a shift. Around
710 or 41% of our beds are swing Care Beds which are
available for either rest home or hospital level care depending
on resident needs. This is 22% or 128 beds up on last year but
is indicative of where this is likely to continue to sit in future
years.
For the financial year 2021 2020
Number of Care Beds (period end) 1,715 1,704
Average Care Bed occupancy 92.4% 90.0%
For the 12 months to 31 March 2021 some 11 additional
beds were added to the pool that Radius Care operates. Our
bed portfolio is heavily oriented to the provision of aged care
to the high acuity and specialist care segments. The overall
proportion of high acuity and specialist care beds is 86% of
our overall beds. These types of bed typically generate higher
margins across the industry. This reflects our long term
expectation for the proportion of beds in this segment.
SwingDementiaPhysical and intellectual
Rest HomeHospitalPsychogeriatric
Radius Care operates a significant number of swing
Care Beds which are able to provide rest home or
hospital level care depending on resident needs
14.4
%
26.5
%
32.8
%
49.6
%
10.8
%
11.1
%
5.7
%
0.5
%
5.8
%
1.0
%
41.4
%
Our people
Our day to day operations are heavily reliant on our ability to
continue to attract and retain suitably skilled and experienced
people. Once employed by us, we want to support our staff
to ensure they’re able to offer their very best every day. It’s
important that Radius Care consistently delivers high-quality
service to our residents so it’s also important that an enjoyable
and stimulating work environment is offered to our staff.
Staff retention and turnover improved significantly over 2020.
Our staff turnover rate for the FY21 year for staff working in
our facilities was 32% and has averaged 37% over the past
three years.
Radius Care is an NZ Immigration accredited employer. This
would normally significantly increase the speed with which
staff can be brought on board. Closed borders meant we were
unable to rely on immigrant nurses whereas over the last three
years, around one third of new Radius Care registered nurses
have come through the NZ Immigration pathway. We have
pushed for changes to the immigration arrangements for our
nurses’ families and were delighted to see the Government
recently announce changes to allow the families’ immigration
arrangements to be fast tracked.
Chief Executive’s Report continued
Radius Care (monthly)
Industry average (quarterly)
Jun 19
95%
94%
93%
92%
91%
90%
89%
88%
87%
86%
85%
Sep 19Dec 19Mar 20Jun 20Sep 20Dec 20Mar 21
Occupancy Rates
Occupancy Rate
Annual Report 2021
17
Retirement village sales
Our retirement village business is currently based around villa
style units rather than an apartment products.
Financial period FY20 FY21
Number of Units (period end) 73 76
Number of new Unit sales 8 6
Number of existing Unit resales - 7
Development activity and building
programme
Radius Care operates a nationwide portfolio of aged care
facilities with a focus on both key urban and regional centres. It
also owns and operates two retirement villages, both of which
are co-located with Radius Care aged care facilities, providing a
continuum of care to residents.
Our overall approach to development is to continue to
predominantly look to care facilities as being the anchor of our
business.
As at 31 March 2021 the average time to the next lease renewal
stood at 9.1 years with an average time to expiry of 27.7 years,
assuming all leases continue to be renewed.
Rent increases across the portfolio of leased facilities is based
on a mix of CPI increases and independently assessed market
rent reviews. Rents increased by an average of 4.9% during
FY2021.
Radius Care has a strong track record in undertaking Brownfield
and Greenfield developments. Brownfields is a development on
land that already includes operational aged care or retirement
villages. Greenfields is a development on land that does not
contain any operational aged care or retirement village facilities.
Development work will remain a core part of our growth
strategy.
Our most recent Greenfield development, Elloughton Grange
Village in Timaru, had just one villa unsold and three going
unconditional as at 31 March 2021 of the 54 in the village.
This is an outstanding success for a development for which
construction started in October 2014.
Over the next three years, Radius Care intends to undertake:
• two Brownfield Developments on owned facilities, totalling
approximately 64 Care Beds/Care Suites in aggregate;
• three Brownfield Developments on leased facilities,
totalling approximately 60 Care Beds/Care Suites and 20
Units in aggregate;
• two Greenfield Developments, totalling approximately 200
Care Beds/Care Suites and 200 Units in aggregate. The
Belfast, Christchurch facility (outlined in more detail below)
will be the first of these developments.
In line with this strategy and just after balance date we
announced that Radius Care had exercised its right to acquire
some 4.3 hectares of development land in Belfast, Christchurch
for a Greenfield Development. Resource consent has been
issued by Christchurch City Council for a new integrated aged
care and retirement village facility totalling 70 care beds, 30
care suites and 94 retirement village units to be constructed on
the property.
Settlement of the land is expected to take place in early 2022.
We are currently progressing the final facility design, obtaining
building consents and commencing construction contracting
discussions in relation to this development.
While the retirement village offering is a core part of our growth
strategy, we remain committed to being a predominantly aged
care provider and will not undertake village-only Greenfield
developments. We have a minimum age requirement for
entering our retirement village facilities of 70 years. The average
resident age as at 31 March 2021 was 80.4 years.
Radius Residential Care Limited
18
Stuart Bilbrough
Chief Executive
Outlook
The 2022 financial year has started well for us. We have seen a
continuation of the high occupancy levels experienced through
the last half of the 2021 year.
Industry dynamics are supportive of Radius Care’s overall
business performance in the medium and longer term seeing
continuing growth. Demand for Care Beds, particularly at high
acuity and specialist care levels, is expected to remain strong
as supported by EY’s Aged Residential Care Funding Model
Review undertaken in September 2019.
Radius Care’s operations and portfolio are heavily oriented
to the high acuity and specialist care segments of the aged
care industry. Government spending has historically been a
very significant contributor to Radius Care’s revenue however
private funding is an increasingly important driver of growth in
overall revenue. This provides a clear demand-driven growth
pathway alongside which Radius will continue to expand its
care bed and village offering and deliver compassionate and
outstanding clinical care outcomes.
At the time Radius Care listed on NZX it provided guidance
in relation to three key financial metrics. It has chosen to
again provide guidance in relation to the FY22 year for these
measures. Radius Care does not commit to providing guidance
for future financial periods.
Guidance for the 12 months to 31 March 2022:
• Underlying EBITDA of $23.5m to $25.5m;
• Pre-NZ IFRS 16 Underlying EBITDA of $10.5m to $12.5m;
and
• AFFO of $3.7m to $4.7m.
An update on the 2022 year will be given at the Annual
Meeting.
Chief Executive’s Report continued
Annual Report 2021
19
Annual Report 2021
19
Case Studies
Radius Residential Care Limited
20
Innovative IT
Radius Care’s custom-built self-check in kiosk.
COVID-19’s arrival in New Zealand saw Radius Care take an industry leading
response in quickly installing practical restrictions to visitors to ensure residents
were kept protected from the virus. A new self-check in kiosk was developed,
custom-built for us to keep our facilities safe, secure and protected from
COVID-19 and other transmissible viruses. The kiosk became affectionately
known as Florence.
Prompted by the additional restrictions on visitation during the COVID-19
pandemic, the kiosk combines the visitor’s health and safety register with a
health questionnaire and temperature check.
When a visitor enters the Radius Care facility they will:
• See a tablet on a pedestal to check in
• Enter standard details about the visit such as their name and who they are
visiting
• Fill out a COVID-19 health questionnaire
• Place their fist, palm down, under the temperature scanner to be
accurately temperature checked.
The software will give the green light for ‘safe visitors’ to enter. However, if their
temperature is elevated or answers to health questions spark an issue, the
screen will refer them to the receptionist. This allows Radius Care staff to get
more detailed information and make an informed decision around visitation.
Pilot tested at Radius St Joans, visitors can pre-register online ahead of time to
receive a QR code. When they arrive, perhaps during a short lunch break, they
simply scan the QR code and undertake a quick temperature check before
proceeding.
Units will be installed throughout Radius Care facilities by the end of 2021.
Looking ahead, the health questionnaire is adaptable to any COVID-strand,
dangerous flu variant, or transmissible virus that New Zealand encounters.
The kiosks will greatly reduce paperwork which is currently required to be
collected and stored for 10 years. A larger facility could receive up to 100 visitors
a day, who would each need to complete two forms. The cumulative impact is
an immense amount of paperwork.
Problem
The immense amount
of paperwork to keep
facilities safe, secure
and protected from
COVID-19 and other
transmissable viruses.
Solution
Radius Care’s
custom-built self-check
in kiosk to combine
visitor’s health and
safety register with a
health questionnaire
and temperature check.
Result
Units will be installed
throughout Radius Care
facilities by the end of
2021.
The kiosk prototype being tested at
Radius St Joans in Hamilton.
Annual Report 2021
21
Vaccine Education
Radius Care’s proactive approach.
The Pfizer/BioNTech vaccine is the best way to protect residents
and staff from the most severe symptoms of COVID-19. It
allows facilities nationwide to reduce their exposure risk as the
borders begin to open.
Our Head of Infection Control, Corrie Bronkhurst, was confident
that much like the annual flu vaccination campaign, Radius
Care would manage the COVID-19 vaccination rollout
effectively.
However, rumours swirled when the Pfizer/BioNTech vaccine
first reached New Zealand shores, and there was a risk that
low uptake – especially amongst our staff or residents – would
leave the people we care for vulnerable to the virus.
Radius Care took a proactive approach, undertaking a
comprehensive internal communications plan which
included posters, videos, and brochures with essential, factual
information for staff to understand the vaccination ahead of
being offered it. Staff continue act as trusted influencers to
those around them.
Facilities work closely with DHBs to book in vaccination dates,
and on the day, facilities distribute stickers to vaccinated
staff and residents to highlight an individual’s contribution to
protecting the Radius community.
The uptake amongst both staff and residents is high, with
many facilities reporting around 90% uptake of the vaccine. By
taking a one team approach to encourage all of the Radius
Community to take the vaccine – staff, residents, family and
friends – we aim to provide the safest care for residents.
Problem
The misinformation
and rumours regarding
the safety of the Pfizer/
BioNTech vaccine.
Solution
Create an internal
communication
program filled with
factual information
to inform residents
and staff before the
vaccination is offered.
Result
High vaccination
uptake of residents
and staff.
Elloughton Gardens staff in Timaru received their
second vaccination in May 2021
Radius Residential Care Limited
22
Caring is
our calling
Commitment, courage and compassion are the
three values that all Radius Care staff live each
day. We’re committed to providing the best
possible care; have the courage to advocate for our
residents; and knowing that compassion is the most
important part of our role.
The fact that over 140 staff members have worked at Radius Care
for over 10 years is testimony to a supportive and challenging work
environment. This support includes regular in-house training and
ongoing skills development which ensures our staff are updated
on the latest health care practices and feel confident in their role.
Examples of this are:
Radius Care employs more than 1500 people,
and all our staff – Management, Nurses,
Health Care Assistants, Cleaners, Cooks – are
highly qualified and committed to providing
the best in aged care. Neethu Roji and Nofo
Nauma are examples of staff who were
supported in their career progression by
management.
A talented Registered Nurse originally
from India, Neethu has through sheer
determination and hard work progressed
from a Health Care Assistant to Facility
Manager at Radius St Helenas – in less
than five years! Neethu is very passionate
about looking after people, both staff and
the residents, and is proud to be part of
the excellent team at the 52-bed facility in
Christchurch.
Neethu Roji
Facility Manager
After being encouraged by her manager at
Radius Fulton in Dunedin, Nofo enrolled at
New Zealand Tertiary College to complete
the New Zealand Certificate in Health
and Wellbeing to further progress her
career. Nofo says that: “It’s so rewarding
contributing to a team; bringing out the
best in myself and my colleagues to fulfil
our goals and see positive results in the
healthcare setting.”
Nofa Mauma
Health Care Assistant
Pure Wellness
The once a year wellbeing month sees facilities across the
country offering complimentary wellness initiatives including
physio appointments, pilates and Zumba classes, steps
challenge and a healthy soup available all day for staff.
Rhythm of Leadership
The nine-month programme for Clinical Managers, Facility
Managers and Support Office staff provides everyone with the
opportunity to be the best version of themselves.
Value Cards
Staff who show great examples of value-led work are rewarded
with presents such as special tokens, prezzie cards or a coffee
vouchers, to value and recognise staff effort throughout the year.
Cap Course
Radius Care regularly assists healthcare assistants to have
overseas qualifications officially recognised in New Zealand.
NZQA Level 2 & 3
Radius Care also offers financial and practical assistance
for all cleaning staff towards obtaining the NZQA Level 2 & 3
qualification. This not only helps their career but improves their
pride in what they do.
Annual Report 2021
23
Board of Directors
Directors and
Senior Management
Radius Care’s Directors
and Senior Management
Brien Cree
Executive Chairman and
Managing Director
Brien Cree is the founding shareholder
of Radius Care and has been Managing
Director from the company’s inception
in 2003. Brien has built the Radius
Care’s property portfolio from nothing
to its current 22 aged care facilities and
two retirement villages. As Executive
Chairman and Managing Director, Brien
is focused on the formulation and
execution of Radius Care’s strategic
growth objectives.
Brien has more than 30 years’
experience in the aged care sector. He
is a board member of the NZACA and
past board member of the Retirement
Villages Association.
Duncan Cook
Non-Executive Director
LLB
Duncan Cook has been a director
of Radius Care since 2010, and
worked with Radius Care’s founders
to establish, structure and grow
Radius Care’s business. Duncan is a
partner at Sharp Tudhope Lawyers
(Tauranga and Auckland) and has
over 30 years’ experience in practice.
His key areas of practice are mergers
and acquisitions, and turnaround and
restructuring. Duncan is a member of
the New Zealand Law Society, Institute
of Directors New Zealand (Inc) and
Restructuring Insolvency & Turnaround
Association New Zealand Incorporated.
Duncan has governance experience
across a range of industry sectors,
including fishing, exports and housing
construction. He has volunteered on
the boards of the Tauranga Chamber
of Commerce and agencies associated
with economic development in the
Tauranga region.
Board of Directors
Radius Care’s Board currently comprises:
Bret Jackson
Non-Executive Director
BCom (Honours),
MBA (Harvard Business School)
Bret Jackson has been a director of
Radius Care since 2014. Bret is an
experienced business professional
with over two decades of business
experience. Bret is a co-founder
of Knox Investment Partners (a
leading private equity manager)
and has been a Managing Director
of Knox Investment Partners since
2005 (focusing on deal origination,
strategy and value creation). Bret
has represented Knox Investment
Partners on the board of every
portfolio investment made by it and is
currently Chairman of AAM Group in
Australia. Bret is also a past President
of the Harvard Business School Alumni
Association of New Zealand. Previously
Bret held corporate roles at Mobil
Oil New Zealand, as a management
consultant at Boston Consulting Group
(Sydney and London) and has founded
and successfully operated his own
private businesses.
2. RADIUS CARE AND WHAT IT DOES
44 NZX LISTING PROFILE | RADIUS RESIDENTIAL CARE LIMITED
Brien Cree is the founding shareholder of Radius Care
and has been Managing Director from the company’s
inception in 2003. Brien has built the Radius Care’s
property portfolio from nothing to its current 22 aged
care facilities and two retirement villages. As Executive
Chairman and Managing Director, Brien is focused on
the formulation and execution of Radius Care’s strategic
growth objectives.
Brien has more than 30 years’ experience in the aged
care sector. He is a board member of the NZACA and past
board member of the Retirement Villages Association.
Duncan Cook has been a director of Radius Care since 2010,
and worked with Radius Care’s founders to establish, structure
and grow Radius Care’s business. Duncan is a partner at Sharp
Tudhope Lawyers (Tauranga and Auckland) and has over 30 years’
experience in practice.
His key areas of practice are mergers and acquisitions, and
turnaround and restructuring. Duncan is a member of the New
Zealand Law Society, Institute of Directors New Zealand (Inc) and
Restructuring Insolvency & Turnaround Association New Zealand
Incorporated.
Duncan has governance experience across a range of industry
sectors, including fishing, exports and housing construction.
He has volunteered on the boards of the Tauranga Chamber of
Commerce and agencies associated with economic development in
the Tauranga region.
Radius Care’s Directors
and Senior Management
Brien Cree
Executive Chairman and
Managing Director
Brien Cree is the founding shareholder
of Radius Care and has been Managing
Director from the company’s inception
in 2003. Brien has built the Radius
Care’s property portfolio from nothing
to its current 22 aged care facilities and
two retirement villages. As Executive
Chairman and Managing Director, Brien
is focused on the formulation and
execution of Radius Care’s strategic
growth objectives.
Brien has more than 30 years’
experience in the aged care sector. He
is a board member of the NZACA and
past board member of the Retirement
Villages Association.
Duncan Cook
Non-Executive Director
LLB
Duncan Cook has been a director
of Radius Care since 2010, and
worked with Radius Care’s founders
to establish, structure and grow
Radius Care’s business. Duncan is a
partner at Sharp Tudhope Lawyers
(Tauranga and Auckland) and has
over 30 years’ experience in practice.
His key areas of practice are mergers
and acquisitions, and turnaround and
restructuring. Duncan is a member of
the New Zealand Law Society, Institute
of Directors New Zealand (Inc) and
Restructuring Insolvency & Turnaround
Association New Zealand Incorporated.
Duncan has governance experience
across a range of industry sectors,
including fishing, exports and housing
construction. He has volunteered on
the boards of the Tauranga Chamber
of Commerce and agencies associated
with economic development in the
Tauranga region.
Board of Directors
Radius Care’s Board currently comprises:
Bret Jackson
Non-Executive Director
BCom (Honours),
MBA (Harvard Business School)
Bret Jackson has been a director of
Radius Care since 2014. Bret is an
experienced business professional
with over two decades of business
experience. Bret is a co-founder
of Knox Investment Partners (a
leading private equity manager)
and has been a Managing Director
of Knox Investment Partners since
2005 (focusing on deal origination,
strategy and value creation). Bret
has represented Knox Investment
Partners on the board of every
portfolio investment made by it and is
currently Chairman of AAM Group in
Australia. Bret is also a past President
of the Harvard Business School Alumni
Association of New Zealand. Previously
Bret held corporate roles at Mobil
Oil New Zealand, as a management
consultant at Boston Consulting Group
(Sydney and London) and has founded
and successfully operated his own
private businesses.
2. RADIUS CARE AND WHAT IT DOES
44 NZX LISTING PROFILE | RADIUS RESIDENTIAL CARE LIMITED
Brien CreeDuncan Cook
Executive
Chairman and
Managing Director
Non Executive Director
LLB
Radius Residential Care Limited
24
Directors continued
Bret Jackson has been a director of Radius Care since 2014.
Bret is an experienced business professional with over two
decades of business experience. Bret is a co-founder of Knox
Investment Partners (a leading private equity manager) and
has been a Managing Director of Knox Investment Partners
since 2005 (focusing on deal origination, strategy and value
creation). Bret has represented Knox Investment Partners
on the board of every portfolio investment made by it and
is currently Chairman of AAM Group in Australia. Bret is also
a past President of the Harvard Business School Alumni
Association of New Zealand.
Bret held corporate roles at Mobil Oil New Zealand, as a
management consultant at Boston Consulting Group (Sydney
and London) and has founded and successfully operated his
own private businesses.
Mary Gardiner was appointed as an independent director
of Radius Care in December 2020. She is an Independent
Director and Chair of the Audit and Risk Committee of
Southern Cross Pet Insurance, Chair of Netball Northern
Zone and trustee of Mangere Mountain Education Trust, an
Auckland Council controlled organisation.
Mary has previously been Chair of Auckland Netball Centre
and Badminton NZ. Her commercial experience includes roles
as Chief Financial Officer of Instant Finance and Radius Health
Group, and Governance Risk Manager at Air New Zealand,
following a career focused primarily in financial services with
KPMG in New Zealand, Germany and Australia.
Mary is a Chartered member of the Institute of Directors,
Fellow of Governance New Zealand and is a New Zealand
Fellow Chartered Accountant.
Tim Sumner has been a director of Radius Care since 2014.
Tim is a New Zealand Chartered Accountant and finance
professional with over two decades of financial services
experience. He started his career with KPMG (Auckland and
Moscow) and then moved into banking and private equity
with Credit Suisse (London and New York). Tim is a co-founder
of Knox Investment Partners and has worked as a Managing
Director of Knox Investment Partners since 2005, focusing on
deal structuring and execution and fund administration.
Hamish Stevens was appointed as an Independent Director of
Radius Care in December 2020. Hamish is an Auckland based
independent director having held directorships in both the
listed and private company sectors since 2010. Hamish is also
currently Chair of Evolve Education Group, East Health Services
and Pharmaco and a director of Marsden Maritime Holdings,
Northport, Pacific Radiology Group and Counties Power. Prior
to his governance career Hamish held senior finance positions
with Heinz Wattie, Tip Top Ice Cream and DB Breweries.
Hamish is a qualified chartered accountant and a chartered
fellow of the Institute of Directors.
Bret Jackson
Mary Gardiner
Timothy Sumner
Hamish Stevens
Non-Executive Director
BCom (Honours), MBA
(Harvard Business School)
Independent Director
BCom, FCA, FCIS, CMInstD
Non-Executive Director
BCom, DipGrad, CA
Independent Director
MCom (Honours), MBA,
CA, CFInstD
Annual Report 2021
25
Senior Management
Radius Care’s senior management team currently comprises:
Stuart Bilbrough was appointed Chief Executive Officer
of Radius Care in June 2020, following successful roles
in the healthcare industry. He was Chief Financial Officer
at Radius Care from 2010 to 2017. Stuart has over 30
years’ experience in finance roles in industries including
healthcare, fast moving consumer goods (FMCG), logistics,
telecommunications and financial services. Notable companies
include PricewaterhouseCoopers, Fonterra, Deutsche Bank
and American Express. Stuart is a New Zealand Chartered
Accountant and holds an MBA with distinction from Massey
University. Stuart is a board member of the New Zealand
Underwater Association Inc.
Steven Heesen joined Radius Care in 2007 and heads up the
Radius Care commercial services team.
He has over 20 years’ experience in hospitality management
and over 16 years’ experience in the aged care sector.
His disciplines include all property matters, procurement,
marketing, hospitality and information services. Steven was
trained in Europe and has a business management degree.
Jane Smart was appointed Chief Operations Officer of Radius
Care in February 2011. She has over 30 years’ experience
in healthcare and extensive experience in the aged care
sector. Jane has spent most of her career in leadership and
management positions.
Michelle Slabber joined Radius Care in 2016.
Michelle has nearly 25 years’ experience in finance roles in
various industries including healthcare and financial services.
Michelle trained with PricewaterhouseCoopers in South Africa
and is a New Zealand Chartered Accountant.
Stuart Bilbrough
Steven Heesen
Jane Smart
Michelle Slabber
Chief Executive
Officer
BCom, MBA
(Distinction), CA
General Manager,
Commercial Services
Bachelor of International
Hospitality & Hotel
Management (Hons)
Chief Operations Officer
BSc Physiotherapy,
Dip.Business Administration,
MBS
General Manager, Finance
BCom (Hons), CA
Radius Residential Care Limited
26
Senior Management continued
Margaret Paramore joined Radius Care as General Manager
of People and Culture early 2021. Margaret has 25 years’
experience in a variety of industries including sales, marketing,
market research, and learning and development. She has
worked in a number of different industries such as fast moving
consumer goods (FMCG), over the counter medicines (OTC),
pharmaceuticals, and primary care. Notable companies
include GlaxoSmithKline, Roche, Smith and Nephew and
Nielsen. Margaret has worked extensively abroad in the United
Kingdom, Ireland and Europe and has recently returned home
to New Zealand.
Gared Thomas completed a Bachelor of Business, majoring
in Management at AUT in 2010. Gared joined Radius Care in
2019 and is responsible for all Radius property development
across New Zealand. Gared has over 20 years of construction
experience in various disciplines, including starting and
growing a successful weather tightness business which he sold
in 2015. He is passionate about delivering our village and care
home residents with high-quality, well designed, and enjoyable
spaces to live.
Sam Carey completed a Bachelor of Business, majoring in
Marketing and International Business at AUT in 2008. He
subsequently travelled through Europe and North America
looking to test his trade. In 2011 Sam was employed to start up
in-house marketing at Radius. He now oversees the national
brand strategy, regional campaigns and PR. Since 2015
Sam was an integral part of developing the newest revenue
generator for the company, the Radius Online Shop – www.
radiusshop.co.nz. Outside of work Sam loves all things sports
and is an avid competitor in Squash and Golf. He is a current
member of the Remuera Rackets Club Board Committee.
Margaret
Paramore
Gared Thomas
Sam Carey
General Manager,
People and Culture
Bachelor of Science;
Postgraduate Diploma in Marketing
General Manager,
Village and
Development
Bachelor of Business
General Manager,
Marketing and Retail
Bachelor of Business
Consolidated Statement of Comprehensive Income 28
Consolidated Statement of Changes in Equity 29
Consolidated Statement of Financial Position 30
Consolidated Statement of Cash Flows 31
Notes to the Consolidated Financial Statements 34
Independent Auditor's Report 67
Financial
Statements
Contents
Annual Report 2021
27
Radius Residential Care Limited
28
2021 2020
Note $’000 $’000
Revenue
Revenue from contracts with customers 2.2 121,217 113,359
Deferred management fees 2.2 1,081 671
Total revenue 122,298 114,030
Fair value movement of investment properties 3.1 2,879 (649)
Government subsidy received 794 353
Interest income 71 49
Total revenue and other income 126,042 113,783
Expenses
Employee costs (74,457) (70,852)
Depreciation expense 2.3 (11,552) (10,911)
Finance costs 2.3 (9,706) (10,583)
Other expenses 2.3 (28,298) (24,770)
Total expenses (124,013) (117,116)
Profit/(loss) before income tax 2,029 (3,333)
Income tax (expense)/ benefit 5.1 (324) 500
Profit /(loss) for the year 1,705 (2,833)
Other comprehensive income
Items that will not be reclassified subsequently to profit and loss
Revaluation of property, plant and equipment, net of tax 3.2 1,104 5,708
Other comprehensive income for the year 1,104 5,708
Total comprehensive income 2,809 2,875
Earnings per share
Basic and diluted earnings per share (cents per share) 4.2 0.97 (22.66)
The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.
Statement of
Comprehensive Income
CONSOLIDATED
For the year ended 31 March 2021
Annual Report 2021
29
Asset
Contributed Revaluation Retained Total
Equity Reserve Earnings Equity
Note $’000 $’000 $’000 $’000
Balance as at 1 April 2019 4,736 - 13,434 18,170
Loss for the year - - (2,833) (2,833)
Other comprehensive income for the year 3.2 - 5,708 - 5,708
Total comprehensive income for the year - 5,708 (2,833) 2,875
Transactions with owners:
Dividends paid 4.1 - - (225) (225)
Total transactions with owners - - (225) (225)
Balance as at 31 March 2020 4,736 5,708 10,376 20,820
Balance as at 1 April 2020 4,736 5,708 10,376 20,820
Profit for the year - - 1,705 1,705
Other comprehensive income for the year 3.2 - 1,104 - 1,104
Total comprehensive income for the year - 1,104 1,705 2,809
Transactions with owners:
Share issue 4.1 1,196 - - 1,196
Dividends paid 4.1 - - (732) (732)
Total transactions with owners 1,196 - (732) 464
Balance as at 31 March 2021 5,932 6,812 11,349 24,093
The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.
Statement of
Changes in Equity
CONSOLIDATED
For the year ended 31 March 2021
Radius Residential Care Limited
30
2021 2020
Note $’000 $’000
Assets
Cash and cash equivalents 2,761 2,317
Trade and other receivables 5.3 7,744 7,648
Inventories 548 308
Property, plant and equipment 3.2 32,896 32,303
Right-of-use assets 3.4 177,170 181,431
Investment properties 3.1 31,675 27,831
Deferred tax assets 5.1 3,635 2,006
Intangible assets 5.2 16,996 16,996
Total assets 273,425 270,840
Liabilities
Trade and other payables 5.4 14,911 14,086
Current tax liabilities 1,135 723
Borrowings 4.3 27,212 31,427
Deferred management fee 3.3 1,178 962
Refundable occupation right agreements 3.3 20,591 17,518
Lease liabilities 3.4 184,305 185,304
Total liabilities 249,332 250,020
Net assets 24,093 20,820
Equity
Share capital 4.1 5,932 4,736
Asset revaluation reserve 4.1 6,812 5,708
Retained earnings 11,349 10,376
Total equity 24,093 20,820
The Board of Directors of the Company authorised these consolidated financial statements for issue on 25 May 2021.
For and on behalf of the Board
Brien Cree - Chair, Board of Directors Hamish Stevens - Chair, Audit and Risk Committee
The above Consolidated Statement of Financial Position should be read in conjunction with the accompanying notes.
Statement of
Financial Position
CONSOLIDATED
As at 31 March 2021
Annual Report 2021
31
2021 2020
$’000 $’000
Cash flows from operating activities
Receipts from residents for care fees and village fees 122,337 113,282
Receipts of government subsidy 1,210 -
Payments to suppliers and employees (101,724) (95,436)
Proceeds from the sale of Refundable occupation right agreements 3,927 3,705
Payments for the repurchase of Refundable occupation right agreements (464) -
Interest received 71 49
Interest paid - borrowings (883) (1,183)
Interest paid - lease liabilities (8,823) (9,400)
Income tax paid (1,744) (814)
Net cash provided by operating activities 13,907 10,203
Cash flows from investing activities
Proceeds from the sale of property, plant and equipment 54 114
Payments for the purchase of plant and equipment (3,577) (11,305)
Payments for village developments (965) (3,723)
Net cash used in investing activities (4,488) (14,914)
Cash flows from financing activities
Proceeds from bank borrowings - 15,120
Repayment of bank borrowings (4,215) (4,038)
Repayment of shareholder loans - (5,030)
Principal repayment of lease liabilities (4,028) (3,035)
Dividends paid (732) (225)
Net cash (used in)/provided by financing activities (8,975) 2,792
Reconciliation of cash and cash equivalents
Cash and cash equivalents at beginning of the year 2,317 4,236
Net increase/(decrease) in cash held 444 (1,919)
Cash and cash equivalents at end of year 2,761 2,317
The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.
Statement of
Cash Flows
CONSOLIDATED
For the year ended 31 March 2021
Radius Residential Care Limited
32
2021 2020
$’000 $’000
Reconciliation of profit/(loss) for the year to net cash provided by operating activities
Profit/(loss) for the year 1,705 (2,833)
Adjustments for non-cash items
Depreciation 11,552 10,911
Share based payments 1,196 -
Net (gain)/loss on disposal of property, plant and equipment (26) 91
Fair value adjustment to investment properties (2,879) 649
Fair value adjustment to financial instruments - (42)
Movement in deferred tax (1,831) (1,533)
Changes in operating assets and liabilities
- Trade and other receivables and other assets (79) (465)
- Inventories (240) (140)
- Trade and other payables and other liabilities 798 482
- Current tax liabilities 412 220
- Refundable occupation rights agreements 3,299 2,863
Net cash provided by operating activities 13,907 10,203
The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.
Statement of
Cash Flows
continued
CONSOLIDATED
For the year ended 31 March 2021
Annual Report 2021
33
Reconciliation of liabilities arising from financing activities
Liabilities arising from financing activities are liabilities for which cash flows are, or will be, classified as ‘cash flows from financing
activities’ in the statement of cash flows. Changes in the carrying amount of such liabilities, which comprise bank borrowings and lease
liabilities, are summarised below.
Lease
Borrowings Liabilities Total
$’000 $’000 $’000
Balance as at 1 April 2020 31,427 185,304 216,731
- Repayment of bank borrowings and lease liabilities (4,215) (4,028) (8,243)
Total changes from financing cash flows (4,215) (4,028) (8,243)
Non-cash changes
- Remeasurements - 3,029 3,029
Balance as at 31 March 2021 27,212 184,305 211,517
Balance as at 1 April 2019 25,375 191,903 217,278
- Proceeds from bank borrowings 15,120 - 15,120
- Repayment of bank borrowings and lease liabilities (9,068) (3,035) (12,103)
Total changes from financing cash flows 6,052 (3,035) 3,017
Non-cash changes
- Remeasurements - (3,564) (3,564)
Balance as at 31 March 2020 31,427 185,304 216,731
The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.
Statement of
Cash Flows
continued
CONSOLIDATED
For the year ended 31 March 2021
Radius Residential Care Limited
34
For the year ended 31 March 2021
Notes to the Consolidated
Financial Statements
1. General Information
1.1 Basis of Preparation
(i) Reporting Entity
The consolidated financial statements are for Radius Residential Care Limited (‘the Company’) and its subsidiaries (together ‘the
Group’).
The Group provides rest home and hospital care of the elderly along with development and operation of integrated retirement villages
in New Zealand.
(ii) Statutory Basis and Statement of Compliance
Radius Residential Care Limited is a limited liability company, incorporated and domiciled in New Zealand. It is registered under the
Companies Act 1993 and is a FMC Reporting Entity in terms of Part 7 of the Financial Markets Conduct Act 2013. The Company is listed
on the NZX Main Board (“NZX”). The consolidated financial statements have been prepared in accordance with the requirements of the
NZX, and Part 7 of the Financial Markets Conduct Act 2013.
These consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Practice in New
Zealand (‘NZ GAAP’), except for Note 2.1: Non-GAAP Underlying Net Profit after tax (“Underlying Profit”) and Non-GAAP AFFO
(“Available Funds from Operations”), which is presented in addition to NZ GAAP compliant information. They comply with New Zealand
equivalents to International Financial Reporting Standards (‘NZ IFRS’), International Financial Reporting Standards (‘IFRS’) and other
applicable New Zealand Financial Reporting Standards, as appropriate for for-profit entities. The Group is a Tier 1 for-profit entity in
accordance with XRB A1 Application of the Accounting Standards Framework.
The consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of normal
business activities and the realisation of assets and the settlement of liabilities in the ordinary course of business.
The balance sheet for the Group is presented on the liquidity basis where the assets and liabilities are presented in the order of their
liquidity.
(iii) Functional and Presentation Currency
The consolidated financial statements are presented in New Zealand dollars which is the Group’s functional currency. All amounts
have been rounded to the nearest thousand, unless otherwise indicated.
(iv) Measurement Basis
These consolidated financial statements have been prepared under the historical cost convention, with the exception of investment
properties (note 3.1) and land and buildings included within property, plant and equipment (note 3.2).
(v) Key Estimates and Judgements
The Board of Directors and Management are required to make judgements, estimates and assumptions in applying the accounting
policies. The estimates and associated assumptions are based on experience and other factors that are believed to be reasonable
under the circumstances, the results of which form the basis of making the judgements. Actual results may differ from the estimates,
judgements and assumptions made by the Board of Directors and Management.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the
period in which the estimate is revised and in any future periods affected.
Annual Report 2021
35
The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the
consolidated financial statements are described in the following notes:
• Valuation of investment properties (note 3.1)
• Valuation of land and buildings (note 3.2)
• Lease extension and termination options & incremental borrowing rates (note 3.4)
• Impairment testing of goodwill (note 5.2)
• Impairment testing of right-of-use assets (note 3.4)
• Recognition of deferred tax (note 5.1)
In March 2020, the World Health Organization declared an ongoing global outbreak of a novel coronavirus (‘COVID-19’) as a pandemic.
In response, the New Zealand Government implemented a range of public health and economic measures to mitigate the impact
of the COVID-19 pandemic. Whilst the COVID-19 pandemic and measures implemented have lowered overall economic activity, the
Group’s earnings, cash flow and financial position have not been impacted since the outbreak began and up to the date of the signing
of these consolidated financial statements. The Directors have assessed the impact of COVID-19 on these judgements and estimates
and concluded that limited changes are necessary. This is primarily due to the Group being classified as a provider of essential
services.
It is not possible to estimate the impact of the COVID-19 pandemic’s short and long-term effects. As at the date of the signing of these
consolidated financial statements, all reasonably known and available information with respect to the COVID-19 pandemic, has been
taken into consideration and all reasonably determinable adjustments have been made in preparing these consolidated financial
statements.
(vi) Comparative Information
During the current year, Management has simplified the consolidated financial statements to provide more relevant information that
is easier to understand. Consequently, certain comparative information has been re-ordered, re-labelled; or where considered non-
essential or immaterial, has been removed.
In the 2020 consolidated financial statements:
• the Group presented segment reporting information, however, this was not in accordance with how operating results are
reported to the Groups’ chief operating decision maker, and was included for consistency with retirement village and aged care
listed peers in New Zealand; and
• cash flows from the sale and repurchase from refundable occupation right agreements are now included as part of cash flows
from operating activities instead of cash flows from investing activities.
(vii) New and Amended Accounting Standards and Interpretations
All mandatory new standards, amendments and interpretations to existing standards that came into effect during the current
accounting period have been adopted in the current year. None of these have had a material impact on the Group. The Group
has not early adopted any standards, amendments or interpretations to existing standards that are not yet effective. They are
not expected to have a material impact on the Group. There are a number of new standards and amendments to standards and
interpretations that are not yet effective for the year beginning 1 April 2021. None of these have been identified as having a material
effect on the Group’s consolidated financial statements in the future.
Radius Residential Care Limited
36
Notes to the Consolidated Financial Statements continued
(viii) Segment Reporting
An operating segment is a component of an entity that engages in business activities which earn revenue and incur expenses and
where the chief operating decision maker reviews the operating results on a regular basis and makes decisions on resource allocation.
The Group operates in one operating segment being the provision of aged care in New Zealand. The chief operating decision maker,
the Board of Directors, reviews the operating results on a regular basis and makes decisions on resource allocation based on the
review of Group results and cash flows as a whole. The nature of the services provided and the type and class of residents have similar
characteristics within the operating segment. The Ministry of Health is a significant customer of the Group as disclosed in note 2.2, as
the Group derives care fee revenue in respect of eligible Government subsidised aged care residents. No other customers individually
contribute a significant proportion of the Group’s revenue. All revenue earned and assets held are in New Zealand.
1.2 Accounting Policies
Accounting policies which are relevant to understanding the consolidated financial statements are disclosed in each of the applicable
notes. They have been applied on a consistent basis across all periods presented in these consolidated financial statements.
Other relevant policies are provided as follows:
(i) Goods and Services Tax (GST)
Revenues, expenses and purchased assets are recognised net of the amount of GST, except where the amount of GST incurred is
not recoverable from the Inland Revenue Department (‘IRD’). In these circumstances the GST is recognised as part of the cost of
acquisition of the asset or as part of an item of the expense. Receivables and payables in the consolidated statement of financial
position are shown inclusive of GST.
Cash flows are presented in the consolidated statement of cash flows on a net basis, except for the GST component of investing and
financing activities, which are disclosed as operating cash flows.
(ii) Measurement of Fair Value
For financial reporting purposes, ‘fair value’ is the price that would be received to sell an asset, or paid to transfer a liability, in an
orderly transaction between market participants (under current market conditions) at the measurement date, regardless of whether
that price is directly observable or estimated using another valuation technique.
When estimating the fair value of an asset or liability, the Group uses valuation techniques that are appropriate in the circumstances
and for which sufficient data is available to measure fair value, maximising the use of relevant observable inputs and minimising the
use of unobservable inputs. Inputs to valuation techniques used to measure fair value are categorised into three levels according to
the extent to which the inputs are observable:
• Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the
measurement date.
• Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either
directly or indirectly.
• Level 3 inputs are unobservable inputs for the asset or liability.
Further information about the assumptions made in measuring fair values is included in notes 3.1, 3.2, 4.1 and 5.2.
(iii) Government Grants
Government grants and subsidies to the Group are not recognised until there is reasonable assurance that the Group will comply
with the conditions attached to them and that the grants will be received. Government grants are recognised in profit or loss on a
systematic basis over the periods in which the Group recognises as expenses the related costs for which the grants are intended to
compensate. Grants relating to expense items are recognised as income over the periods necessary to match the grant to the costs
they are compensating.
Annual Report 2021
37
2. Operating Performance
2.1 Non-GAAP financial measures: Non-GAAP Underlying Net Profit after tax (“Underlying Profit”) and Non-GAAP
Available Funds from Operations (“AFFO”)
Underlying Profit and AFFO are non-GAAP (non-Generally Accepted Accounting Practice) financial measures and differ from NZ GAAP,
NZ IFRS and IFRS Net Profit after Tax and Net cash provided by Operating Activities, respectively. Underlying Profit and AFFO do not
have a standardised meaning prescribed by NZ GAAP (Generally Accepted Accounting Practice in New Zealand) and so may not be
comparable to similar financial information and measures presented by other entities. The Group uses Underlying Profit and AFFO,
with other measures, to monitor financial performance and for shareholder dividend determination considerations. The Group uses
these measures consistently across reporting periods.
The Group believes that these non-GAAP financial measures, which are not considered to be a substitute for or superior to NZ GAAP,
NZ IFRS and IFRS measures, provide stakeholders with additional helpful information on the performance of the business. The non-
GAAP measures are consistent with how the business performance is planned and reported within the internal management reporting
to the Board and Audit and Risk Committee. Underlying Profit and AFFO are prepared in accordance with the basis of preparation
described below.
Underlying Profit
Underlying Profit is a non-GAAP measure of financial performance and considered in the determination of shareholder dividends.
The calculation of Underlying Profit requires a number of estimates to be approved by the Directors in its preparation. Both the
methodology and the estimates may differ among other entities in the retirement village and aged care sector. Underlying Profit does
not represent cash flow generated during the period.
Basis of preparation: Underlying Profit
The Group calculates Underlying Profit by making the following adjustments to reported Net Profit after Tax:
Adjustments
Non-recurring or infrequent items
1. COVID-19 related expenses. As part of the response to COVID-19, the Group incurred additional expenses, including personal
protective equipment (PPE) costs and expenses in relation to additional sick leave and isolation leave from April 2020 to
September 2020. The Group required staff to take a COVID-19 test before returning to work following any sick leave or isolation
leave, to ensure the safety of residents and staff in the aged care facilities.
2. Government COVID-19 related subsidy. As with other aged care providers in New Zealand, the Group received funding during
the year ended 31 March 2021 from the New Zealand Government in relation to the increased costs associated with COVID-19
which covered higher staff and PPE costs.
3. One-off listing costs. Costs incurred with the compliance listing on the NZX on 10 December 2020.
4. Share based payments. Shares were issued to employees and service providers as part of the compliance listing (note 4.1).
Structural changes and other
1. NZ listed & other listed entity related costs. Following its listing the Group incurred costs associated with operating in a listed
environment in respect of Directors’ fees (including the additional independent Directors recently appointed to the Group),
audit costs, listing fees, share registry fees, enhanced shareholder reporting costs and additional Director & Officer insurance
costs. From the date of listing, the Group also incurred a fee of 3.5% per annum of annual rental and outgoings in relation to the
personal guarantee in place with one landlord.
2. Historical governance costs. These relate to nonrecurring historical Directors, consulting and management fees previously
incurred by the Group but now replaced by NZ Listed and other listed entity related costs.
The effect of these adjustments is to present the Group as if it has been listed for the current and comparative year.
Radius Residential Care Limited
38
Notes to the Consolidated Financial Statements continued
Income tax
Included is the potential income tax impact of the above adjustments (described under non-recurring or infrequent items and
structural changes and other above). An effective tax rate of 28% has been assumed, where applicable.
Underlying adjustments
Underlying adjustments allow for direct comparison to other NZX listed aged care and retirement village operators and include:
• The removal of changes in the fair value of investment properties relating to the Group’s owned retirement villages (Elloughton
Grange Village and Windsor Lifestyle Estate Village).
• Inclusion of realised development margins on the cash settlement of the first sale of new Occupation Right Agreements (ORA)
Units following development.
• Inclusion of realised gains on Unit resales. Realised gains are calculated as the net cash flow received by the Group on the cash
settlement of the resale of pre-existing ORA Units (i.e. the difference between the value of the ORA licence payment received
from the incoming resident and the ORA licence payment previously received from the outgoing resident). Realised gains are net
of incurred refurbishment costs. The margin on the repurchase of legacy units under a unit title subsequently sold under an ORA
contract is also included. Note, no adjustment is made for differences between accrued deferred management fees (DMF) and
actual cash DMF realised.
• Removal of deferred tax expenses including those related to the application of NZ IFRS 16 Leases, where applicable.
AFFO
AFFO is a non-GAAP measure of available cash used by the Group to indicate the level of shareholder dividend it may pay.
Basis of preparation: AFFO
AFFO is calculated from Pre-NZ IFRS 16 Underlying Profit by removing Pre-NZ IFRS 16 depreciation and amortisation and instead
including maintenance capital expenditure. Pre-NZ IFRS 16 Underlying Profit is used as the starting point for this calculation as it
reflects the Pre-NZ IFRS 16 operating rental lease expense which largely represents the actual cash lease payment made, rather than
the NZ IFRS 16 equivalent which instead includes depreciation on right-of-use assets and interest expense on lease liabilities, which
materially exceed the actual cash operating rental lease expense payments.
Annual Report 2021
39
Reconciliation of NZ GAAP financial measures to non-GAAP financial measures
2021 2020
$’000 $’000
Profit/(loss) for the year 1,705 (2,833)
Adjustments
Non-recurring or infrequent items
Remove: COVID-19 related expenses 653 34
Remove: Government COVID-19 Subsidy (857) (353)
Remove: One-off listing costs 1,227 -
Remove: Share based payments 1,464 -
Structural changes and other
Include: Listed & other company costs (714) (1,084)
Remove: Historical governance costs 417 350
Include: Income tax impact from adjustments (270) 295
Underlying adjustments
Remove: Change in fair value of investment properties (2,879) 649
Include: Realised development margins 343 512
Include: Realised gains on resales 480 -
Remove: Deferred tax expense (1,831) (1,533)
Underlying Net profit before tax (262) (3,963)
Remove: Depreciation 11,552 10,911
Remove: Net interest expense 9,636 10,534
Remove: Current tax expense 2,155 1,033
Remove: Income tax impact from adjustments 270 (295)
Underlying EBITDA 23,351 18,220
Include: Pre-NZ IFRS 16 operating lease expense (12,850) (12,435)
Pre-NZ IFRS 16 Underlying EBITDA 10,501 5,785
Include: Depreciation (Pre-NZ IFRS 16) (4,262) (3,700)
Include: Net interest expense (Pre-NZ IFRS 16) (812) (1,134)
Include: Current tax expense (2,155) (1,033)
Include: Income tax impact from adjustments (270) 295
Pre-NZ IFRS 16 Underlying Net profit after tax 3,002 213
Remove: Depreciation (excl. NZ IFRS 16 related) 4,262 3,700
Include: Maintenance capital expenditure (3,543) (4,400)
AFFO 3,721 (487)
Radius Residential Care Limited
40
Notes to the Consolidated Financial Statements continued
2.2 Revenue
Revenue from contracts with customers
Revenue from care and village fees and recoveries income is recognised in accordance with NZ IFRS 15 Revenue from Contracts with
Customers (“NZ IFRS 15”). Deferred management fees and rental income are considered leases under NZ IFRS 16 Leases (“NZ IFRS 16”),
and are therefore excluded from the scope of NZ IFRS 15. None of the Group’s revenue, as defined by NZ IFRS 15, contains significant
financing components.
Care and village fees and recoveries income
The Group derives revenue from the provision of residential care and related services. Rest home, hospital and service fee charges
are governed by the individual care admission agreement with each care resident. The resident incurs a daily care fee charged per the
agreement, as set by the Government each year. Care fees are recognised net of any rebates to residents.
The Group derives care fee revenue in respect of eligible Government subsidised aged care residents who receive rest home,
dementia or hospital level care. Government aged care subsidies received from the Ministry of Health included in care fees and village
services amounted to $78,019k (2020: $72,483k).
There are no elements of variable consideration of significant financing component associated with care and village fees and
recoveries income.
Village fees are detailed within each resident’s occupation right agreement and relate to the operating costs of the village. Revenue is
recognised based on the daily or weekly fees charged, reflecting the period a resident has occupied a unit.
The performance obligation of providing the care and village services is satisfied over time, as the customer simultaneously receives
and consumes the benefits of the service as it is provided. Billing and revenue recognition are generally done during the same period
that the performance obligation is satisfied. Payments received in advance are recorded on the statement of financial position as a
contract liability and subsequently recognised through profit or loss when the services are rendered.
Lease income
Deferred management fees
Occupation Right Agreements (ORAs) confer the right to occupancy of a retirement unit and are considered leases under NZ IFRS 16
Leases.
A management fee is payable by the residents of the Group’s independent living units for the right to share in the use and enjoyment
of common facilities. The management fee is calculated as a percentage of the ORA amount and accrues either daily, monthly or
annually for a set period, based on the terms of the individual contracts. The current ORAs accrue management fees at rates ranging
from 6.67% to 10% per annum.
The management fee is payable in cash by the resident at the time of repayment (to the resident) of the refundable ORA amount due.
The Group has the right to set-off of the refundable occupation right agreement amount and the management fee receivable.
At year end, the management fee receivable that has yet to be recognised through profit or loss as management fee revenue is
recognised as a deferred management fee liability in the statement of financial position.
Key accounting estimates and judgements
Deferred management fees are recognised as revenue on a straight-line basis. This requires Management to estimate the period of
occupancy for independent living units. The expected periods of tenure, being based on historical results, experience and industry
averages, are estimated at 8 years (2020 : 8 years).
Annual Report 2021
41
2.3 Expenses
Accounting policy
Operating expenses are recognised on an accrual basis.
Interest expense is measured in accordance with the effective interest method.
2021 2020
Note $’000 $’000
Depreciation of property, plant and equipment:
- buildings 3.2 249 33
- motor vehicles 3.2 140 155
- furniture, fixtures and fittings 3.2 3,037 2,703
- information technology 3.2 746 737
- medical equipment 3.2 90 72
4,262 3,700
Depreciation of right-of-use assets:
- buildings 3.4 7,290 7,211
7,290 7,211
Total depreciation 11,552 10,911
Finance costs:
- interest - bank 883 1,183
- interest - lease liabilities 8,823 9,400
Total finance costs 9,706 10,583
Other expenses:
Fees paid to Auditors
Audit and review of consolidated financial statements 154 60
Assurance engagement to report on the compilation of
Pro forma financial information included in a listing profile 21 -
Tax compliance services 90 41
Total fees paid to auditor 265 101
Facility operating expenses 20,039 18,967
Listing costs 1,227 -
Operating rental expenses relating to low value and short-term leases 69 53
Directors’ fees 410 107
Donations and sponsorships 14 14
(Gain)/loss on sale of property, plant and equipment (26) 91
Gain on derivative financial instruments - (42)
Other expenses (no items of individual significance) 6,300 5,479
Total other expenses 28,298 24,770
Radius Residential Care Limited
42
Notes to the Consolidated Financial Statements continued
3. Property Assets
3.1 Investment Properties
Accounting policy
Investment properties include completed freehold land and buildings, freehold development land and buildings under development
comprising independent living units and common facilities, provided for use by residents under the terms of a Occupation Right
Agreement (ORA). Investment properties are held for long term yields and are not occupied by the Group.
Investment properties are initially recognised at cost. After initial recognition, investment properties are measured at fair value. Gains
or losses arising from a change in the fair value of investment properties are recognised in profit or loss.
Land acquired with the intention of constructing investment properties are classified as investment properties from the date of
acquisition.
Rental income from investment properties, being deferred management fees, is accounted for as described in note 2.2.
When the use of a property changes such that it is reclassified as property, plant and equipment, its fair value at the date of
reclassification becomes its cost for subsequent accounting.
2021 2020
$’000 $’000
Investment properties
Opening carrying amount 27,831 23,727
Development expenditure 338 3,057
Development expenditure transfer - (3,221)
Net fair value gain/(loss) 2,879 (649)
Occupation right agreements settled (4,894) -
Occupation right agreements entered 5,421 3,705
Purchases 100 187
Transferred from property, plant and equipment - 1,025
Closing carrying amount 31,675 27,831
A reconciliation between the valuation and the amount recognised on the Consolidated Statement of Financial Position as investment
properties is as follows:
Notes
Valuation of operator’s interest 8,345 6,215
Refundable occupation right agreements 3.3 20,591 17,518
Deferred management fee 3.3 1,178 962
Unsold units 1,561 3,136
31,675 27,831
Annual Report 2021
43
Valuation process and key inputs
The Group’s investment properties are valued on an annual basis by CBRE Limited (CBRE), an independent valuer. CBRE is registered
with the Property Institute of New Zealand, employs registered valuers and has appropriate recognised professional qualifications and
recent experience in the location and category of properties being valued.
Fair value as determined by CBRE is adjusted for assets and liabilities already recognised in the Consolidated Statement of Financial
Position which are also reflected in the discounted cash flow model. The valuation of investment properties is then grossed up for
cash flows relating to refundable occupation right agreements, which are recognised separately in the Consolidated Statement of
Financial Position (refer also note 3.3).
Retirement villages under development
The cost of retirement villages includes directly attributable construction costs and other costs necessary to bring the retirement
villages to working condition for their intended use. These other costs include professional fees and consents, borrowing costs
during the build period and head office costs directly related to the construction of the retirement villages. Where costs are
apportioned across more than one asset, the apportionment methodology is determined by considering the nature of the cost. The
borrowing costs capitalised during the period was $49k (2020: $130k). The related borrowing costs were solely for the villages under
development.
If the fair value of investment properties under development and construction cannot be reliably determined but it is expected the fair
value of the property can be reliably determined when construction is complete, then investment properties under construction will
be measured as cost less any impairment, until either its fair value can be reliably determined or construction is complete. Impairment
is determined by considering the value of work in progress and Management’s estimate of the value of the investment properties on
completion.
Unsold units
Any developed but not yet sold units (unsold units) is valued based on recent comparable transactions, adjusted for disposal costs,
holding costs and an allowance for profit and risk. This represents the fair value of the Group’s interest in unsold units at reporting date.
Key accounting estimates and judgements
As the fair value of investment properties is determined using inputs that are significant and unobservable, the Group has categorised
investment properties as Level 3 under the fair value hierarchy in accordance with NZ IFRS 13 Fair Value Measurement.
Valuation uncertainty
As at the 31 March 2021 valuation date, the valuers, CBRE, have included a valuation uncertainty clause in their valuation reports
as a result of the COVID-19 pandemic. This clause highlights the difficulties in undertaking valuations due to the absence of, or
limited relevant transactional evidence that demonstrates current market pricing. Therefore, less certainty and a higher degree of
caution should be attached to the point estimate valuations. This represents an increase in the significant estimation uncertainty
in the valuation of investment properties. Given the valuation uncertainty, the valuers have recommended in their reports that the
valuations of the properties be kept under frequent review. As at the 31 March 2020 valuation date, the valuers CBRE, had included a
similar clause in their valuation reports, however it was highlighted as a “material” valuation uncertainty on the basis that there was an
absence of relevant transactional evidence that demonstrates current market pricing.
Significant unobservable inputs
The significant unobservable input used in the fair value measurement of the Group’s development land is the value per square metre
assumption. Increases in the value per square metre rate result in the corresponding increases in the total valuation.
The significant unobservable inputs used in the fair value measurement of the Group’s portfolio of completed investment properties
are the discount rate and the property growth rate.
Radius Residential Care Limited
44
Notes to the Consolidated Financial Statements continued
The following assumptions have been used to determine fair value:
Inter-relationship
between the key inputs
and fair value measurement
Significant input Description 2021 2020
Discount rate The pre-tax discount rate A significant increase/(decrease)
in the discount rate would result
in a significantly (lower)/higher
fair value measurement 15.75% - 18.0% 16.0% - 18.25%
Property price Anticipated annual property A significant increase/(decrease)
growth rate price growth over the cash in the Property price growth rate
flow period 0 - 4 years would result in a significantly
higher/(lower) fair value
measurement 2.0% - 2.5% -2.0% - 3.0%
Property price Anticipated annual property A significant increase/(decrease)
growth rate price growth over the cash in the Property price growth rate
flow period 5+ years would result in a significantly
higher/(lower) fair value
measurement 3.0% 3.0%
Due to the valuation uncertainty disclosed, the range of reasonably possible changes to key assumptions is uncertain and could be
significantly greater than the ranges used in the sensitivity analysis.
Sensitivities
Adopted Value
of Operator’s Interest Discount Rate Property Growth Rate
As at 31 March 2021 +0.5% -0.5% +0.5% -0.5%
Valuation $000’s 8,345
Difference $000’s (320) 280 515 (515)
Difference % -3.8% 3.4% 6.2% -6.2%
Adopted Value
of Operator’s interest Discount Rate Property Growth Rate
As at 31 March 2020 +0.5% -0.5% +0.5% -0.5%
Valuation $000’s 6,215
Difference $000’s (235) 255 398 (423)
Difference % -3.8% 4.1% 6.4% -6.8%
The stabilised occupancy is a key driver of the CBRE valuation. A significant increase/(decrease) in the occupancy period would result in
a significant lower/(higher) fair value measurement.
Significant input
2021 2020
Stabilised occupancy period 8.4yrs - 8.7yrs 8.3yrs - 8.6yrs
Current ingoing price, for subsequent resales of ORA’s, is a key driver of the CBRE’s valuation. A significant increase/(decrease) in the
ingoing price (as driven by the property growth rates) would result in a significantly higher/(lower) fair value measurement.
Annual Report 2021
45
3.2 Property, Plant and Equipment
Accounting policy
Property, plant and equipment is measured at cost or fair value less, where applicable, any accumulated depreciation and any
accumulated impairment losses.
Cost includes expenditures that are directly attributable to the acquisition of the asset. The cost of self constructed assets includes the
cost of materials and direct labour and any other costs directly attributable to bringing the asset to a working condition for its intended
use. Purchased software that is integral to the functionality of the related equipment is capitalised as part of that equipment.
Subsequent costs are added to the carrying amount of an item of plant and equipment when that cost is incurred if it is probable that
the future economic benefits embodied with the item will flow to the Group and the cost of the item can be measured reliably. All
other costs are recognised in the profit or loss as an expense as incurred. The costs of the day to day servicing of property, plant and
equipment are recognised in profit or loss as incurred.
Freehold land and buildings are measured at revalued amounts, being the fair value at the date of the revaluation, less any
subsequent accumulated depreciation and any accumulated impairment losses. At each reporting date the carrying amount of each
asset is reviewed to ensure that it does not differ materially from the asset’s fair value at reporting date. Where necessary, the asset is
revalued to reflect its fair value.
Increases in the carrying amounts arising on revaluation of land and buildings are recognised in other comprehensive income and
accumulated in equity. To the extent that the increase reverses a decrease of the same asset previously recognised in profit or
loss, the increase is recognised in profit or loss. Decreases that offset previous increases of the same asset are recognised in other
comprehensive income; all other decreases are recognised in profit or loss.
Leasehold improvements are depreciated over the shorter of either the unexpired period of the lease or the estimated useful lives of
the improvements.
Land is not depreciated. The depreciable amount of all other property, plant and equipment is depreciated using the straight line
method over their estimated useful lives commencing from the time the asset is held available for use, consistent with the estimated
consumption of the economic benefits embodied in the asset.
Category Useful Life Range
- Buildings 10 - 50 years
- Motor vehicles 3 - 5 years
- Furniture, fixtures and fittings 5 - 10 years
- Information technology 3 - 4 years
- Medical equipment 5 - 7 years
The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each balance date. No depreciation is charged
in the year of sale for all assets other than buildings in which case depreciation is charged to the earlier of the date of classification to
held for sale or the date of sale.
Assets are assessed for impairment whenever events or circumstances arise that indicate the asset may be impaired. An asset’s
carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated
recoverable amount. Impairment losses in respect of individual assets are recognised immediately in profit or loss unless the asset
is measured at a revalued amount, in which case the impairment loss is treated as a revaluation decrease and is recognised in other
comprehensive income to the extent that it does not exceed the amount in the revaluation surplus for the same asset.
Gains and losses on disposals are determined by comparing the net disposal proceeds with the carrying amount of the asset. These
are included in the profit or loss.
Radius Residential Care Limited
46
Notes to the Consolidated Financial Statements continued
Furniture
Land and Motor Fixtures & Information Medical
$000’s Buildings Vehicles Fittings Technology Equipment Total
Year ended 31 March 2021
Opening net book value 17,265 297 12,905 1,637 199 32,303
Additions 3 205 2,633 587 150 3,578
Net amount of revaluation
increments less decrements* 1,307 - - - - 1,307
Disposals - (1) (21) (5) (3) (30)
Depreciation (249) (140) (3,037) (746) (90) (4,262)
Closing net book value 18,326 361 12,480 1,473 256 32,896
Year ended 31 March 2021
Cost 115 1,212 34,380 4,766 647 41,120
Valuation 18,225 - - - - 18,225
Accumulated depreciation (14) (851) (21,900) (3,293) (391) (26,449)
Net book value 18,326 361 12,480 1,473 256 32,896
Furniture
Land and Motor Fixtures & Information Medical
$000’s Notes Buildings Vehicles Fittings Technology Equipment Total
Year ended 31 March 2020
Opening net book value 3,954 514 12,467 1,774 177 18,886
Additions 104 101 3,448 633 94 4,380
Additions through purchase
of new land and buildings 6,925 - - - - 6,925
Net amount of revaluation
increments less decrements* 7,047 - - - - 7,047
Disposals - (163) (14) (33) - (210)
Depreciation (33) (155) (2,703) (737) (72) (3,700)
Transfer to investment properties 3.1 (732) - (293) - - (1,025)
Closing net book value 17,265 297 12,905 1,637 199 32,303
Year ended 31 March 2020
Cost 127 1,282 31,772 4,183 500 37,864
Valuation 17,150 - - - - 17,150
Accumulated depreciation (12) (985) (18,867) (2,546) (301) (22,711)
Net book value 17,265 297 12,905 1,637 199 32,303
* The revaluation noted in the Consolidated Statement of Comprehensive Income differs from the above due to deferred tax, refer to note 5.1.
Annual Report 2021
47
Valuations
Three of the Group’s properties, St Helenas, Thornleigh Park and Lexham Park, which are included in land and buildings were revalued
on 31 March 2021 to $18,225k from a carrying value prior to revaluation of $16,918k resulting in a revaluation gain of $1,307k. (2020:
Two of the Group’s properties, St Helenas and Thornleigh Park, which are included in land and buildings were revalued on 31 March
2020 to $10,225k from a carrying value prior to revaluation of $3,208k resulting in a revaluation gain of $7,047k. The remaining
property included in land and buildings, Lexham Park, was purchased on 31 July 2019 for $6,925k. LVC Limited (LVC) was involved in
providing valuation services for the purchase of Lexham Park. The valuer confirmed that the purchase price as at 31 July 2019 was
materially consistent with its fair value as at 31 March 2020).
The fair values of the three revalued land and buildings on freehold land have been determined by reference to independent
valuations obtained as at 31 March 2021. These valuations were undertaken by a Property Institute of New Zealand registered valuer,
LVC. LVC, an external independent valuation company employing registered valuers, have appropriate recognised professional
qualifications and recent experience in the location and category of properties being valued. LVC Limited determined the fair value of
land and buildings on freehold land using the direct comparison approach and capitalisation of market income approaches.
Valuation uncertainty
As at the 31 March 2021 valuation date, the valuers, LVC, have included a valuation uncertainty clause in their valuation reports as
a result of the COVID-19 pandemic. This clause highlights the difficulties in undertaking valuations due to the absence of relevant
transactional evidence that demonstrates current market pricing. Therefore, less certainty and a higher degree of caution should
be attached to the point estimate valuation. This represents an increase in the significant estimation uncertainty in the valuation of
the properties. Given the valuation uncertainty, the valuers have recommended in their reports that the valuations of the properties
be kept under frequent review. As at the 31 March 2020 valuation date, the valuers, LVC, had included a similar clause in their
valuation reports, however it was highlighted as a “material” valuation uncertainty on the basis that there was an absence of relevant
transactional evidence that demonstrated current market pricing.
Key accounting estimates and judgements
Property measurements are categorised as Level 3 (2020: Level 3) of the fair value measurement hierarchy as the fair value is
determined using inputs that are unobservable.
Significant unobservable inputs
The significant unobservable input used in the fair value measurement of the Group’s land and buildings is the capitalisation rate
applied to earnings. A significant decrease/(increase) in the capitalisation rate would result in significantly higher/(lower) fair value
measurement.
Sensitivities
Adopted Value Capitalisation Rate
As at 31 March 2021 +0.5% -0.5%
Valuation $000’s 18,225
Difference $000’s 1,318 (1,318)
Difference % 7.2% -7.2%
As at 31 March 2020 +0.5% -0.5%
Valuation $000’s 17,150
Difference $000’s 1,217 (1,217)
Difference % 7.1% -7.1%
Radius Residential Care Limited
48
Notes to the Consolidated Financial Statements continued
3.3 Refundable Occupation Right Agreements
Accounting policy
Occupation Right Agreements (ORAs) confer the right to occupy a retirement unit and are considered leases under NZ IFRS 16
Leases.
A new resident is charged a refundable security deposit, on being issued the right to occupy one of the Group’s units, which is
refunded to the resident subject to a new ORA for the unit being issued to an incoming resident, net of any amount owing to the
Group. The Group has a legal right to set off any amounts owing to the Group by a resident against that resident’s security deposit.
Such amounts include management fees, rest home and hospital fees, service fees and village fees. As the refundable occupation right
is repayable to the resident upon vacating the unit (subject to a new ORA for the unit being issued to an incoming resident), the fair
value is equal to the face value, being the amount that can be refunded.
The right of residents to occupy the investment properties of the Group is protected by the statutory supervisor restricting the ability
of the Group to fully control these assets without undergoing a consultation process with all affected parties.
A resident is charged a village contribution fee in consideration for the right to occupy one of the Group’s units:
• for Windsor Lifestyle Estate Limited, to a maximum of 21% of the entry payment; and
• for Elloughton Grange Village Limited, to a maximum of 30% of the entry payment.
The village contribution is payable by the resident on termination of the ORA. Village contribution is recognised as deferred
management fees, note 2.2. The management fee receivable is recognised in accordance with the terms of the resident’s ORA.
The deferred management fee represents the difference between the management fees receivable under the ORA and the portion of
the management fee accrued which is recognised on a straight-line basis over the longer of the term specified in a resident’s ORA or
the average expected occupancy for the relevant accommodation i.e. 8 years (2020 : 8 years).
The management fee recognised in the Consolidated Statement of Comprehensive Income represents income earned in line with the
average expected occupancy.
As a refundable occupation license payment is repayable to the resident upon termination (subject to a new ORA being issued to an
incoming resident), the fair value is equal to the face value, being the amount that can be demanded.
The expected maturity of the refundable obligations to residents is beyond 12 months.
2021 2020
$’000 $’000
Refundable Occupation Right Agreements
Refundable occupation license payments 24,125 20,350
Less: Management fee receivable (per contract) (3,534) (2,832)
20,591 17,518
Reconciliation of Management Fees recognised under NZ IFRS and per ORA
Management fee receivable (per contract) (3,534) (2,832)
Deferred management fee 1,178 962
Management fee receivable (per NZ IFRS) (2,356) (1,870)
Annual Report 2021
49
3.4 Leases
Accounting policy
At the commencement date of a lease (other than leases of 12 months or less and leases of low value assets), the Group recognises a
lease asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments.
Right-of-use assets
Right-of-use assets are initially recognised at cost, comprising the amount of the initial measurement of the lease liability, any lease
payments made at or before the commencement date of the lease, less any lease incentives received, any initial direct costs incurred
by the Group, and an estimate of costs to be incurred by the Group in dismantling and removing the underlying asset, restoring the
site on which it is located or restoring the underlying asset to the condition required by the terms and conditions of the lease.
Subsequent to initial recognition, lease assets are measured at cost (adjusted for any remeasurement of the associated lease liability),
less accumulated depreciation and any accumulated impairment loss. Right-of-use assets are assessed for impairment whenever
events or circumstances arise that indicate the asset may be impaired. An asset’s carrying amount is written down immediately to its
recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount.
Right-of-use assets are depreciated over the shorter of the lease term and the estimated useful life of the underlying asset, consistent
with the estimated consumption of the economic benefits embodied in the underlying asset.
Lease liabilities
Lease liabilities are initially recognised at the present value of the future lease payments (i.e., the lease payments that are unpaid at
the commencement date of the lease). These lease payments are discounted using the interest rate implicit in the lease, if that rate
can be readily determined, or otherwise using the Group’s incremental borrowing rate.
Subsequent to initial recognition, lease liabilities are measured at the present value of the remaining lease payments (i.e., the lease
payments that are unpaid at the reporting date). Interest expense on lease liabilities is recognised in profit or loss (as a component
of finance costs). Lease liabilities are remeasured to reflect changes to lease terms, changes to lease payments and any lease
modifications not accounted for as separate leases.
Variable lease payments not included in the measurement of lease liabilities are recognised as an expense when incurred.
Leases of 12 months or less and leases of low value assets
Lease payments made in relation to leases of 12 months or less and leases of low value assets (for which a lease asset and a lease
liability has not been recognised) are recognised as an expense on a straight line basis over the lease term.
Key accounting estimates and judgements
Extension and termination options are included in a number of leases across the Group. These terms are used to maximise the
operational flexibility of contracts. The majority of extension and termination options are exercisable only by the Group and not by the
respective lessor. In determining the lease term management considers all facts and circumstances that lead to an economic incentive
to exercise an extension option or not exercise a termination option. Extension options or periods after termination options are
only included in the lease term if the lease is reasonably certain to be exercised. This assessment is reviewed if a significant event or
significant change in circumstances occurs which effects this assessment and that is within the Group’s control. All extension options
have been assumed for the calculations of the Groups’ lease liabilities.
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is
generally the case for leases in the Group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee
would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic
environment with similar terms, security and conditions. The weighted average incremental borrowing rates applied by the Group is
5% (2020: 5%). No new leases were entered into during the year (2020: none) and no leases were modified or cancelled during the
year (2020: one was cancelled).
Radius Residential Care Limited
50
Notes to the Consolidated Financial Statements continued
2021 2020
$’000 $’000
(a) Right-of-use assets
Land and Buildings under lease 191,603 188,574
Accumulated depreciation (14,433) (7,143)
Total carrying amount of right-of-use assets 177,170 181,431
Reconciliations
Reconciliation of the carrying amount of lease assets at the beginning and end of the financial year:
Land and buildings
Opening carrying amount 181,431 192,205
Additions - 1,393
Depreciation (7,290) (7,211)
Remeasurements 3,029 1,861
Disposals - (6,817)
Closing carrying amount 177,170 181,431
(b) Lease liabilities
Current
Land and buildings 4,051 3,907
Non-current
Land and buildings 180,254 181,397
184,305 185,304
(c) Lease expenses and cash flows
Interest expense on lease liabilities 8,823 9,400
Depreciation expense on right-of-use assets 7,290 7,211
Cash outflow in relation to leases 12,850 12,435
(d) Maturity analysis - contractual undiscounted cash flows:
- Not later than 1 year 12,933 12,710
- Later than 1 year and not later than 5 years 52,035 51,105
- Later than 5 years 292,002 300,654
356,970 364,469
Annual Report 2021
51
4. Shareholder Equity and Funding
4.1 Shareholder Equity and Reserves
Accounting policy
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares are shown in equity as a
deduction, net of tax, from the proceeds.
The grant date fair value of equity settled share-based payment arrangements granted to employees is recognised as an expense, with
a corresponding increase in equity.
2021 2020
Shares $’000 Shares $’000
Share Capital
Authorised, issued and fully paid up capital 176,495,000 5,932 12,500,000 4,736
Total contributed equity 176,495,000 5,932 12,500,000 4,736
Movements
Opening balance of ordinary shares issued 12,500,000 4,736 12,500,000 4,736
Share split 162,500,000 - - -
Shares issued to employees and service providers 1,495,000 1,196 - -
Closing balance of ordinary shares issued 176,495,000 5,932 12,500,000 4,736
All ordinary shares are authorised and rank equally with one vote attached to each fully paid ordinary share. The shares have no par
value. The Group incurred no transaction costs issuing shares during the period (2020:$nil).
Share split
On 8 December 2020 the Group undertook a 14:1 split of existing ordinary shares prior to listing on the NZX.
Shares issued to employees and service providers
Shares $’000
On 10 December 2020 the Company issued 1,245,000 new ordinary shares as follows:
838,750 shares (@ $0.80 per share) were issued to employees
as share based payments.* 838,750 671
250,000 shares (@ $0.80 per share) were issued to Duncan Cook, Director
for legal services rendered to the group and for services provided in connection
with the Company’s listing on the NZX.*
250,000 200
156,250 shares (@ $0.80 per share) were issued to Tom Wilson for consultancy
services rendered to the Group and for services provided to the Group in
connection with the Company’s listing on the NZX.*
156,250 125
1,245,000 996
Also on 10 December 2020, 250,000 (@ $0.80 per share) ordinary shares were issued to
Harmos Horton Lusk Limited in consideration for $200,000 of legal services
provided to the Group in connection with the Company’s listing on the NZX.* 250,000 200
1,495,000 1,196
Radius Residential Care Limited
52
Notes to the Consolidated Financial Statements continued
* On 10 December 2020 when the Group listed, 1,245,000 new shares were issued at $0.80 per share which was determined to be the
fair value on issuance by the Board of Directors. This value was derived by using a market approach valuation technique. The technique
used was the multiples method utilising comparable company analysis. This involved comparing the Group’s implied enterprise value
/ underlying earnings before interest, tax depreciation and amortisation to its retirement village and aged care listed peers in New
Zealand. The valuation was assessed using independent advisor reports prepared to assist the Directors in establishing the share price.
As the fair value of shares issued as share based payments was determined using inputs that are significant and unobservable, the
Group has categorised these inputs as Level 3 under the fair value hierarchy in accordance with NZ IFRS 13 Fair Value Measurement. The
significant unobservable inputs used in the fair value measurement of the Group’s shares was the market multiples applied. A significant
increase/(decrease) in the market multiples would result in a significantly higher/(lower) fair value measurement.
The total share based payments expense recognised for the year ended 31 March 2021 was $996k (refer to subtotal above) and a
further $468k in PAYE, totalling $1,464k.
Dividends
Dividend distributions to shareholders are recognised as a liability in the period in which dividends are declared. On 5 February 2021
a dividend of $0.00576031 per share (fully imputed) was declared and was paid on 26 February 2021 (2020: On 28 June 2019, a
dividend of $0.0180 per share (fully imputed) was declared and was paid on 28 June 2019).
Asset Revaluation Reserve
The asset revaluation reserve is used to record the revaluation of freehold land and buildings.
4.2 Earnings per share
Basic and diluted
Basic earnings per share is calculated by dividing the (loss)/profit after tax of the Group by the weighted average number of ordinary
shares outstanding during the year. Diluted earnings per share is calculated by adjusting the weighted average number of ordinary
shares outstanding to assume conversion of all dilutive potential ordinary shares. As at 31 March 2021, there were no shares with a
dilutive effect (31 March 2020: none) and therefore basic and diluted earnings per share were the same.
2021 2020 2020*
Profit/(Loss) after tax ($’000) 1,705 (2,833) (2,833)
Weighted average number of ordinary shares outstanding (‘000s) 175,455 12,500 175,000
Cents per share 0.97 (22.66) (1.62)
* As described above a 14:1 share split took place on 8 December 2020, the Group has also presented the basic earnings per share for
the year ended 31 March 2020 taking into consideration this share split.
4.3 Borrowings
Accounting policy
Borrowings are initially recognised at fair value, including transaction costs incurred. Borrowings are subsequently measured at
amortised cost. Any difference between the proceeds (net of transaction costs) and the redemption amount is recognised in the
Statement of Comprehensive Income over the period of the borrowings, using the effective interest method.
Specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that
necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until
such a time as the assets are substantially ready for their intended use. Other borrowing costs are recognised in the Statement of
Comprehensive Income in the period in which they are incurred. The borrowing costs capitalised during the period was $49,000 (2020:
$130,000). The related borrowing costs were solely for the villages under development (note 3.1).
Annual Report 2021
53
2021 2020
$’000 $’000
Secured Liabilities
Current
Bank Loans 1,000 500
Non-Current
Bank Loans 26,212 30,927
27,212 31,427
Terms and conditions and assets pledged as security
Effective
Current Non-current Facility interest Expiry
Limit rate date
$’000 $’000 $’000 %
31 March 2021
Committed Cash Advance - 17,387 18,000 2.01% 29 April 2023
Committed Cash Advance - 9,825 9,825 1.76% 29 July 2023
- 27,212 27,825
31 March 2020
Committed Cash Advance - 19,583 19,583 2.10% 29 April 2021
Revolving Committed Cash Advance - 2,019 3,000 2.18% 3 June 2021
Committed Cash Advance - 9,825 9,825 2.56% 29 July 2022
- 31,427 32,408
Security
The bank loans of the Group are guaranteed by certain Group entities and secured by mortgages over the Group’s care centre
freehold land and buildings and rank second behind the Statutory Supervisors when the land and buildings are classified as
investment property and investment property under development.
As at 31 March 2021 the balance of the bank loans over which the properties are held as security is $9,825k (31 March 2020:
$11,844k), the total commitment as at 31 March 2021 is $9,825k (31 March 2020: $12,825k).
Other
The Group has a Corporate Banking Overdraft Facility Agreement with ASB Bank Limited (ASB) for $1.5m (2020: $1.5m) that has an
expiry date on 31 March 2049 (2020: 31 March 2049). This facility bears interest at an effective interest rate of 3.75% (2020: 4.04%)
and is secured over the assets of the Group and guaranteed by certain Group entities. At reporting date this overdraft facility was not
drawn (2020:$Nil).
Financing arrangements
Under the Group’s bank loan arrangements with ASB, the Group must comply with externally imposed banking covenant. These
covenants are tested and reported to the ASB on a quarterly basis. During the year ended 31 March 2021, the Group complied with
all externally imposed banking covenant requirements to which it is subject (2020: complied with all). The Group has agreed with
its banks that the calculation of Adjusted EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) and Net Interest, for
the purposes of the financial covenants, shall continue to be based on the accounting treatment in use before the introduction and
adoption of NZ IFRS 16 Leases.
Radius Residential Care Limited
54
Notes to the Consolidated Financial Statements continued
5. Other Disclosure
5.1 Income Tax
Accounting policy
Current income tax expense or credit is the tax payable on the current period’s taxable income based on the applicable income tax
rate adjusted by changes in deferred tax assets and liabilities.
Deferred tax assets and liabilities are recognised for temporary differences at the applicable tax rates when the assets are expected
to be recovered or liabilities are settled. Deferred tax liabilities are not recognised if they arise from the initial recognition of goodwill.
Deferred income tax is also not recognised if it arises from the initial recognition of an asset or liability in a transaction other than a
business combination that at the time of the transaction affects neither accounting nor taxable profit or loss.
Deferred tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable
amounts will be available to utilise those temporary differences and losses.
Current and deferred tax balances attributable to amounts recognised directly in equity are also recognised directly in equity.
Key accounting estimates and judgements
Deferred tax on Investment Property
Deferred tax on investment property is assessed on the basis that the asset value will be realised through use (“Held for Use”).
An initial recognition exemption has been applied to newly developed village sites in accordance with NZ IAS 12, Income Taxes.
The Group’s ORAs comprise two distinct cash flows (being an ORA deposit upon entering the unit and the refund of this deposit upon
exit). In determining the tax base of investment property, the Group considered whether taxable cash flows are received at the end of
the ORA period (i.e. upon refund of the ORA deposit by way of set off on exit by a resident) or at the beginning of the ORA period (i.e.
at time of the receipt of the ORA deposit). The Group has carefully evaluated all the available information and considers it appropriate
to recognise and measure the tax base and associated deferred tax based on the taxable cash flows being receivable at the end of the
ORA period as this best represents the Group’s contractual entitlement.
In calculating deferred tax under the Held for Use methodology, the Group has made significant judgements to determine taxable
temporary differences. The carrying value of the Group’s investment property is determined on a discounted cash flow basis and
includes cash flows that are both taxable and non-taxable in the future. The Group has recognised deferred tax on the cash flows with
a future tax consequence being DMF as provided by CBRE, to the extent that it arises from depreciable components (i.e. buildings)
of the investment property. The Group uses the valuers’ valuations to estimate the apportionment of cash flows arising from the
depreciable (i.e. buildings) and non-depreciable components (i.e. land).
2021 2020
$’000 $’000
(a) Components of tax expense/(benefit)
Current tax 2,155 1,033
Deferred tax (1,831) (1,533)
324 (500)
Annual Report 2021
55
2021 2020
$’000 $’000
(b) Income tax reconciliation
The prima facie tax payable on profit before tax is reconciled to the income tax expense as follows:
Prima facie income tax payable on profit before tax at 28.0% 568 (933)
Permanent differences (443) 268
Under provision for income tax in prior year 223 165
Other (24) -
Income tax expense/(benefit) attributable to profit 324 (500)
(c) Deferred tax
Deferred tax relates to the following:
Non-current asset
Deferred tax assets
The balance comprises:
Lease liabilities 51,605 51,885
Provisions 1,970 1,408
Deferred management fee income 765 659
54,340 53,952
Deferred tax liabilities
The balance comprises:
Property, plant and equipment 1,098 1,145
Right-of-use assets 49,607 50,801
50,705 51,946
Net deferred tax assets 3,635 2,006
(d) Deferred income tax revenue comprises
Through profit/(loss) included in income tax expense
(Increase)/decrease in deferred tax assets (388) 1,677
Decrease in deferred tax liabilities (1,443) (3,210)
(1,831) (1,533)
Through other comprehensive income
Increase in deferred tax liabilities 202 1,339
Through other comprehensive income included in revaluation of property,
plant and equipment 202 1,339
Increase in deferred tax liabilities (1,629) (194)
Deferred tax assets are recognised for deductible temporary differences as Management considers that it is probable that future
taxable profits will be available to utilise those temporary differences.
Radius Residential Care Limited
56
Notes to the Consolidated Financial Statements continued
2021 2020
$’000 $’000
(e) Imputation credits available for use in subsequent periods
Balance at the beginning of the year 4,104 3,380
Dividends paid (285) (88)
New Zealand tax payments, net of refunds 1,744 814
Other debits (14) (2)
Balance at the end of the year 5,549 4,104
5.2 Intangible Assets
Accounting policy
Goodwill
Goodwill represents the future economic benefits arising from other assets acquired in a business combination that are not
individually identifiable or separately recognised. Goodwill is initially recognised at an amount equal to the excess of: (a) the aggregate
of the consideration transferred, the amount of any non controlling interest, and the acquisition date fair value of the acquirer’s
previously held equity interest (in the case of a step acquisition), over (b) the net fair value of the identifiable assets acquired and
liabilities assumed. For accounting purposes, such measurement is treated as the cost of goodwill at that date.
Goodwill is not amortised, but is tested for impairment annually, or more frequently if events or changes in circumstances indicate that
it might be impaired. Subsequent to initial recognition, goodwill is measured at cost less any accumulated impairment losses.
2021 2020
$’000 $’000
Goodwill at cost 16,996 16,996
Key accounting estimates and judgements
Goodwill has been assessed as having indefinite useful lives, as there is no foreseeable limit to the period over which the asset is
expected to generate net cash inflow for the Group.
Goodwill is allocated to twenty individual CGUs within the residential care business (various acquired residential care facilities).
Corporate office cash flows incurred by the Group as a whole cannot be allocated to individual CGUs on a reasonable basis. Therefore,
these cash flows and related corporate assets are impairment tested at the overall Group level.
The recoverable amount of CGUs as at reporting date has been determined based on its fair value less costs of disposal, determined
using discounted cash flows (2020: based on its value-in-use, determined by discounting the future cash flows to be generated from
its continuing use of the CGU) that includes Management’s estimates based on past performance and its expectation for the future
performance for up to 3 years. These estimates are based on budgeted projections of occupancy levels, sales growth and changes
to cost structures. Cash flows from performance thereafter are estimated using a standard growth rate deemed to be reasonable by
Management.
Annual Report 2021
57
The key assumptions used for discounted cash flows (2020: value-in-use) calculations are as follows:
• The year 1 forecast cash flows are based on Management forecasts approved by the Board of Directors
• The year 2 and 3 forecast cash flow period growth rate used in the calculations was 3.0% (2020: 3.0%)
• The cash flow period used in the calculations was 3 years (2020: 3 years)
• The pre-tax discount rate applied in the calculations was between 12.6% and 13.3% (2020: pre-tax 18.1%)
• The terminal growth rate applied in the calculations was 2.0% (2020: 2.0%)
• Occupancy projections vary between CGUs based on actual and expected occupancy rates.
Management believes that no reasonably possible changes in any of the above key assumptions would cause the carrying value of the
goodwill to be materially lower than its recoverable amount.
Care CGUs Recoverable Amount
The recoverable amount of the individual care sites as at 31 March 2021 has been determined based on fair value less costs of
disposal, determined using discounted cash flows. As the recoverable amount of individual care sites was determined using inputs
that are significant and unobservable, the Group has categorised these inputs as Level 3 under the fair value hierarchy in accordance
with NZ IFRS 13 Fair Value Measurement. The significant unobservable inputs used in the fair value measurement of the recoverable
amount of the Group’s individual care sites were as described above, year 1 to 3 forecast cash flows, a pre-tax discount rate, a terminal
growth rate and occupancy projections based on actual and expected occupancy rates.
• A significant increase/(decrease) in the forecast cash flows, terminal growth rate, and occupancy projections and rates,
assumptions would result in a significantly higher/(lower) fair value measurement.
• A significant increase/(decrease) in the pre-tax discount rate would result in a significantly (lower)/higher fair value measurement.
5.3 Trade and Other Receivables
Accounting policy
Trade receivables are amounts due from residents and Government agencies in the ordinary course of business and are recognised
initially at fair value being the transaction price plus any transaction costs. Subsequent to initial recognition, receivables from
contracts with customers are measured at amortised cost and are tested for impairment.
2021 2020
$’000 $’000
Current
Trade receivables 6,945 7,097
Allowance for credit losses (722) (688)
6,223 6,409
Grant receivable - 353
NZX listing bond 75 -
Prepayments 522 492
Accrued Income 10 6
Development costs 777 207
7,607 7,467
Non-current
Prepayments 5 17
Accrued Income 132 164
137 181
7,744 7,648
Radius Residential Care Limited
58
Notes to the Consolidated Financial Statements continued
Recognition, measurement and judgements in applying accounting policies
When measuring expected credit losses (‘ECL’) the Group uses reasonable and supportable forward looking information, which is
based on assumptions for future movement of different economic drivers and how these drivers will affect each other.
The expected credit losses on trade receivables are estimated using a provision matrix by reference to past default experience of
the debtors and an analysis of the debtors’ current financial positions, adjusted for factors that are specific to the debtors, general
economic conditions of the industry in which the debtors operate and an assessment of both the current as well as the forecast
direction of conditions at the reporting date.
The Group has the following financial assets subject to the application of the expected credit loss model:
• Trade receivables from care operations for the provision of care fees revenue for rest home and hospital fees. These are split
between private amounts owed by residents and amounts due from agencies such as the Ministry of Health and Accident
Compensation Corporation.
• Trade receivables from village operations for the provision of weekly service fees and occupation licence payment receivables.
These are receivable from residents.
The following table provides information about the risk profile of trade receivables from contracts with residents and Government
agencies using a provision matrix. The information in the below table does not distinguish between resident or product types as the
Group’s historical credit loss experience does not show different patterns for different resident or product types.
12-month expected credit losses
Days past due
Not past due 31-60 61-90 91 and over Total
2021
Estimated total gross carrying amount at default (‘$000) 5,152 434 246 1,113 6,945
Expected credit loss rate (%) 0.3% 0.5% 2.9% 62.7% 10.4%
Expected credit loss rate (‘$000) 16 2 7 697 722
2020
Estimated total gross carrying amount at default (‘$000) 4,280 754 357 1,706 7,097
Expected credit loss rate (%) 0.4% 0.5% 3.6% 38.3% 9.7%
Expected credit loss rate (‘$000) 18 4 13 653 688
5.4 Trade and Other Payables
Accounting policy
Trade payables are recognised initially at fair value less transaction costs and subsequently measured at amortised costs using the
effective interest method.
Employee benefits
(i) Short-term employee benefit obligations
Liabilities arising in respect of wages and salaries, annual leave and other employee benefits (other than termination benefits)
expected to be settled wholly before twelve months after the end of the reporting period are measured at the (undiscounted)
amounts based on remuneration rates which are expected to be paid when the liability is settled.
Annual Report 2021
59
(ii) Long-term employee benefit obligations
The provision for other long-term employee benefits, including obligations for long service leave and annual leave, which are not
expected to be settled wholly before twelve months after the end of the reporting period, are measured at the present value of the
estimated future cash outflow to be made in respect of the services provided by employees up to the reporting date.
When the Group does not have an unconditional right to defer settlement for at least twelve months after the reporting date, those
employee entitlements are presented as current. All other long-term employee benefit obligations are presented as non-current
liabilities.
(iii) Retirement benefit obligations: Defined contribution superannuation plan
The Group makes superannuation contributions to the employee’s defined contribution superannuation plan of choice in respect
of employee services rendered during the year. These superannuation contributions are recognised as an expense in the same
period when the related employee services are received. The Group’s obligation with respect to employee’s defined contributions
entitlements is limited to its obligation for any unpaid superannuation guarantee contributions at the end of the reporting period.
2021 2020
$’000 $’000
Current
Unsecured liabilities
Trade creditors 3,893 4,574
GST payable 714 690
Other payable 33 11
Accrued expenses 926 610
Annual leave 5,339 4,219
Other employee entitlements 3,846 3,822
Deferred government grants income 160 160
14,911 14,086
5.5 Related Party Transactions
Subsidiaries are entities controlled by the Group. The Group controls an entity when it is exposed to, or has rights to, variable returns
from its involvement with the entity and has the ability to affect those returns through its power over the entity.
The financial statements of subsidiaries are prepared for the same reporting period as the parent entity, using consistent accounting
policies. Adjustments are made to bring into line any dissimilar accounting policies which may exist.
All intercompany transactions and balances are eliminated. The subsidiaries are consolidated from the date the Group gains control
until the date on which control ceases.
Radius Residential Care Limited
60
Notes to the Consolidated Financial Statements continued
Subsidiaries
The following are the Group’s subsidiaries
Ownership interests
and voting rights
Class of
Name of Entity Principal Activities 2021 2020 shares
Radius Arran Court Limited Lessee entity for Radius Arran Court facility 100% 100% Ordinary
Windsor Lifestyle Estate Limited Operating entity for Windsor retirement village 100% 100% Ordinary
Radius Care Limited (non-trading) Dormant 100% 100% Ordinary
Elloughton Grange Village Limited Operating entity for Elloughton retirement village 100% 100% Ordinary
Radius Care Holdings Limited Property owning entity for St Helenas,
Thornleigh Park and Lexham Park facilities 100% 100% Ordinary
On 1 May 2020, Radius Health Limited, a wholly owned subsidiary of the Group was amalgamated into Radius Residential Care Limited.
All subsidiaries are incorporated in New Zealand and have a balance date of 31 March.
Key management personnel compensation and other related parties
Key management personnel are all executives with the authority for the strategic direction and management of the Group.
Related Party Relationship
Brien Cree Director and Ultimate Shareholder
Duncan Cook Director and Shareholder
Bret Jackson Director and Ultimate Shareholder
Timothy Sumner Director and Ultimate Shareholder
Mary Gardiner Director
Hamish Stevens Director
Wave Rider Holdings Limited Shareholder
Knox Radius LP Shareholder
Knox Fund IV AUD LP Shareholder
Knox Fund IV NZD LP Shareholder
Sharp Tudhope Lawyers Limited Consultant (Duncan Cook)
Cibus Catering Limited Common Director (Brien Cree)
Valhalla Capital Limited Common Director (Brien Cree)
Harmos Horton Lusk Limited Shareholder
Tom Wilson Shareholder
Time Capital NZ Limited Director (Tom Wilson)
Annual Report 2021
61
2021 2020
$’000 $’000
Directors’ remuneration and expenses 410 107
Dividends to director related entities 523 225
Key Management personnel salaries and other short term employee benefits 1,294 880
Key Management personnel dividends 3 -
2,230 1,212
Other related parties
Trade creditors
- Cibus Catering Limited 86 54
Trade debtors
- Cibus Catering Limited 7 7
Legal Fees
- Sharp Tudhope Lawyers Limited 149 63
- Duncan Cook - Share based payments 299 -
- Harmos Horton Lusk Limited 547 -
- Harmos Horton Lusk Limited - Share based payments 200 -
2021 2020
$’000 $’000
Personal guarantee fee
- Brien Cree 85 -
Management fee expense
- Knox Radius LP - 83
Catering services
- Cibus Catering Limited 4,777 4,872
Consulting fees
- Time Capital NZ Limited (since Tom Wilson became a shareholder) 33 -
- Tom Wilson - share based payments 125 -
Purchase of property, plant and equipment
- Valhalla Capital - Ashburton Laundry Assets - 550
Assignment of an agreement for the purchase of land from a Director
Brien Cree (Director) and the Group are party to an agreement (“the Assignment Agreement”), whereby, Brien has agreed to assign to
the Group his rights under an agreement for sale and purchase of real estate (“Land SPA”), to acquire a circa 4.3 hectare development
property at Main North Road, Belfast, Christchurch (‘the development property’) from an unrelated third party.
Radius Residential Care Limited
62
Notes to the Consolidated Financial Statements continued
The purchase price under the Land SPA is $5.8m, of which a non-refundable deposit of $300k had already been paid by Brien, with the
balance payable on the date of settlement, being 16 April 2021.
The Assignment Agreement also requires the Group to pay the Brien an additional $400k on 16 April 2021, for preserving the
development opportunity for the Group and for taking the risk on resource consent being obtained at a time that the Group was not
able to respond to the opportunity the land presented.
A condition of the Assignment Agreement was approval of the transaction by the Board of the Group by 2 April 2021. On 2 April 2021
the Board (excluding Brien as an interested director) exercised its right to approve the Assignment Agreement and the Group now
holds the rights to acquire the development property. The Board approved the Assignment Agreement on 2 April 2021, as the Group
had obtained:
• resource consent and funding for the development of an integrated aged care facility and retirement village on the property; and
• an independent valuation had confirmed that the property’s fair value after resource consent exceeded the purchase price of the
property (including the additional $400k consideration payable to Brien).
The Group paid Brien for the $300k non-refundable deposit in July 2020 and the additional $400k on 16 April 2021.
The balance of the purchase price under the SPA amounting to $5.5m is payable to the third party vendor on settlement, which will be
completed when the title of the property is issued. It is currently expected that title will be issued prior to 31 March 2022.
5.6 Financial Risk Management
The Group is exposed to the following financial risks in the normal course of business:
(a) Credit risk
(b) Liquidity risk
(c) Interest rate risk
The Board of Directors reviews and agrees on policies for managing each of these risks as summarised below:
2021 2020
Note $’000 $’000
Financial Assets
Amortised cost
Cash and cash equivalents 2,761 2,317
Trade receivables 5.3 6,223 6,409
Total assets 8,984 8,726
Financial Liabilities
Amortised cost
Trade and other payables 5.4 5,566 5,885
Lease liabilities 3.4 184,305 185,304
Borrowings 4.3 27,212 31,427
Refundable occupation right agreements 3.3 20,591 17,518
Total liabilities 237,674 240,134
(a) Credit Risk
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an
obligation.
The Group’s exposure to credit risk, or the risk of counterparties defaulting arises mainly from cash at bank, trade and other
receivables.
Annual Report 2021
63
The maximum exposure to credit risk, excluding the value of any collateral or other security, at reporting date, of recognised financial
assets is the carrying amount of those assets, net of any provisions for impairment of those assets, as disclosed in the consolidated
statement of financial position and notes to consolidated financial statements.
The Group has no significant concentrations of credit risk. The Group’s trade receivables represent distinct trading relationships with
each of its residents and various Government agencies. The only large trade receivables relate to residential care subsidies which are
receivable in aggregate from various District Health Boards and Work and Income New Zealand. These entities are not considered a
credit risk.
The Group does not have any material credit risk exposure to any single counterparty or group of counterparties under financial
instruments entered into by the Group.
(i) Cash deposits and other receivables
Credit risk for cash deposits is managed by holding all cash deposits with high credit rating financial institutions, i.e. major registered
New Zealand banks.
(ii) Trade receivables
Credit risk with respect to trade receivables is limited due to the large number of customers which qualify for Ministry of Health
funding in relation to payment of our services. Amounts owed by the residents are generally unsecured. Credit risk is managed
through the use of admission agreements for all residents, which gives contractual rights to the Group in relation to security and
collection of debts in circumstances where there is no entitlement to Ministry of Health funding. All admissions are reviewed to ensure
a duly completed admission agreement is available. The loss allowance for expected credit losses of trade receivables is provided in
note 5.3. As the Group undertakes transactions with a large number of customers and regularly monitors payment in accordance with
credit terms, the financial assets that are neither past due nor impaired, are expected to be received in accordance with the credit
risk.
(b) Liquidity risk
Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities.
The Group has liquidity risk with respect to its repayment obligations of financial liabilities.
The Group maintains a rolling 90 day forecast of daily cash flows to ensure it will have sufficient liquidity to meet its liabilities as they
fall due. This is linked to a monthly rolling forecast which provides directional liquidity expectations for a minimum of a further twelve
months.
The Group has a bank facility which is subject to certain covenant clauses, whereby it is required to meet certain key performance
indicators. This bank facility is provided by the ASB Bank.
The following table outlines the Group’s remaining contractual maturities for non-derivative financial instruments. The amounts
presented in the table are the undiscounted contractual cash flows of the financial liabilities allocated to time bands based on the
earliest date on which the Group can be required to pay:
Less than Between Between Over
1 year 1 and 2 years 2 and 5 years 5 years
$’000 $’000 $’000 $’000
2021
Trade and other payables 5,566 - - -
Lease liabilities 12,933 12,988 39,047 292,002
Borrowings - - 27,212 -
Refundable occupation right agreements* 20,591 - - -
39,090 12,988 66,259 292,002
Radius Residential Care Limited
64
Notes to the Consolidated Financial Statements continued
Less than Between Between Over
1 year 1 and 2 years 2 and 5 years 5 years
$’000 $’000 $’000 $’000
2020
Trade and other payables 5,885 - - -
Lease liabilities 12,710 12,723 38,382 300,654
Borrowings - 21,602 9,825 -
Refundable occupation right agreements* 17,518 - - -
36,113 34,325 48,207 300,654
* The refundable ORAs are repayable to the resident on vacation of the unit or on the termination of the occupation right agreement and subsequent resale of the unit. The
expected maturity of the refundable ORAs is shown in note 3.3.
c) Interest rate risk
The Group is exposed to interest rate risk in relation to its interest earning cash deposits and its interest bank borrowings. Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate as a result of changes in market
interest rates. The Group manages its interest rate risk by maintaining a mix of variable rate and fixed rate borrowings, and by utilising
interest rate swap contracts.
Interest rates on cash at bank are subject to market risk in the event of changes in interest rates. As these securities are carried at net
market value, the effective interest rate is reflected in the market price. Interest rates on non-current bank borrowings are generally
subject to review annually or at shorter intervals, and interest rates on current borrowings can be reviewed at the lender’s discretion.
The following table outlines that Group’s exposure to interest rate risk in relation to future cash flows and the effective weighted
average interest rates on classes of financial assets and financial liabilities:
Total
Interest Non-interest carrying Weighted average
bearing bearing amount effective interest rate
2021 $’000 $’000 $’000
Financial Instruments
Financial assets
Cash 2,761 - 2,761 0.0% Fixed
Financial liabilities
Bank and other loans (27,212) - (27,212) 1.9% Fixed
Lease liabilities (184,305) - (184,305) 5.0% Fixed
(211,517) - (211,517)
Annual Report 2021
65
Total
Interest Non-interest carrying Weighted average
bearing bearing amount effective interest rate
2020 $’000 $’000 $’000
Financial Instruments
Financial assets
Cash 2,317 - 2,317 0.0% Fixed
Financial liabilities
Bank and other loans (31,427) - (31,427) 2.3% Fixed
Lease liabilities (185,304) - (185,304) 5.0% Fixed
(216,731) - (216,731)
No other financial assets or financial liabilities are expected to be exposed to interest rate risk.
Sensitivity
If interest rates were to increase/decrease by 100 basis points from the rates prevailing at the reporting date, assuming all other
variables remain constant, then the impact of profit for the year and equity would be as follows:
2021 2020
$’000 $’000
+ / - 100 basis points
Impact on profit after tax (272) (314)
Impact on equity (196) (226)
5.7 Contingent Liabilities
Lester Heights business
On 26 June 2013, the Group entered into an agreement to sell the Lester Heights business. The sale was settled on 31 August 2013.
One of the conditions of sale is that in the event that the new business owner defaults on the rental payments, the Group is required
to guarantee the rent. For the years ended 31 March 2019 and 2020, no amounts were paid, but in the event that a default occurs, the
potential cost to the Group is an annual rent of $238k per annum until 2029. The Group will likely assume operations at this facility, in
the event of a default.
Other
There were no other material contingent liabilities at reporting date (2020:Nil).
5.8 Commitments
There were no material commitments at reporting date (2020: Nil).
Radius Residential Care Limited
66
67
/HYHO4XHHQ6WUHHW$XFNODQG
32%R[$XFNODQG
1HZ=HDODQG
T:
F:
E:
DXFNODQG#EDNHUWLOO\VUQ]
W:ZZZEDNHUWLOO\VUQ]
INDEPENDENT AUDITOR’S REPORT
To the Shareholders of Radius Residential Care Limited
Report on the Audit of the Consolidated Financial Statements
Opinion
We have audited the consolidated financial statements of Radius Residential Care Limited and its subsidiaries
('the Group') on pages 28 to 66, which comprise the consolidated statement of financial position as at 31 March
2021, and the consolidated statement of comprehensive income, consolidated statement of changes in equity
and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial
statements, including significant accounting policies.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the
consolidated financial position of the Group as at 31 March 2021, and its consolidated financial performance
and its consolidated cash flows for the year then ended in accordance with New Zealand Equivalents to
International Financial Reporting Standards ('NZ IFRS') and International Financial Reporting Standards ('IFRS').
Our report is made solely to the Shareholders of the Group. Our audit work has been undertaken so that we
might state to the Shareholders of the Group those matters we are required to state to them in an auditor’s
report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume
responsibility to anyone other than the Shareholders of the Group as a body, for our audit work, for our report
or for the opinions we have formed.
Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (New Zealand) ('ISAs (NZ)').
Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of
the Consolidated Financial Statements section of our report. We are independent of the Group in accordance
with Professional and Ethical Standard 1 (Revised) International Code of Ethics for Assurance Practitioners
(including International Independence Standards) (New Zealand) issued by the New Zealand Auditing and
Assurance Standards Board and the International Ethics Standards Board for Accountants’ Code of Ethics for
Professional Accountants (including International Independence Standards) (‘IESBA Code’), and we have fulfilled
our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that
the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Other than in our capacity as auditor and provider of other assurance services, our firm carries out other
assignments for Radius Residential Care Limited and its subsidiaries in the area of taxation compliance
services. The provision of these other services has not impaired our independence.
Notes to the Consolidated Financial Statements continued
5.9 Events subsequent to reporting date
Assignment of an agreement for the purchase of land from a Director
On 2 April 2021 the Board (excluding Brien Cree) exercised its right to approve an Assignment Agreement between the Group and
Brien Cree and now holds the rights under an agreement for sale and purchase of real estate to acquire 4.3 hectare development
property for a purchase price of $5.8m. Refer to Note 5.5 for the detailed disclosure.
Dividends
On 25 May 2021, the Board declared a final dividend of $0.00888048 per share (fully imputed), that will be paid on 21 June 2021.
Other
There has been no other matter or circumstance, which has arisen since 31 March 2021 that has significantly affected or may
significantly affect:
(a) the operations, in financial years subsequent to 31 March 2021, of the Group, or
(b) the results of those operations, or
(c) the state of affairs, in financial years subsequent to 31 March 2021, of the Group.
Annual Report 2021
67
67
/HYHO4XHHQ6WUHHW$XFNODQG
32%R[$XFNODQG
1HZ=HDODQG
T:
F:
E:
DXFNODQG#EDNHUWLOO\VUQ]
W:ZZZEDNHUWLOO\VUQ]
INDEPENDENT AUDITOR’S REPORT
To the Shareholders of Radius Residential Care Limited
Report on the Audit of the Consolidated Financial Statements
Opinion
We have audited the consolidated financial statements of Radius Residential Care Limited and its subsidiaries
('the Group') on pages 28 to 66, which comprise the consolidated statement of financial position as at 31 March
2021, and the consolidated statement of comprehensive income, consolidated statement of changes in equity
and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial
statements, including significant accounting policies.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the
consolidated financial position of the Group as at 31 March 2021, and its consolidated financial performance
and its consolidated cash flows for the year then ended in accordance with New Zealand Equivalents to
International Financial Reporting Standards ('NZ IFRS') and International Financial Reporting Standards ('IFRS').
Our report is made solely to the Shareholders of the Group. Our audit work has been undertaken so that we
might state to the Shareholders of the Group those matters we are required to state to them in an auditor’s
report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume
responsibility to anyone other than the Shareholders of the Group as a body, for our audit work, for our report
or for the opinions we have formed.
Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (New Zealand) ('ISAs (NZ)').
Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of
the Consolidated Financial Statements section of our report. We are independent of the Group in accordance
with Professional and Ethical Standard 1 (Revised) International Code of Ethics for Assurance Practitioners
(including International Independence Standards) (New Zealand) issued by the New Zealand Auditing and
Assurance Standards Board and the International Ethics Standards Board for Accountants’ Code of Ethics for
Professional Accountants (including International Independence Standards) (‘IESBA Code’), and we have fulfilled
our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that
the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Other than in our capacity as auditor and provider of other assurance services, our firm carries out other
assignments for Radius Residential Care Limited and its subsidiaries in the area of taxation compliance
services. The provision of these other services has not impaired our independence.
Radius Residential Care Limited
68
68
Key Audit Matters
Key audit matters are those matters that, in our professional judgement, were of most significance in our audit
of the consolidated financial statements of the current year. These matters were addressed in the context of
our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do
not provide a separate opinion on these matters.
Key audit matter How our audit addressed the key audit matter
Impairment testing of Goodwill
As
disclosed in Note 5.2 of the Group’s
consolidated financial statements, the Group
has goodwill of $17.0m allocated across 20
cash-generating units (‘CGUs’) as at 31
March 2021.
Goodwill was significant to our audit due to
the size of the asset and the subjectivity,
complexity and uncertainty inherent in the
measurement of the recoverable amount of
these CGUs for the purpose of the required
annual impairment test. The measurement of
a CGUs recoverable amount includes the
assessment and calculation of its ‘fair value
less costs of disposal’.
Management has completed the annual
impairment test for all CGUs as at 31 March
2021.
This annual impairment test involves
complex and subjective estimation and
judgement by Management on the future
performance of the CGUs, discount rates
applied to the future cash flow forecasts, the
terminal growth rates, costs of disposal and
future market and economic conditions.
Management has also engaged an external
valuation expert to assist in the annual
impairment testing.
Our audit procedures among others included:
•Understanding and evaluating the Group’s internal controls relevant to the
accounting estimates used to determine the recoverable value of the
Group’s CGUs.
•Evaluating Management’s determination of the Group’s CGUs base
d on
our understanding of the nature of the Group’s business and the economic
environment in which the segments operate. We also analysed the internal
reporting of the Group to assess how CGUs are monitored and reported.
•Evaluating the competence, capabilities, objectivity and expertise of
Management's external valuation expert and the appropriateness of the
expert's work as audit evidence for the relevant assertions.
•Challenging Management’s assumptions and estimates used
to
determine the recoverable value of the Group’s CGUs, including those
relating to forecasted revenue, costs, capital expenditure, discount rates,
by adjusting for future events and corroborating the key market-related
assumptions to external data
(including considering the impact of the
COVID-19 pandemic).
Procedures included:
oEvaluating the logic of the ‘fair value less costs of disposal’
calculations supporting Management’s annual impairment test
and testing the mathematical accuracy of these calculations;
oEvaluating Management’s process regarding the preparation and
review of forecasts
(balance sheet, income statement, and cash
flow statement);
oComparing forecasts used in the calculations to Board approved
forecasts;
oEvaluating the accuracy of the Group’s forecasting to actual
historical performance;
oEvaluating the forecast growth assumptions;
oEvaluating the inputs to the calculation of the discount rates
applied;
oEngaging our own internal valuation experts to evaluate the logic
of the ‘fair value less costs of disposal’ calculations and the inputs
to the calculations of the discount rates applied;
oEvaluating the forecasts, inputs and any underlying assumptions
with a view to identifying Management bias;
oEvaluating Management’s sensitivity analysis for reasonably
possible changes in key assumptions; and
oPerforming sensitivity analysis for reasonably possible changes in
key assumptions, the two main assumptions being: the discount
rate and forecast growth assumptions.
•Evaluating the related disclosures (including the accounting policies and
accounting estimates) about goodwill assets in the Group’s consolidated
financial statements.
69
Key audit matter How our audit addressed the key audit matter
Valuation of investment properties and freehold land
and buildings
As respectively disclosed in Notes 3.1 and 3.2 of the
Group’s consolidated financial statements, as at 31
March 2021, the Group has: investment properties
(operated by the Group as retirement villages) totalling
$31.7m; and
freehold land and buildings totalling
(operated by the Group for provision of care services)
$18.2m. For the purpose of this key audit matter, the
Group’s investment properties and freehold land and
buildings, when referred to, together or collectively as ‘the
properties’).
Investment properties and freehold land and buildings
were significant to our audit due to the size of the assets
and the subjectivity, complexity and uncertainty inherent
in estimating the fair value of the investment properties
and freehold land and buildings.
Management has engaged independent external valuers
(‘the Valuers’) to determine the fair value of the Group’s
investment properties and freehold land and buildings as
at 31 March 2021. The Valuers performed their work in
accordance with the International Valuation Standards
and the Australia and New Zealand Valuation and
Property Standards, NZ IFRS 13 Fair Value Measurement
and NZ IAS 40 Investment Property or NZ IAS 16 Property,
plant and equipment, respectively. The Valuers engaged
by the Group have appropriate experience in the sector in
which the Group operates.
For each investment property, the Valuers took into
account property specific information such as the income
generated by departures and the re-sale of independent
living units. They then applied assumptions in relation to,
the timing of unit re-sale, the length of occupancy of
existing residents, the price paid by new residents, price
movements, type of Occupancy Right Agreement,
discount rate, growth rate and terminal yield. The Valuer
also considered the individual characteristics of each
village, its location, its nature, its resident profile and the
expected future cash flows for that particular village.
For each freehold land and building property, the Valuers
took into account property specific information such as
capitalisation rates and earnings per care bed. The
Valuers also considered the individual characteristics of
each property, its location, and its nature.
The Group has adopted the assessed values determined
by the Valuers.
As at valuation date, the Valuers have included a
valuation uncertainty clause in their reports as a result of
the COVID-19 pandemic. This clause highlights the
difficulties in undertaking valuations due to the absence
of or limited relevant transactional evidence that
demonstrates current market pricing. Therefore, less
certainty and a higher degree of caution, should be
attached to the point estimate valuation.
This represents an increase in the significant estimation
uncertainty in the valuation of investment properties.
Given the valuation uncertainty, the Valuers have
recommended in their reports that the valuations of the
properties be kept under frequent review.
Our audit procedures among others included:
•Understanding and evaluating the Group’s internal controls
relevant to the accounting estimates used to determine the
fair value of the Group’s investment properties and freehold
land and buildings.
•Reading the external valuation reports for the Group’s
investment properties and freehold land and buildings as at
31 March 2021.
•Confirming that the valuation approaches for the properties
were in accordance with NZ IFRS 13 and NZ IAS 40 or NZ
IAS 16, respectively, and suitable for determining the fair
value of the Group’s investment properties and freehold land
and buildings as at 31 March 2021.
•Evaluating the competence, capabilities, objectivity and
expertise of Management's external valuation expert and the
appropriateness of the expert's work as audit evidence for
the relevant assertions.
•Agreeing property related data provided by Management to
the Valuers, to the Group’s records.
•Engaging our own external property valuation expert to
assist in understanding and evaluating the following, based
on their specialist knowledge from performing and reviewing
valuations of similar properties, known relevant transactional
evidence and available market data:
othe work and findings of the Group’s external valuation
expert engaged by Management;
o
the Group’s valuation methods and assumptions to
assist us in challenging the appropriateness of
valuation methods and assumptions used by
Management; and
othe acceptable range of values considered reasonable
to evaluate Management’s adopted valuation
estimate.
•Evaluating the selection of valuation methods, inputs and
assumptions with a view to identifying Management bias.
•Evaluating the related disclosures (including the accounting
policies and accounting estimates) about the investment
properties and freehold land and buildings which are
included in the Group’s consolidated financial statements
including disclosure on the valuation uncertainty as a result
of the COVID-19 pandemic.
Annual Report 2021
69
69
Key audit matter How our audit addressed the key audit matter
Valuation of investment properties and freehold land
and buildings
As respectively disclosed in Notes 3.1 and 3.2 of the
Group’s consolidated financial statements, as at 31
March 2021, the Group has: investment properties
(operated by the Group as retirement villages) totalling
$31.7m; and
freehold land and buildings totalling
(operated by the Group for provision of care services)
$18.2m. For the purpose of this key audit matter, the
Group’s investment properties and freehold land and
buildings, when referred to, together or collectively as ‘the
properties’).
Investment properties and freehold land and buildings
were significant to our audit due to the size of the assets
and the subjectivity, complexity and uncertainty inherent
in estimating the fair value of the investment properties
and freehold land and buildings.
Management has engaged independent external valuers
(‘the Valuers’) to determine the fair value of the Group’s
investment properties and freehold land and buildings as
at 31 March 2021. The Valuers performed their work in
accordance with the International Valuation Standards
and the Australia and New Zealand Valuation and
Property Standards, NZ IFRS 13 Fair Value Measurement
and NZ IAS 40 Investment Property or NZ IAS 16 Property,
plant and equipment, respectively. The Valuers engaged
by the Group have appropriate experience in the sector in
which the Group operates.
For each investment property, the Valuers took into
account property specific information such as the income
generated by departures and the re-sale of independent
living units. They then applied assumptions in relation to,
the timing of unit re-sale, the length of occupancy of
existing residents, the price paid by new residents, price
movements, type of Occupancy Right Agreement,
discount rate, growth rate and terminal yield. The Valuer
also considered the individual characteristics of each
village, its location, its nature, its resident profile and the
expected future cash flows for that particular village.
For each freehold land and building property, the Valuers
took into account property specific information such as
capitalisation rates and earnings per care bed. The
Valuers also considered the individual characteristics of
each property, its location, and its nature.
The Group has adopted the assessed values determined
by the Valuers.
As at valuation date, the Valuers have included a
valuation uncertainty clause in their reports as a result of
the COVID-19 pandemic. This clause highlights the
difficulties in undertaking valuations due to the absence
of or limited relevant transactional evidence that
demonstrates current market pricing. Therefore, less
certainty and a higher degree of caution, should be
attached to the point estimate valuation.
This represents an increase in the significant estimation
uncertainty in the valuation of investment properties.
Given the valuation uncertainty, the Valuers have
recommended in their reports that the valuations of the
properties be kept under frequent review.
Our audit procedures among others included:
•Understanding and evaluating the Group’s internal controls
relevant to the accounting estimates used to determine the
fair value of the Group’s investment properties and freehold
land and buildings.
•Reading the external valuation reports for the Group’s
investment properties and freehold land and buildings as at
31 March 2021.
•Confirming that the valuation approaches for the properties
were in accordance with NZ IFRS 13 and NZ IAS 40 or NZ
IAS 16, respectively, and suitable for determining the fair
value of the Group’s investment properties and freehold land
and buildings as at 31 March 2021.
•Evaluating the competence, capabilities, objectivity and
expertise of Management's external valuation expert and the
appropriateness of the expert's work as audit evidence for
the relevant assertions.
•Agreeing property related data provided by Management to
the Valuers, to the Group’s records.
•Engaging our own external property valuation expert to
assist in understanding and evaluating the following, based
on their specialist knowledge from performing and reviewing
valuations of similar properties, known relevant transactional
evidence and available market data:
othe work and findings of the Group’s external valuation
expert engaged by Management;
o
the Group’s valuation methods and assumptions to
assist us in challenging the appropriateness of
valuation methods and assumptions used by
Management; and
othe acceptable range of values considered reasonable
to evaluate Management’s adopted valuation
estimate.
•Evaluating the selection of valuation methods, inputs and
assumptions with a view to identifying Management bias.
•Evaluating the related disclosures (including the accounting
policies and accounting estimates) about the investment
properties and freehold land and buildings which are
included in the Group’s consolidated financial statements
including disclosure on the valuation uncertainty as a result
of the COVID-19 pandemic.
Radius Residential Care Limited
70
70
Key audit matter How our audit addressed the key audit matter
Valuation and completeness of lease
liabilities and right-of-use assets
As disclosed in Note 3.4 of the Group’s
consolidated financial statements, the Group
has lease liabilities of $184.3m, and, right-of-
use assets of $177.2m as at 31 March 2021.
Lease liabilities and right-of-use assets are
significant to our audit due to the size of the
assets and liabilities and the subjectivity,
complexity and uncertainty inherent in the
application of NZ IFRS 16 Leases and the
assumptions required by Management for the
calculations of the lease balances and interest
and depreciation expenses.
Management has completed calculations of
the lease balances for all leases for the year
ended, and as at 31 March 2021.
These calculations require estimates regarding
the lease term and the incremental borrowing
rates. In addition, Management has exercised
their judgement in determining the
recoverability of right-of-use assets. No
impairment has been determined.
Our audit procedures among others included:
•Understanding and evaluating the Group’s internal controls relevant to
the accounting estimates used to determine the expected term of the
Group’s leases and applicable incremental borrowing rates.
•Evaluating Management’s process relating to the identification,
recording, recognition and measurement of leases within the scope of
NZ IFRS 16.
•For all leases:
oAgreeing key inputs in the lease calculation to the underlying
lease agreement(s);
oRecalculating the lease liability and right-of-use assets based on
the key inputs noted above and comparing our recalculations to
the balances recognised by the Group; and
oChecking the appropriateness of the classification of the lease
liability between current and non-current based on the remaining
term of the lease.
•For all existing leases, evaluating Management’s calculations for the
subsequent measurement of the leases, including lease modifications
and rent revisions.
•Evaluating the completeness of identified lease contracts by checking
that all leased facilities were included in the calculation.
•Evaluating Management’s estimates regarding terms of the leases and
Management’s consideration of options to extend or terminate the
leases (including considering the impact of the COVID-19 pandemic).
•Evaluating Management’s assessment of the incremental borrowing
rates applied to individual leases or portfolios of leases.
•Evaluating the inputs and any underlying assumptions with a view to
identifying Management bias.
•Evaluating Management’s assessment of any indicators of impairment
for the right of use assets in accordance with NZ IAS 36 Impairment of
Assets (including considering the impact of the COVID-19 pandemic).
•Evaluating the disclosures (including the accounting policies and
accounting estimates) related to leases which are included in the
Group’s consolidated financial statements.
Other Matter - Non-NZ GAAP financial measures
Note 1(ii) of the consolidated financial statements describes that the consolidated financial statements include
the presentation of two non-NZ GAAP (non-Generally Accepted Accounting Practice in New Zealand) financial
measures in Note 2.1, which are presented in addition to NZ GAAP (Generally Accepted Accounting Practice in
New Zealand) financial measures. These two non-NZ GAAP financial measures are not defined under the
requirements of NZ GAAP, NZ IFRS and IFRS. Our opinion is not modified in respect of this matter.
Other Information
The Directors are responsible for the other information. The other information comprises the information
included in the Group’s annual report for the year ended 31 March 2021 (but does not include the consolidated
financial statements and our auditor’s report thereon).
71
Our opinion on the consolidated financial statements does not cover the other information and we do not
express any form of audit opinion or assurance conclusion thereon.
In connection with our audit of the consolidated financial statements, our responsibility is to read the other
information and, in doing so, consider whether the other information is materially inconsistent with the
consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially
misstated.
If, based on the work we have performed, we conclude that there is a material misstatement of this other
information, we are required to report that fact. We have nothing to report in this regard.
Responsibilities of the Directors for the Consolidated Financial Statements
The Directors are responsible on behalf of the Group for the preparation and fair presentation of the
consolidated financial statements in accordance with NZ IFRS and IFRS, and for such internal control as the
Directors determine is necessary to enable the preparation of the consolidated financial statements that are
free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, the Directors are responsible on behalf of the Group for
assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting unless the Directors either intend to liquidate the
Group or to cease operations, or have no realistic alternative but to do so.
Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a
whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that
includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit
conducted in accordance with ISAs (NZ) will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they
could reasonably be expected to influence the economic decisions of users taken on the basis of these
consolidated financial statements.
As part of an audit in accordance with ISAs (NZ), we exercise professional judgement and maintain professional
scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the consolidated financial statements, whether
due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit
evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a
material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve
collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Annual Report 2021
71
71
Our opinion on the consolidated financial statements does not cover the other information and we do not
express any form of audit opinion or assurance conclusion thereon.
In connection with our audit of the consolidated financial statements, our responsibility is to read the other
information and, in doing so, consider whether the other information is materially inconsistent with the
consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially
misstated.
If, based on the work we have performed, we conclude that there is a material misstatement of this other
information, we are required to report that fact. We have nothing to report in this regard.
Responsibilities of the Directors for the Consolidated Financial Statements
The Directors are responsible on behalf of the Group for the preparation and fair presentation of the
consolidated financial statements in accordance with NZ IFRS and IFRS, and for such internal control as the
Directors determine is necessary to enable the preparation of the consolidated financial statements that are
free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, the Directors are responsible on behalf of the Group for
assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting unless the Directors either intend to liquidate the
Group or to cease operations, or have no realistic alternative but to do so.
Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a
whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that
includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit
conducted in accordance with ISAs (NZ) will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they
could reasonably be expected to influence the economic decisions of users taken on the basis of these
consolidated financial statements.
As part of an audit in accordance with ISAs (NZ), we exercise professional judgement and maintain professional
scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the consolidated financial statements, whether
due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit
evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a
material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve
collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Radius Residential Care Limited
72
72
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness
of the Group’s internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates
and related disclosures made by management.
Conclude on the appropriateness of the use of the going concern basis of accounting by the Directors and,
based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions
that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that
a material uncertainty exists, we are required to draw attention in our auditor’s report to the related
disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our
opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report.
However, future events or conditions may cause the Group to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the consolidated financial statements, including
the disclosures, and whether the consolidated financial statements represent fairly the underlying
transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business
activities within the Group to express an opinion on the consolidated financial statements. We are
responsible for the direction, supervision and performance of the group audit. We remain solely responsible
for our audit opinion.
We communicate with the Directors regarding, among other matters, the planned scope and timing of the audit
and significant audit findings, including any significant deficiencies in internal control that we identify during
our audit.
We also provide the Directors with a statement that we have complied with relevant ethical requirements
regarding independence, and to communicate with them all relationships and other matters that may
reasonably be thought to bear on our independence, and where applicable, related safeguards.
From the matters communicated with the Directors, we determine those matters that were of most significance
in the audit of the consolidated financial statements of the current year and are therefore the key audit matters.
We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about
the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated
in our report because the adverse consequences of doing so would reasonably be expected to outweigh the
public interest benefits of such communication.
73
Matters Relating to the Electronic Presentation of the Audited Consolidated Financial Statements
This audit report relates to the consolidated financial statements of Radius Residential Care Limited and its
subsidiaries for the year ended 31 March 2021 included on Radius Residential Care Limited ’s website. The
Directors of Radius Residential Care Limited are responsible for the maintenance and integrity of Radius
Residential Care Limited ’s website. We have not been engaged to report on the integrity of Radius Residential
Care Limited ’s website. We accept no responsibility for any changes that may have occurred to the
consolidated financial statements since they were initially presented on the website.
The audit report refers only to the consolidated financial statements named above. It does not provide an
opinion on any other information which may have been hyper linked to or from these consolidated financial
statements. If readers of this report are concerned with the inherent risks arising from electronic data
communication they should refer to the published hard copy of the audited consolidated financial statements
and related audit report dated 25 May 2021 to confirm the information included in the audited consolidated
financial statements presented on this website.
Legislation in New Zealand governing the preparation and dissemination of consolidated financial statements
may differ from legislation in other jurisdictions.
The engagement partner on the audit resulting in this independent auditor’s report is S Patel.
BAKER TILLY STAPLES RODWAY AUCKLAND
Auckland, New Zealand
25 May 2021
Annual Report 2021
73
73
Matters Relating to the Electronic Presentation of the Audited Consolidated Financial Statements
This audit report relates to the consolidated financial statements of Radius Residential Care Limited and its
subsidiaries for the year ended 31 March 2021 included on Radius Residential Care Limited ’s website. The
Directors of Radius Residential Care Limited are responsible for the maintenance and integrity of Radius
Residential Care Limited ’s website. We have not been engaged to report on the integrity of Radius Residential
Care Limited ’s website. We accept no responsibility for any changes that may have occurred to the
consolidated financial statements since they were initially presented on the website.
The audit report refers only to the consolidated financial statements named above. It does not provide an
opinion on any other information which may have been hyper linked to or from these consolidated financial
statements. If readers of this report are concerned with the inherent risks arising from electronic data
communication they should refer to the published hard copy of the audited consolidated financial statements
and related audit report dated 25 May 2021 to confirm the information included in the audited consolidated
financial statements presented on this website.
Legislation in New Zealand governing the preparation and dissemination of consolidated financial statements
may differ from legislation in other jurisdictions.
The engagement partner on the audit resulting in this independent auditor’s report is S Patel.
BAKER TILLY STAPLES RODWAY AUCKLAND
Auckland, New Zealand
25 May 2021
Radius Residential Care Limited
74
Corporate
Governance
Statement
The Board of Radius Residential Care
Limited (Radius Care, the Company) is
committed to ensuring that the Company
meets best practice governance
principles and maintains the highest
ethical standards by conducting our
business safely and ethically and within
the legal and regulatory framework, so
we can deliver the best outcomes for our
residents, their families, shareholders,
employees, customers and suppliers, and
the communities in which we operate.
This Corporate Governance Statement provides an overview of the Company’s governance framework. It is structured to follow the
NZX Corporate Governance Code (NZX Code) and discloses the practices relating to the NZX Code’s recommendations.
The Board regularly reviews the Company’s corporate governance structures against the eight principle recommendations in the
Code, and considers that during the period from its listing to 31 March 2021 its practices and procedures substantially met NZX Code
recommendations. Any differences, where recommendations of the NZX Code have not been followed are set on page 85 of this
annual report.
The Company’s governance policies are available on its website, see www.radiuscare.co.nz/investors-centre/governance.
The Radius Care Board approved this Corporate Governance Statement on 25 May 2021.
For detailed information on the Group’s corporate
governance policies, practices and processes please refer to
the Investors section on the Radius Care website:
www.radiuscare.co.nz/investors-centre/governance
This contains the following documents:
Constitution
Charters
• Board Charter
• Audit and Risk Committee Charter
• Remuneration and Human Resources Committee Charter
Policies
• Code of Conduct
• External Auditor Independence Policy
• Financial Product Trading Policy
• Fraud Policy
• Market Disclosure Policy
• Whistleblower Policy
Annual Report 2021
75
Principle 1. Code of ethical behaviour
Directors should set high standards of ethical behaviour, model this behaviour and hold management accountable for these
standards being followed throughout the organisation.
Code of Conduct
The Company’s ethical standards are included in the Company’s Code of Conduct and the Board Charter.
Radius Care commits to high ethical standards in all dealings undertaken by the Group’s directors, employees and suppliers. We are a
New Zealand owned and operated company that is committed to providing quality rest home and private hospital care. Our business
spans healthcare, cultural and regulatory boundaries, and our directors and management understand that high ethical standards
deliver the best outcomes for our residents, their families, employees, shareholders, suppliers and customers, and communities.
Our commitment to ethical dealings is captured by the Company’s core brand attribute “Exceptional People, Exceptional Care” and in
the Code of Conduct and Board Charter.
The Radius Care Code of Conduct outlines how directors and employees are to consistently act with honesty and integrity.
The Code of Conduct will be reviewed by the Board every two years.
Annual Report 2021
75
Radius Residential Care Limited
76
Corporate Governance continued
Trading in Financial Products
Radius Care also has a Financial Product Trading Policy, prohibiting the direct or indirect dealing of the Company’s financial products
when holding inside information, and setting out a duty of confidentiality that protects the dissemination and use of confidential
company information. The Financial Product Trading Policy also defines black-out periods during which certain restricted persons are
prohibited in trading in Radius Care shares unless provided by a specific exemption by the Radius Care Chair or Chief Executive (CEO).
Principle 2. Board composition and performance
To ensure an effective board, there should be a balance of independence, skills, knowledge, experience and perspectives.
Responsibilities of the Board
The Board has overall responsibility for all decision making within Radius Care. Day-to-day management of the Company, including
being the company’s principal representative, is delegated to the CEO. The Boards’ functions are set out in the Board Charter and
include:
• Establishing corporate objectives and strategies
• Reviewing and approving the strategic, business, risk, and financial plans prepared by management.
• Monitoring performance against these plans.
• Appointing, providing counsel to and reviewing the performance of the CEO.
• Approving major investments and divestments.
• Ensuring ethical behaviour by the Company, Board, management and employees.
• Assessing its own effectiveness in carrying out its functions.
• Ensuring timely and transparent stakeholder and market communication.
The Board monitors these matters by receiving reports and plans from management, maintaining an active programme of divisional
visits and through its annual work programme.
The Board uses committees to address certain issues that require detailed consideration by members of the Board who have
specialist knowledge and experience. The Board retains ultimate responsibility for the functions of its committees and determines
their responsibilities.
The Board has a statutory obligation to reserve responsibility for certain matters.
Details of the Radius Care Board’s role, composition, responsibilities, operation, policies and committees are provided in the Board
Charter.
Director nomination, appointment and reappointment
The Board is responsible for the process of appointment and reappointment of Directors, who are elected by Shareholders. The Board
identifies candidates to be nominated or re-elected as a Director through a procedure outlined in the Board Charter.
The Board is comprised of Directors who have a mix of skills, knowledge, experience and diversity to adequately discharge its
responsibilities and add value to Radius Care.
Letter of appointment
All Directors have entered into a written agreement with Radius Care setting out the terms of their appointment.
Annual Report 2021
77
Board composition
Directors
As at 31 March 2021 and the date of this Annual Report, the Board comprised of the following six Directors:
Brien Cree Chair, Executive Director Appointed August 2003
Duncan Cook Executive Director Appointed July 2010
Bret Jackson Non-Executive Director Appointed September 2014
Timothy Sumner Non-Executive Director Appointed September 2014
Mary Gardiner Independent Director Appointed December 2020
Hamish Stevens Independent Director Appointed December 2020
Four of the Directors are non-executive Directors. The Board has considered which of the Directors are Independent Directors for the
purposes of the NZX Listing Rules and has determined that, as at 31 March 2021, two Directors are Independent Directors, including
the Chair of the Audit Committee. The factors relevant to determining whether a Director is an Independent Director are the criteria in
the NZX Listing Rules for Director independence, having regard to the factors described in the NZX Corporate Governance Code that
may impact Director independence.
The Company’s Constitution specifies that the Board shall have a minimum of three directors; at least two Directors shall be ordinarily
resident in New Zealand; and while the Company is Listed, it shall have not less than the minimum number of Independent Directors
prescribed by the Listing Rules.
A profile of each Director is available on the Radius Care website (www.radiuscare.co.nz) at pages 23 – 24 of this report. The profiles
include information on the skills, experience and background of each Director. Radius Care complies with Listing Rule 2.1.1(c) (namely
“at least two Directors must be Independent Directors”). Having only recently listed on NZX in December 2020, it does not yet comply
with NZX Code Recommendation 2.8 that a majority of the Board should be Independent Directors. Radius Care aims to comply with
this Recommendation in the medium term.
Ownership of Radius Care shares by Directors is encouraged rather than being a requirement. Directors’ ownership interests are
disclosed at page 89.
At this stage the Board does not have a tenure policy however it is committed to a regular refreshment programme to introduce new
perspectives, skills, attributes and experience. A formal evaluation will be undertaken in FY2022 which will identify any skills gap that
should be addressed over the next one to two years.
Interests Register
The Board maintains an Interests Register. Any Director who is interested in a transaction with the Company must immediately
disclose to the Board the nature, monetary value and extent of the interest. A Director who is interested in a transaction may attend
and participate at a Board meeting at which the transaction is discussed but may not be counted in the quorum for that meeting or
vote in respect of the transaction, unless it is one in respect of which Directors are expressly required by the Companies Act 1993 to
sign a certificate. Particulars of entries made in the Interests Register for the year ended 31 March 2021 are included in the Director
Disclosures section on page 86.
Diversity
The Board seeks diversity in the skills, attributes, perspectives and experience of its members across a broad range of criteria so as to
represent the diversity of shareholders, business types and regions in which it operates. Diversity, both at Board level and throughout
the Company, is actively considered and reviewed by the Board. A formal Diversity Policy will be adopted by the Board in FY2022.
Radius Care recruits, promotes and compensates on the basis of merit, regardless of gender, ethnicity, religion, age, nationality, sexual
orientation, union membership or political opinion. A fundamental tenet of the Company’s values is Exceptional people, Exceptional
Care together with: Commitment: Leaders in care; Courage: Do the right thing; Compassion: Act with empathy.
Radius Residential Care Limited
78
Corporate Governance continued
Responsibility for workplace diversity and the setting of measurable objectives is held by the Remuneration and Human Resources
Committee.
The following table reports gender composition of the Board and officers as at 31 March 2021. Radius Care has determined that the
category of Officers comprises the members of its senior management team.
As at 31 March 2021 As at 31 March 2020
Position Female Male Female Male
Director 1 (17%) 5 (83%) - 4 (100%)
Officers 3 (43%) 4 (57%) 2 (40%) 3 (60%)
Director training
The Board ensures that there is appropriate training available to all Directors to enable them to remain current on how best to
discharge their responsibilities and keep up to date on changes and trends in areas relevant to their work. Directors are provided with
industry information and receive copies of appropriate Company documents to enable them to perform their role. In addition, visits to
Radius Care’s facilities, briefing from senior management and key advisors to Radius Care are arranged for Directors. Where training is
undertaken at the Company’s expense, directors are expected to brief the Board on key learnings.
The Board also ensures that new Directors are appropriately introduced to Management and the businesses.
Board Performance Evaluation
The Board undertakes an annual assessment of Board, director and committee performance, seeking assistance, as required, from
external advisors.
Principle 3 – Board Committees
The Board should use committees where this will enhance its effectiveness in key areas, while still retaining Board responsibility.
Board Committees
The Board currently has two committees – the Audit and Risk Committee and the Remuneration and Human Resources Committee.
The Board may set up ad-hoc committees when required to efficiently and effectively carry out key governance functions, while
retaining ultimate responsibility for all decisions and actions.
Each Committee focuses on specific areas of governance and together they strengthen the Board’s oversight of the Company.
Committee membership is reviewed annually. Each Committee has a written charter that is approved by the Board, which sets out its
mandate. The charters are reviewed annually with any proposed changes recommended to the Board for approval. The charters are
available at www.radiuscare.co.nz/investors-centre/governance.
Each Committee has an annual work programme of matters to be addressed over the following 12 month period. Included in the work
programme is an annual review of performance against the Committee charter and objectives for the year. The Committee’s review
findings are reported to the Board.
Standing committees of the Board
Audit and Risk Committee
CompositionRolesMembers
• At least three members of the Board;
a majority of members must be
independent.
• At least one member who has an
accounting or financial background.
• Committee Chair appointed by the Board;
must be an independent director; not the
Chair of the Board.
Responsibility for:
• External financial reporting;
• Internal control environment;
• Business Assurance / Internal Audit
and external audit functions;
• Risk management.
Hamish Stevens (Chair)
Mary Gardiner
Tim Sumner
Annual Report 2021
79
The Committee met on one occasion during the period from listing on 10 December 2020 to 31 March 2021.
Remuneration and Human Resources Committee
CompositionRolesMembers
• At least three members of the Board.
• Committee Chair appointed by the Board;
must be a non-executive director; not the
Chair of the Board.
Responsibility for:
• Establishment of remuneration
policies and practices for the CEO,
Key Management, and Directors;
• Oversee remuneration-setting and
review; and
• Oversee the management of human
resources activities.
Duncan Cook (Chair)
Mary Gardiner
Bret Jackson
The Committee did not meet during the period from listing on 10 December 2020 to 31 March 2021. Radius Care does not currently
fully comply with NZX Code Recommendation 3.3 given that the Remuneration and Human Resource Committee does not currently
comprise of a majority of Independent Directors.
Meeting Attendance by Officers
Officers and other employees only attend Committee meetings at the invitation of the relevant Committee.
The CEO and General Manager, Finance are regularly invited to attend Audit and Risk Committee meetings.
Attendance at Meetings
Director attendance at Board and Committee meetings during the period from 10 December 2020 when Radius Care listed on NZX to
31 March 2021 are set out below.
Board, Audit and Risk Committee, Remuneration and Human Resources Committee
Board Audit & Risk Committee Remuneration & Human
Resources Committee
Eligible to Eligible to Eligible to
attend Attended attend Attended attend Attended
Brien Cree 3 3
Duncan Cook 3 3 0 0
Mary Gardiner 3 3 1 1 0 0
Bret Jackson 3 3 0 0
Hamish Stevens 3 3 1 1
Tim Sumner 3 3 1 1
No separate Nomination Committee
The Board has decided not to have a separate Nomination Committee as Director appointments are considered by the Board as a
whole, as further disclosed in Principle 2 above.
Takeover offer protocols
In the event a takeover offer is received, the Board would engage legal and financial experts to provide advice on procedure. Forward
takeover protocols will be developed and adopted in FY2022.
Radius Residential Care Limited
80
Principle 4 – Reporting and Disclosure
The Board should demand integrity in financial and non-financial reporting, and in the timeliness and balance of corporate
disclosures.
Shareholder Communications and Market Disclosure
The Board is committed to providing timely, orderly, consistent, accurate, and credible information in accordance with legal and
regulatory requirements to enable orderly behaviour in the market. The Board believes objective disclosure is fundamental to building
shareholder value and earning the confidence of the investment community.
The Company has in place a written Market Disclosure Policy designed to ensure this occurs. The policy includes procedures intended
to ensure that disclosure is made in a timely and balanced manner and in compliance with the NZX Listing Rules, such that the
Board is able to fulfil its obligation to keep investors and the market informed through a timely, clear, and balanced approach that
communicates all information which may have a material effect on the price of Radius Care’ shares, whether it is positive or negative, in
accordance with the NZX Listing Rules.
Procedures are set out in the Policy to guide Directors, officers and employees on the appropriate steps to take if they become aware
of any information that may be material that is not generally available to the market. All NZX and media releases are subject to an
agreed sign off procedure which requires approval from the Chair of the Board or CEO. Significant market announcements, including
the preliminary announcement of the half year and full year results, the consolidated financial statements for those periods, and any
advice of a change in earnings forecast are approved by the Board.
Directors consider at the end of each Board meeting whether there is any material information that should be disclosed to the market.
Financial and Non-Financial Reporting
The Board is committed to ensuring integrity and timeliness in its financial reporting and in providing information to the market
and shareholders. A programme of clear, meaningful, timely and effective communications with shareholders is centred around a
comprehensive set of information regarding the Company’s operations and results being available primarily in its six monthly and full
year reports, in ad hoc releases lodged with NZX and also on its website.
The Audit and Risk Committee oversees the quality and integrity of external financial reporting including the accuracy, completeness,
balance and timeliness of financial statements. It reviews interim and annual financial statements and makes recommendations to the
Board concerning accounting policies, areas of judgement, compliance with financial reporting standards, stock exchange and legal
requirements, and the results of the external audit.
All interim and full-year consolidated financial statements are prepared in accordance with relevant financial standards.
Principle 5 - Remuneration
The remuneration of directors and executives should be transparent, fair and reasonable.
Director Remuneration
In accordance with best practice corporate governance, the structure of Director remuneration is separate and distinct from the
remuneration of the CEO and other officers, and is reviewed on an annual basis.
The Board intends to review Director remuneration annually to ensure the Company’s Directors are fairly remunerated for their
services and level of skill and experience required to fulfil the role is recognised. They have no entitlement to any performance-based
remuneration or participation in any share-based incentive schemes.
Each Director receives a base fee for services as a Director of the Company and an additional fee is also paid for being a member of
the Board Committees. The payment of an additional fee recognises the additional time commitment and specific skills required by
each Director who serves on those Committees. All Directors are also entitled to be reimbursed for costs associated with carrying out
their duties.
Corporate Governance continued
Annual Report 2021
81
Fees paid to the Directors of the Company (in their capacity as director) for year ended 31 March 2021 were as follows:
Fees for serving
on Remuneration
Fees for serving and Human
on Audit and Risk Resources Total
Directors Base fee Committee Committee Remuneration
Brien Cree $52,083 $52,083
Duncan Cook $113,333 $4,000 $117,333
Mary Gardiner $30,000 $2,000 $2,000 $34,000
Bret Jackson $82,083 $2,000 $84,083
Hamish Stevens $30,000 $4,000 $34,000
Tim Sumner $82,083 $2,000 $84,083
As of listing, Brien Cree as Executive Chairman of Radius Care did not receive any fees in his capacity as a Director. The fees paid to
Brien Cree in the table above were paid in the period prior to Radius Care’s listing on 10 December 2020.
The fees for directors of Radius Care (in their capacity as directors) that applies from the date of listing on NZX have been fixed as a
total pool of up to $800,000 per annum. In FY2022, the total fees payable to directors of Radius Care (in their capacity as directors) is
expected to be $522,000 excluding the Executive Chairman / Managing Director.
Position Fees per annum
Chair Nil
Directors (other than the Chair) $90,000
Committee Chair $12,000
Committee members $6,000
Remuneration of the CEO
The remuneration of the CEO currently comprises fixed remuneration that is based on the scale and complexity of the role, market
relativities, qualifications and experience. Other benefits, including Kiwisaver and a carpark, are included in fixed remuneration.
Radius Care does not currently have any short-term incentive (STI) or long-term incentive (LTI) arrangements in place for the CEO, and
accordingly no such payments were made in the FY2021 year. Stuart Bilbrough did however receive a one-off issue of 187,500 shares
having a value of $150,000 in connection with the successful listing of Radius Care in FY2021. The Board intends to establish STI and
LTI arrangements for the CEO in FY2022.
Radius Residential Care Limited
82
CEO Remuneration Paid
Share based
Salary
1
$ Benefits
2
$ Subtotal $ payments $ Total $
Stuart Bilbrough* FY2021 339,231 14,577 353,808 150,000 503,808
Brien Cree^ FY2021 880,598 29,981 910,579 - 910,579
Brien Cree FY2020 827,899 28,400 856,299 - 856,299
1 Actual salary paid includes holiday pay paid as per NZ legislation.
2 Benefits include Kiwisaver and car park.
* The CEO was employed on 8 June 2020.
^ In his capacity as Managing Director of Radius Care in the 12 months to 31 March 2021.
Employees’ Remuneration
All employees are employed by Radius Care. The number of employees and former employees, not in relation to being a Director of
Radius Care, who received remuneration and other benefits the value of which exceeded $100,000 during the financial year ended 31
March 2021 is set out in the table of remuneration bands below.
The remuneration figures shown in the “Remuneration” column include all monetary payments actually paid during the course of the
year ended 31 March 2021. The table does not include amounts paid after 31 March 2021 that relate to the year ended 31 March
2021.
Remuneration Number of employees
$910,000 - $919,999 1
$350,000 - $359,999 1
$300,000 - $309,999 1
$200,000 - $209,999 1
$170,000 to $179,999 1
$150,000 to $159,999 1
$140,000 to $149,999 3
$130,000 to $139,999 7
$120,000 to $129,999 1
$110,000 to $119,999 3
$100,000 to $109,999 9
Corporate Governance continued
Annual Report 2021
83
Principle 6 – Risk Management
Directors should have a sound understanding of the material risks faced by the issuer and how to manage them. The Board should
regularly verify that the issuer has appropriate processes that identify and manage potential and material risks.
The Board is responsible for ensuring that key business risks are identified, and that appropriate controls and responses are in place
to effectively manage those risks. The Board considers risk management an important governance function to protect stakeholders
and optimise shareholder value.
The Board composition includes Directors with long-term experience in the care sector and with senior-level governance experience.
The Board’s complementary skill set and understanding of the core business have allowed it to implement strategies to mitigate risk
such as those associated with the COVID-19 pandemic.
The Board retains ultimate oversight of risk management, with the Audit and Risk Committee delegated with responsibility for ensuring
that the Company’s risk management framework is appropriate and that it appropriately identifies, assesses, manages and monitors
risks.
The Committee’s responsibilities in relation to risk include:
• assessing the effectiveness of, and monitor compliance with, the risk management framework;
• identifying areas for fulsome review on significant risks for inclusion in the agenda of the responsible Board and/or Board
Committee meeting;
• reporting to the Board on progress with risk management work; and
• reviewing and recommending policies for Board approval.
Risk management is an integral part of Radius Care’s business. The Board requires management to prepare a risk management
framework incorporating a risk register. This approach is intended to embed a comprehensive, holistic, Group-wide culture of risk
awareness in senior management and in decision makers across the business, supported by a consistent method of identifying,
assessing, controlling, monitoring and reporting Radius Care’s existing and potential risks.
The framework is used to identify those situations and circumstances in which the Company may be materially at risk and for which
risk mitigation activities are appropriate. The objectives of the framework are to:
• Provide a consistent and structured way to identify, assess and manage risk across the Company;
• Ensure the Company manages the risks it faces in achieving its objectives; and
• Ensure staff and management are aware of and meet their responsibilities to identify, evaluate and treat the risks that may
prevent or restrict the Company from achieving its objectives.
Risk management is a standing item on the agenda for Audit and Risk Committee meetings, with detailed reports provided by
management.
Insurance
Radius Care has insurance policies in place covering most areas where risk to its assets and business can be insured at a reasonable
cost.
Radius Residential Care Limited
84
Principle 7 – Auditors
The Board should ensure the quality and independence of the external audit process.
External Auditor
Radius Care’s Audit and Risk Committee Charter outlines the Company’s commitment to an independent audit process that provides
shareholders and the market with objective, robust, clear and timely financial reporting. The Committee’s responsibilities are to:
• Monitor the independence and effectiveness of the external auditors;
• Make recommendations to the Board on the appointment and termination of the external auditors;
• Approve the external audit terms of engagement, audit partner rotation, and audit fee;
• Review the annual audit plan of the external auditors;
• Review and approve non-audit services performed by the external auditor in accordance with the External Auditor Independence
Policy;
• Review the External Auditor Independence Policy on a regular basis; and
• Ensure the Key Audit Partner is rotated at least every five years.
The Audit and Risk Committee in consultation with management and the external auditor reviews the efficiency and effectiveness of
the external audit process, and provides a formal channel of communication between the Board, senior management and the external
auditor.
Radius Care’s external auditor is Baker Tilly Staples Rodway. Baker Tilly Staples Rodway has confirmed independence to the Audit and
Risk Committee and that its independence was not compromised during the reporting period.
The External Auditor Independence Policy is available at www.radiuscare.co.nz/investors-centre/governance.
The fees paid to the external auditor is included in note 2.3 of the Notes to the Consolidated Financial Statements. A total of $175k
was paid for audit and assurance-related services, $90k was paid for tax compliance services. No other fees were paid to the external
auditor for professional fees.
All non-assurance services provided must have the prior approval of the Audit and Risk Committee.
The external auditor is regularly invited to meet with the Committee including without management present.
The external auditor has been invited to attend the Annual Shareholders’ Meeting and will be available to answer questions about the
audit process and the independence of the auditor.
Internal Audit
The Company does not have an inhouse internal audit function. The internal control framework that Radius Care uses to manage risk
is described in further detail under Principle 6 above. External specialists will be appointed to carry out the internal audit plan, once
set by the Audit and Risk Committee.
Principle 8. Shareholder rights and relations
The board should respect the rights of shareholders and foster constructive relationships with shareholders that encourage them to
engage with the issuer.
Shareholder Relations
The Board is committed to maintaining open and transparent communications with investors and other stakeholders. Radius
Care listed in December 2020 and has not yet completed a full 12 months as an NZX-listed company. The Board’s shareholder
communications programme will see the annual report, NZX releases, governance policies and charters and a variety of corporate
information posted to the Company’s website.
Recordings of results briefings, when undertaken, will be in the Investors section of the website.
Each shareholder is entitled to receive a hard copy of the annual report, unless they have elected to receive it electronically.
A Shareholder Meetings page will be available in the Investor’s Centre section of the website and will include all relevant documents
relating to the meeting. Shareholder meetings will be held at a time and location to encourage participation in person by shareholders.
Corporate Governance continued
Annual Report 2021
85
Electronic Communications
Shareholders have the option of receiving their communications electronically. Contact details for Radius Care’s support office and its
share registrar, Computershare, are available on the website.
Major Decisions
The Market Disclosure Policy sets out directors’ commitment to timely and balanced disclosure and to advising shareholders on any
major decisions. Where voting on a matter is required, the Board encourages investors to attend the meeting or to send in a proxy
vote. Shareholders may raise matters for discussion at the Annual Shareholders’ Meeting either in person or by emailing Radius Care
with a question to be asked.
Radius Care will conduct voting at its Annual Shareholders’ Meetings by way of poll and on the basis of one share, one vote.
Additional equity
Should additional equity be sought through a capital raising the Board will take NZX Code Recommendation 8.4 into account.
Availability of ASM / ESM notices of meeting
The Board is committed to ensuring that notices of meetings of shareholders are posted to Radius Care’s website as soon as possible
and, where practicable, at least 20 working days prior to the meeting. Where a notice of meeting is circulated less than 20 working
days in advance of the meeting in question, Radius Care will explain why in its next corporate governance statement. There have been
no shareholder meetings held in the period to which this annual report relates.
Differences in practice to NZX Code
Material differences between Radius Care’s corporate governance practices and the NZX Code in the period between listing on 10
December 2020 and 31 March 2021 are set out below. Where there are differences, these have been approved by the Board. Further
developments in corporate governance practices are expected to be implemented during FY2022.
NZX Code
PrincipleNZX Code RecommendationKey differenceCurrent status
2. Board
Composition and
Performance
2.5 Diversity policy
An issuer should have a
written diversity policy
Radius Care does not currently have a
written Diversity Policy
A written Diversity Policy
and Inclusion Policy will
be prepared in FY2022
2. Board
Composition and
Performance
2.8 A majority of the board
should be independent
directors
Radius’ Constitution requires that the
Board be comprised of not less than
five Members. The Board will comprise
at least two Independent Directors
Of the six directors, two
have been determined to
be independent
3. Board
Committees
3.3 Majority of the
Remuneration Committee
should be Independent
Directors
The majority of members are not
independent directors
Of the three members,
one has been determined
to be an independent
director
3. Board
Committees
3.6 The Board should
establish appropriate
takeover protocols
Radius Care does not currently have
any takeover protocols
Formal takeover protocols
will be adopted in FY2022
4. Reporting and
Disclosure
Non-financial disclosures,
including environmental,
economic and social
sustainability risks
Yet to fully develop a sustainability
programme
The Board intends
to actively focus
on developing a
sustainability programme
5. Remuneration5.2 Remuneration policy for
directors and officers
An issuer should have a remuneration
policy for directors and officers
A written Remuneration
Policy will be prepared in
FY2022
Radius Residential Care Limited
86
Other
Disclosures
Interests Register
Disclosure of Directors’ Interests
The full list of Directors’ Interests were disclosed in the 31 March 2020 Consolidated Financial Statements that’s available on the
Radius Care website.
The following particulars are updates that were entered in the Interests Register kept for Radius Care and its subsidiaries during the
year ended 31 March 2021:
Duncan Cook: Disclosed he ceased to hold the following positions:
Entity Nature of Interest
M G Hill Trustee Limited Director
New Horizons Limited Shareholder
Landscape Supplies 15th Ave Limited Shareholder
Sharp Tudhope Protector Services Limited Director
Sharp Tudhope Trustee Holdings Limited Director and Shareholder
Sharp Tudhope Trustee Services Limited Director
Sharp Tudhope Trustee Services No 2 Limited Director
Sharp Tudhope Trustee Services No 3 Limited Director
Sharp Tudhope Trustee Services No 4 Limited Director
Sharp Tudhope Trustee Services No 5 Limited Director
Sharp Tudhope Trustee Services No 6 Limited Director
Sharp Tudhope Trustee Services No 7 Limited Director
Sharp Tudhope Trustee Services No 8 Limited Director
Sharp Tudhope Trustee Services No 9 Limited Director
Sharp Tudhope Trustee Services No 10 Limited Director
Sharp Tudhope Trustee Services No 11 Limited Director
Sharp Tudhope Trustee Services No 12 Limited Director
Sharp Tudhope Trustee Services No 13 Limited Director
Sharp Tudhope Trustee Services No 14 Limited Director
Sharp Tudhope Trustee Services No 15 Limited Director
Sharp Tudhope Trustee Services No 16 Limited Director
Sharp Tudhope Trustee Services No 17 Limited Director
Sharp Tudhope Trustee Services No 18 Limited Director
Sharp Tudhope Trustee Services No 19 Limited Director
Sharp Tudhope Trustee Services No 20 Limited Director
Annual Report 2021
87
Entity Nature of Interest
Sharp Tudhope Trustee Services No 21 Limited Director
Sharp Tudhope Trustee Services No 22 Limited Director
Sharp Tudhope Trustee Services No 23 Limited Director
Sharp Tudhope Trustee Services No 24 Limited Director
Sharp Tudhope Trustee Services No 25 Limited Director
Sharp Tudhope Trustee Services No 26 Limited Director
Sharp Tudhope Trustee Services No 27 Limited Director
Sharp Tudhope Trustee Services No 28 Limited Director
Sharp Tudhope Trustee Services No 29 Limited Director
Sharp Tudhope Trustee Services No 30 Limited Director
Sharp Tudhope Trustee Services No 31 Limited Director
Sharp Tudhope Trustee Services No 32 Limited Director
Sharp Tudhope Trustee Services No 33 Limited Director
Sharp Tudhope Trustee Services No 34 Limited Director
Sharp Tudhope Trustee Services No 35 Limited Director
Sharp Tudhope Trustee Services No 36 Limited Director
Sharp Tudhope Trustee Services No 37 Limited Director
Sharp Tudhope Trustee Services No 38 Limited Director
Sharp Tudhope Trustee Services No 39 Limited Director
Sharp Tudhope Trustee Services No 40 Limited Director
Sharp Tudhope Trustee Services No 41 Limited Director
Sharp Tudhope Trustee Services No 42 Limited Director
Mary Gardiner: Disclosed the following positions:
Entity Nature of Interest
Southern Cross Pet Insurance Limited Director
Northern Netball Zone Incorporated Chair
Mangere Mountain Education Trust Trustee
Kidsen Limited Director and Shareholder
Radius Residential Care Limited
88
Other Disclosures continued
Hamish Stevens: Disclosed the following positions:
Entity Nature of Interest
Pacific Radiology Group Limited Director
Marsden Maritime Holdings Limited Director
Pharmaco NZ Limited Director
Pharmaco House Limited Director
Pharmaco (Australia) Limited Director
The Kennedy’s Limited Director
Botany Health Hub Limited Director
Northport Limited Director
ECL Group Limited Director
Counties Power Limited Director
Evolve Education Group Limited Director
Governance and Advisory Limited Director and Shareholder
East Health Services Limited Director
Ormiston Health Properties Limited Director
Health Improvement Group Limited Director
East Health Clinic Investments Limited Director
Au Pair (Evolve) Limited Director
Evolve ECEM Limited Director
Evolve Group 1 Limited Director
Evolve Group 2 Limited Director
Evolve Group 3 Limited Director
Evolve Group 4 Limited Director
Evolve Group 5 Limited Director
Evolve Group 6 Limited Director
Evolve Home Day Care Limited Director
Evolve Management Group Limited Director
Lollipops Educare (Birkenhead) Limited Director
Lollipops Educare (Hastings) Limited Director
Lollipops Educare Centres Limited Director
Lollipops Educare Holdings Limited Director
Lollipops Educare Limited Director
Specific Disclosures
See related party note 5.5 in the consolidated financial statement section for any disclosures made by Directors during the year ended
31 March 2021 of any interests in transactions with Radius Care or any of its subsidiaries.
Use of Company Information
During the year ended 31 March 2021, the Board did not receive any notices from Directors requesting use of Radius Care’s or any of
its subsidiaries’ information.
Annual Report 2021
89
Securities Dealings of Directors
Dealings by Directors in relevant interests in Radius Care’s ordinary shares in the year ended 31 March 2021 as entered in the
Interests Register:
DirectorTransactionNo. of
shares
Nature of relevant interestPrice
per
share
Date of
transaction
Brien CreeShare disposal by
Wave Rider Holdings
Limited as trustee of
Wave Rider Trust
500,000Has the power to control the exercise of the
rights attaching to the shares held by Wave
Rider Holdings Limited as trustee of Wave
Rider Trust, by virtue of having the power to
appoint and remove trustees of the Wave
Rider Trust
-9-Dec-20
Bret JacksonShare disposal by
Knox Radius L.P.
79,187,500Has a relevant interest in shares held by Knox
Radius L.P. as, by virtue of being a director
of Knox Investment Partners, together with
Timothy Sumner, he has the power to control
the exercise of rights attaching to shares held
by Knox Radius L.P.
-9-Dec-20
Bret JacksonShare acquisition
by Takatimu
Investments
Limited as trustee
of the Takatimu
Investment Trust
29,434,590Has a relevant interest in shares held by
Takatimu Investment Trust, by virtue of
being the sole shareholder and a director of
Takatimu Investments Limited
-9-Dec-20
Bret JacksonShare acquisition by
Knox Fund IV NZD LP
22,501,977Has a relevant interest in shares held by Knox
Fund IV NZD LP as, by virtue of being a director
of Knox Investment Partners, together with
Timothy Sumner, he has the power to control
the exercise of the rights attaching to shares
held by Knox Fund IV NZD LP
-9-Dec-20
Bret JacksonShare acquisition by
Knox Fund IV AUD LP
4,320,051Has a relevant interest in shares held by Knox
Fund IV AUD LP as, by virtue of being a director
of Knox Investment Partners, together with
Timothy Sumner, he has the power to control
the exercise of the rights attaching to shares
held by Knox Fund IV AUD LP
-9-Dec-20
Timothy SumnerShare disposal by
Knox Radius L.P.
79,187,500Has a relevant interest in shares held by Knox
Radius L.P. as, by virtue of being a director
of Knox Investment Partners, together with
Bret Jackson, he has the power to control the
exercise of rights attaching to shares held by
Knox Radius L.P.
-9-Dec-20
Timothy SumnerShare acquisition997,456Registered holder and beneficial owner-9-Dec-20
Timothy SumnerShare acquisition by
Knox Fund IV NZD LP
22,501,977Has a relevant interest in shares held by Knox
Fund IV NZD LP as, by virtue of being a director
of Knox Investment Partners, together with
Bret Jackson, he has the power to control the
exercise of the rights attaching to shares held
by Knox Fund IV NZD LP
-9-Dec-20
Timothy SumnerShare acquisition by
Knox Fund IV AUD LP
4,320,051Has a relevant interest in shares held by Knox
Fund IV AUD LP as, by virtue of being a director
of Knox Investment Partners, together with
Bret Jackson, he has the power to control the
exercise of the rights attaching to shares held
by Knox Fund IV AUD LP
-9-Dec-20
Radius Residential Care Limited
90
Other Disclosures continued
Duncan CookShare issue for
services provided
as a long-term
employee
250,000Registered holder and beneficial owner$0.80
per
share
9-Dec-20
Duncan CookShare acquisition125,000Registered holder and beneficial owner-9-Dec-20
Directors’ Interest in Shares
Directors of Radius Care have disclosed the following relevant interests in shares as at 31 March 2021:
Director Number of Shares in which Relevant Interest is Held
Brien Cree 95,312,500
Bret Jackson 29,434,590
Timothy Sumner 27,819,484
Duncan Cook 375,000
Indemnity and Insurance
Radius Care has granted indemnities, as permitted by the Companies Act 1993 and the Financial Markets Conduct Act 2013, in favour
of each of its Directors. Radius Care also maintains Directors’ and Officers’ liability insurance for its Directors and Officers.
Subsidiary Company Directors
Brien Cree and Duncan Cook are Directors of all Radius Care subsidiaries as at 31 March 2021, with the exception of:
Radius Care Limited, Radius Care Holdings Limited and Radius Arran Court Limited (the Directors of which are Brien Cree and Stuart
Bilbrough). No extra remuneration is payable for any directorship of a subsidiary.
Other information
Auditor’s Fees
Baker Tilly Staples Rodway is the external auditor of Radius Care and it’s subsidiaries. Total fees paid by Radius Care and its
subsidiaries to Baker Tilly Staples Rodway in its capacity as auditor during the financial year ended 31 March 2021 were $175k. Total
fees paid to Baker Tilly Staples Rodway for other professional services (being taxation services) during the financial year ended 31
March 2021 were $90k. No other fees were paid to Baker Tilly Staples Rodway for other professional services.
Donations
For the year ended 31 March 2021, Radius Care and it’s subsidiaries paid a total of $14k in donations. No donations were paid to
political parties.
Stock Exchange Listings
Radius Care’s shares are listed on the NZX. Radius Care is required to comply with the NZX Listing Rules. Radius Care confirms that it
has complied with the NZX Listing Rules for the period from its listing to 31 March 2021.
NZX Waivers
Radius Care does not have any waivers from the requirements of the NZX Listing Rules.
Credit Rating
Radius Care has no credit rating.
Annual Report 2021
91
Twenty Largest Shareholders
(as at 31 March 2021)
Registered Shareholder Number of shares % Shares
WAVE RIDER HOLDINGS LIMITED 95,312,500 54.00
KNOX FUND IV NZD LP 22,501,977 12.75
FORSYTH BARR CUSTODIANS LIMITED 6,646,364 3.77
PERPETUAL CORPORATE TRUST LIMITED - ACT PRIVATE EQUITY NO 3 FUND 5,994,760 3.40
PERPETUAL CORPORATE TRUST LIMITED - ROC ALTERNATIVE INVESTMENT TRUST VI 5,994,760 3.40
PERPETUAL CORPORATE TRUST LIMITED - ROC ASIA PACIFIC CO-INVESTMENT FUND II 5,994,760 3.40
KNOX FUND IV AUD LP 4,320,051 2.45
AARON SNODGRASS & BRIAN MALTBY & SIMON CURRAN & FRANCES VALINTINE
& PETER ALEXANDER & JONATHAN MASON 3,750,178 2.12
TAKATIMU INVESTMENTS LIMITED 2,612,562 1.48
HSBC NOMINEES (NEW ZEALAND) LIMITED - NZCSD 1,866,430 1.06
ANDREW JOHN CLARK 1,854,935 1.05
CENTRAL LAKES DIRECT LIMITED 1,750,083 0.99
TIMOTHY SUMNER 997,456 0.57
MCGREGOR CORPORATION PTY LIMITED 943,394 0.53
PETER YOUNG & MARIE YOUNG 896,870 0.51
BRIDGETTE JACKSON & MJ BENNETT TRUSTEES LIMITED 784,725 0.44
NEW ZEALAND DEPOSITORY NOMINEE LIMITED 759,394 0.43
BRENT COOK 749,645 0.42
NICHOLAS WELLS & JEREMY VALENTINE 610,949 0.35
OLGA SKORIK & GEOFF HOSKING 439,861 0.25
Total 164,781,654 93.37
Shareholder
Information
Radius Residential Care Limited
92
Shareholder Information continued
Spread of Holdings
(as at 31 March 2021)
Number
Size of Holding Number of Shareholders % of shares %
1 - 1,000 101 14.28% 67,437 0.04%
1,001 - 5,000 357 50.50% 853,537 0.48%
5,001 - 10,000 91 12.87% 775,636 0.44%
10,001 - 100,000 111 15.70% 3,706,583 2.10%
100,001 and over 47 6.65% 171,091,807 96.94%
Total 707 100% 176,495,000 100%
Substantial Product Holders
According to Radius Care’s records and notices given under the Financial Markets Conduct Act 2013, the following were substantial
product holders of Radius Care as at 31 March 2021:
Substantial Product HolderNumber of shares
% of shares
Held at Date
of Notice
Date
of Notice
Wave Rider Holdings Limited is the registered
holder and beneficial owner of shares as
trustee for the Wave Rider Trust. As a result
of Brien Cree having the right to appoint and
remove trustees of the Wave Rider Trust, he
has a relevant interest in shares held by Wave
Rider Holdings Limited as trustee for the Wave
Rider Trust.
95,312,500 54.00 10 December 2020
Knox Investment Partners is the manager of
Knox Fund IV NZD LP and Knox Fund IV AUD LP
(“Knox Funds”). As a result of the management
role performed by Knox Investment Partners for
the Knox Funds, Knox Investment Partners has a
relevant interest in the shares held by the Knox
Funds, being:
• 22,501,977 shares held by Knox Fund IV NZD LP;
and
• 4,320,051 shares held by Knox Fund IV AUD LP.
Each of Bret Jackson and Timothy Sumner also
has a relevant interest in the shares held by
the Knox Funds as, by virtue of being a director
of Knox Investment Partners, he has (together
with the other) the power to control the
exercise of the rights attaching to the shares
held by the Knox Funds.
26,822,028 15.20 10 December 2020
Knox Fund IV NZD LP is the registered holder
and beneficial owner of shares.
22,501,977 12.75 10 December 2020
Annual Report 2021
93
Substantial Product HolderNumber of shares
% of shares
Held at Date
of Notice
Date
of Notice
ROC Capital Pty Limited is the manager of ACT
Private Equity No.3 Fund, ROC
Alternative Investment Trust VI and ROC Asia
Pacific Co-Investment Fund II (“ROC Funds”). As
a result of the management role performed by
ROC Capital Pty Limited for the ROC Funds, ROC
Capital Pty Limited has a relevant interest in the
shares held by Perpetual Corporate Trust Limited
as custodian for the ROC Funds as follows:
• 5,994,760 shares held on behalf of ACT Private
Equity No.3 Fund;
• 5,994,760 shares held on behalf of ROC
Alternative Investment Trust VI; and
• 5,994,760 shares held on behalf of ROC Asia
Pacific Co-Investment Fund II
17,984,280 10.19 10 December 2020
The total number of ordinary shares (being the only class of quoted voting products) on issue in Radius Care as at 31 March 2021 was
176,495,000.
Radius Residential Care Limited
94
Directory
Registered office
Radius Residential Care Limited
Level 4, 56 Parnell Road
Parnell
Auckland 1052
Postal address
PO Box 450
Shortland Street
Auckland
Phone
+64 9 304 1670
Fax
+64 9 377 6122
Email
investor@radiuscare.co.nz
Share registrar
Computershare Investor Services Limited
Level 2, 159 Hurstmere Road
Takapuna
Auckland 0622
Phone: +64 (9) 488 8700
Postal Address: Private Bag 92119
Victoria Street West
Auckland 1142
Investor Enquiries: 09 488 8777
www.computershare.co.nz/investorcentre
Bankers
ASB
ASB North Wharf
12 Jellicoe Street
Auckland 1010
Lawyers
Harmos Horton Lusk Limited
Level 33, Vero Centre
48 Shortland Street
Auckland 1140
Auditors
Baker Tilly Staples Rodway
Level 9, Tower Centre
45 Queen Street
Auckland 1010
Annual Report 2021
95
---
Results for announcement to the market
Name of issuer Radius Residential Care Limited
Reporting Period 12 months to 31 March 2021
Previous Reporting Period 12 months to 31 March 2020
Currency NZD
Amount (000s) Percentage change
Revenue from continuing
operations
$122,298 7.3%
Total Revenue $126,042 10.8%
Total net profit/(loss) $1,705 NM
Underlying EBITDA (non-
GAAP) – see explanation
below
$23,351
28.2%
AFFO (Available Funds from
Operations)
$3,721
NM
Final Dividend
Amount per Quoted Equity
Security
$0.00888048
Imputed amount per Quoted
Equity Security
$0.00248654
Record Date 14 June 2021
Dividend Payment Date 21 June 2021
Current period Prior comparable period
Net tangible assets (000s) $3,462 $1,818
Net tangible assets per
Quoted Equity Security
$0.02 $0.15
A brief explanation of any of
the figures above necessary
to enable the figures to be
understood
Underlying EBITDA and AFFO are non-GAAP (non-Generally
Accepted Accounting Practice) measures and differ from NZ
IFRS and IFRS Net Profit after Tax and Net cash provided by
Operating Activities, respectively. Underlying EBITDA and AFFO
do not have a standardised meaning prescribed by NZ GAAP
(Generally Accepted Accounting Practice in New Zealand) and
so may not be comparable to similar financial information
presented by other entities. The Group uses Underlying EBITDA
and AFFO, with other measures, to monitor financial
performance and for shareholder dividend determination
considerations. The Group uses these measures consistently
across reporting periods.
AFFO is a non-GAAP measure of available cash used by the
Group to indicate the level of shareholder dividend it may pay.
Where percentage change is listed as NM that metric in the prior
corresponding period was negative.
Net tangible assets per quoted equity share has declined as a
result of the share split undertaken in conjunction with Radius
Care’s December 2020 NZX listing.
Authority for this announcement
Name of person
authorised
to make this announcement
Stuart Bilbrough
Contact person for this
announcement
Stuart Bilbrough
Contact phone number 021 252 5778
Contact email address stuart.bilbrough@radiuscare.co.nz
Date of release through MAP
28 May 2021
Audited financial statements accompany this announcement.
---
Section 1: Issuer information
Name of issuer Radius Residential Care Limited
Financial product name/description Ordinary share
NZX ticker code RAD
ISIN NZRADE0005S4
Type of distribution
(Please mark with an X in the
relevant box/es)
Full Year X Quarterly
Half Year Special
DRP applies
Record date 14/06/2021
Ex-Date (one business day before the
Record Date)
11/06/2021
Payment date (and allotment date for
DRP)
21/06/2021
Total monies associated with the
distribution
$1,128,500
Source of distribution (for example,
retained earnings)
Retained Earnings
Currency NZ$
Section 2: Distribution amounts per financial product
Gross distribution $0.00888048
Gross taxable amount $0.00888048
Total cash distribution $0.00639395
Excluded amount (applicable to listed
PIEs)
N/A
Supplementary distribution amount N/A
Section 3: Imputation credits and Resident Withholding Tax
Is the distribution imputed Fully imputed
If fully or partially imputed, please state
imputation rate as % applied
28%
Imputation tax credits per financial
product
$0.00248654
Resident Withholding Tax per financial
product
$0.00044402
Section 5: Authority for this announcement
Name of person authorised to make this
announcement
Stuart Bilbrough
Contact person for this announcement Stuart Bilbrough
Contact phone number 021 252 5778
Contact email address stuart.bilbrough@radiuscare.co.nz
Date of release through MAP 28/05/2021
=== IR PAGE TRANSCRIPT: FY21 Annual Results – Call Transcriptf ===
28 May 2021
Radius Residential Care Limited FY21 annual results call
The slides are presented at the end of the transcript
Stuart Bilbrough: Good morning. My name is Stuart Bilbrough. I am the chief executive of Radius Care. Thank
you for joining us today as we outline the key aspects of our year ended 31 March 2021.
We have a few slides to provide some colour around the results and we'll open the lines for
questions at the end of the presentation.
I'd like to now move on to slide four.
Slide 4 Here with me today is that executive chairman and managing director, Brien Cree. Brien
founded Radius Care 18 years ago, and the successful aged care business we present today.
Brien now focuses on growth opportunities through development and acquisition, while I
look after the day-to-day business management. Having worked together for about a
decade and with Brien's long membership on the New Zealand Aged Care Association, we
collectively have a significant understanding of our industry. And also joining us is Michelle
Slabber, our general manager of finance, whose done a fantastic job getting the financial
results completed, audited and available for you today.
This is Radius Care's first results announcement as a listed company. And the three of us
are excited to be able to present them to you today.
Move on to slide five.
Slide 5 As a reminder of who Radius Care is, in a nutshell, we provide investors with the exposure
to high-acuity and specialised care end of the aged care sector in New Zealand. This means
caring for patients and residents with hospital, dementia, psychogeriatric, physical and
intellectual care needs. This makes Radius quite different to the other listed retirement
sector providers in New Zealand, in that we are more medical and aged care provider, and
less about the property. 96% of our portfolio caters for aged care.
Moving on to slide six.
Slide 6 In business since 2003, the Radius Care team has grown our portfolio to 24 sites made up
of 22 care facilities and two retirement villages.
We are located throughout New Zealand. Radius Care owns both villages and the land and
building of three facilities and 19 of our facilities are leased. The average time to the next
lease renewal of the leases is currently 9.1 years and with an average time of expiry of 27.7
years. We have over 1700 care beds for our residents and 1500 dedicated team members.
We look forward to expanding our business significantly.
We'll now move to slide seven.
Slide 7 Our agenda for today's briefing will provide you with an overview of the company's strong
financial results. We'll then dive a bit more deeply into the financial and operational aspects
of these results and our strong track record of delivery. We'll outline our strategy, which is
also provided in more detail in the listing profile that you can download from Radius's
website under Investor's Centre, and then provide you with an outlook and guidance for our
full year 2022, and where we see that heading. At the back of this presentation are some
slides that we are sure you will find useful.
Now going to move on to slide number nine.
Slide 9
We are extremely pleased to have met the guidance provided at the time of listing. Radius
has always had a good track record of delivering on our financial result expectations as a
private company. And it is now fantastic that we can demonstrate this delivery as a public
listed company. If you are after more detailed financial information than provided in this
presentation, you can download our audited financial statements from Radius's website
under Investor's Centre.
The 2021 financial year was a record for Radius Care, despite COVID-19. Our success in
keeping COVID-19 out of our sites rests squarely with the impressive and dedicated actions
of our incredible team members at the facilities and support office who tirelessly and quickly
adapted to the changing environment as COVID-19 turned from an obscure virus to a
worldwide pandemic. If that wasn't stressful enough, we decided it would be a great time to
list on the NZX. This happened on the 10th of December last year, and our new ticket
appeared on that day as RAD.
In April of this year, we exercised the option to buy 4.3 hectares of land in Belfast in
Christchurch. Radius has successfully developed our first 54 villa retirement village in
Timaru, alongside our established care home there.
Christchurch will be our first full development as a listed company, acquiring greenfield land
for a fully integrated retirement and aged care village. This is very exciting for us.
Now move to slide number ten.
Slide 10
Our success going forward rests with our people. This starts with Radius Care's board of
directors, which has been strengthened by the addition of incredibly capable new
independent directors, Mary Gardiner and Hamish Stevens. We've also bolstered the
strength of the management team, starting with me realising in early 2020 that I missed
aged care and Radius Care, having left to try another area of the health industry in 2017.
That was after seven years as CFO at Radius. With a renewed passion for aged care, I
returned full-time to Radius in June of 2020 as the CEO to look after the day-to-day, and
Brien moved to the role of Executive Chairman and Managing Director, focusing on the
delivery of our development and acquisition growth strategy.
We also took a critical look at our most important resource, which is our team across the
group, and our continued training needs. We hired highly skilled learning and development
expert, Marg Paramore, into the newly created General Manager of People and Culture, and
expanded the property team to ensure an even greater focus on facility presentation and
stepping up our growth in accommodation supplement revenue.
Move on to slide number 11.
Slide 11 Slide 11 provides a deeper dive into the numbers. Since 2018 and before, revenue has
consistently increased. Revenue includes our villages, which have performed very well,
although a small part of Radius's revenue at this stage. From an underlying EBITDA and
AFFO point of view, we've had a very strong end to the current financial year, achieving our
guidance as provided in the December listing profile.
What is important to note is that Radius Care's growth, excluding the smaller contribution
of our villages, has been largely organically achieved through continuously improving
occupancy and bed mix, weighted towards high-acuity care which Radius focuses on, and
accommodation supplements. This is where we see an area of ongoing improvement in
growth. What has been difficult for Radius and the whole aged care and health industry has
been the containment of staff costs. Radius is a strong supporter of ensuring our team
members at the facility are paid an hourly rate that recognises their incredible
contribution. We do this by striving to provide the training, work environment and pay rate
we can. We also recognise that the ability for health workers, especially registered nurses,
to move freely within the health industry and abroad is a peculiarity that has become
normalised in our industry. We continue to strive to reduce staff turnover.
Moving to slide 12.
Slide 12 Radius' AFFO for the year came in slightly higher than the guidance provided in the recent
listing profile. We are very happy with this great outcome. AFFO is Available Funds From
Operations, and is the non-GAAP estimate of cash generated and available at the end of a
financial period. Paying dividends from cashflow is the preferred approach of Radius Care's
board of directors. This is why the AFFO method is used for calculating investor dividends.
The strong AFFO result for the full year 2021 therefore has a direct and positive impact on
our final dividend. The Radius board of directors has recommended that the dividend for
the full financial year be set at 50% of AFFO, and in line with the dividend policy in the
listing profile. With total AFFO at $3.7 million, this represents a fully imputed gross
dividend per share of 1.46 cents. Net of imputation is 1.05 cents, which is above our listing
profile's guidance, which had an upper end of one cent.
I will now pass across to Michelle.
Michelle Slabber: Thank you, Stuart. And good morning, everybody.
Slide 13 The EBITDA bridge in this slide explains what the material key changes for the year were.
Also, please refer to the appendices at the back of this presentation and the listing profile
for the EBITDA bridge, that explains the key areas of why the full year ending 2020 was a
difficult and unusual year for Radius Care. As we entered the 2021 financial year, those
areas that had impacted our impressive growth from prior years were coming under
control. In FY 2021 COVID assisted, through infection control requirements, a slowing
turnover down. We have not rested on our laurels since the lock downs and continue to
implement ways of ensuring Radius and aged care is the best place for the likes of our
healthcare workers, particularly registered nurses, to start out. Over a number of years this
turnover has become business as usual and the current slowdown in turnover of registered
nurses leaving our employment is an indication we continue to provide the best place for
healthcare workers to work.
This year we have improved our overall aged care EBITDA by $4.3 million. There has been a
significant reduction in bureau staff, extension at two facilities have contributed $800,000,
we have increased private revenue through our focus on growth, accommodation
supplement in revenue, and retirement village EBITDA is up $700,000 as well. We have
invested in more senior management at our support office that has been targeted towards
focusing on issues like bureau costs, training and accommodation supplements. And we are
very happy with the results. The support office team is also getting positioned for the coming
business expansion which is very exciting for us all.
Move to slide 15, and over to you, Brien.
Brien Cree: Thanks, Michelle. It's Brien Cree speaking.
Slide 15
I'll run through a little on our revenue growth and diversification. Slide 15 demonstrates the
strong track record of year on year annual revenue growth that Radius Care has been able to
achieve over a number of years. Ministry of Health fee increases normally sit at around 3%
per annum, yet Radius has been able to achieve 8.5% through our focus on increasing
occupancy, a focus towards higher-acuity care and the higher rate per night from our
accommodation supplement.
Take you now to slide 16.
Slide 16
Radius Care is continuing to move towards higher-acuity care for its residents. We have a bed
mix of 86% of our beds certified for high-acuity care, which includes swing beds. The
opportunity to increase the revenue going forward comes from increased utilisation of the
high-acuity beds, which is currently sitting at 67%. We will be increasing the total available
high-acuity beds this year, with the conversion of 20 rest home rooms at Radius Arran Court
in Henderson into a dementia unit. This is our first dementia unit in the Auckland region and
a much-needed care level for the West Auckland area. This conversion will be a positive
contributor to the next financial year.
Moving now to slide 17.
Slide 17
This slide demonstrates our market and the occupancy growth opportunity. Radius Care's
portfolio is orientated to high-acuity and specialist care, so less driven by property market
cycles, but more by population demographics, which puts us in a strong position for the
future. A number of our 22 facilities run at 95 to 100% bed occupancy. And this number of
sites is expected to keep increasing.
In the 2019 Ernst and Young report, titled "Aged Residential Care Funding Model Review",
they acknowledged the increased acuity of New Zealand residents that often come with a
range of serious health conditions requiring specialist care, and that will likely see the
number of people living over 85 tripling by 2043.
I’ll turn now to slide 18.
Slide 18
This slide demonstrates our continued strong performance. Radius Care has a very
systematic approach to providing care, and that enables us to focus on what is important to
us, and that is providing the best care we can. It is a proven model we have perfected over
almost two decades. Good facility management, strong clinical care, a well-managed roster
and the right people in the right place, doing the right things are the best combination for
delivering a strong underlying EBITDA per care bed. And we worked hard to achieve this.
Accommodation supplements are an important source of non-government revenue for
Radius. It has a lot of potential to continue growing as it has over a number of years, since
first being introduced approximately 10 years ago. We will have a dedicated team member
focusing on this opportunity so that we can improve our penetration beyond the current
60% of total rooms.
I’ll now just flick across to slide 21, and just talk a little bit about strategy.
Slide 21 So the exercising of the option for the Belfast property is a cornerstone of Radius Care's
growth in the immediate future. We are currently focused on the final design process,
obtaining building consents and commencing construction in relation to this development.
The project will be constructed across multiple stages, providing a degree of funding
flexibility, with the optimal timing to be determined as the planning progresses. We have
some other great brownfield expansion opportunities that will kick off in 2022. We have
resource consent at Radius Thornleigh Park in New Plymouth to add 24 hospitals level care
beds. We are also progressing resource consent for the extension at Radius Lexham Park in
Katikati in the Bay of Plenty. And that will also kick off in 2022. Along with that, we're also
reviewing a number of opportunities and we'll update the market as and when required
regarding these.
So now I will pass you back to Stuart.
Stuart Bilbrough: Thank you, Brien. I'm now on slide 23.
Slide 23 So now we will focus on our strong growth trajectory, the trajectory we have in place. Our
outlook for the full year 2022 is that aged care will continue to have staff cost challenges,
as we have always had. For Radius this will be more than offset by revenue opportunities,
with accommodation supplement growth and the government fee increase we get each
year that we expect this year to be higher than CPI.
On the horizon, and not included in our outlook calculations, is an anticipated positive
outcome for nurses' pay equity, which has been discussed by the Labour Government over
the past year, and being pushed vigorously by the New Zealand Aged Care Association. We
also have further occupancy capacity and bed mix opportunities that will further grow
revenue and ensure that earnings for the current year remain achievable.
Moving to slide 24.
Slide 24 Thank you for joining our briefing today. We are looking forward to providing our investors
a strong 2022. Radius is the most experienced manager of the high-acuity aged care in New
Zealand in the care sector. This is a sector we deeply understand and excel at. Our
competitive advantages are our team, state of the art IT solutions and exceptional levels of
care. We see the industry dynamics offer strong growth opportunities, which we will
continue to capture. As Radius moves forward, our strategy as a listed company will be to
ensure clear pathways of growth through acquiring existing leased facilities and extending
them, opportunistic acquisitions of existing businesses from other operators and
undertaking greenfield developments, like what we're about to embark on in Christchurch.
I look forward to sharing our journey with you. Thank you for joining this briefing call. I will
now hand back to you, Harmony.
Operator Thank you. If you wish to ask a question, please press star one on your telephone and wait
for your name to be announced. If you wish to cancel your request, please press star two. If
you're on a speaker phone, please pick up the handset to ask your question. We'll now
pause a moment for any questions to register.
Once again, if you wish to ask a question, please press star one on your telephone and wait
for your name to be announced. Thank you. There are no further questions at this time. I'll
now hand back to Mr. Bilbrough for closing remarks.
Stuart Bilbrough: Thank you everybody for joining the call. We really appreciate you spending the time. This
is our first presentation as a listed company. We're very excited. If you've got any
questions, my details are on our website, and feel free to call me or drop me an email at
any time. Thanks a lot.
1/06/2021
1
Radius Residential Care Limited
Full Year
Results
31 March 2021
Radius Care
2
Importance
Notice and
Disclaimer
This presentation has been prepared by Radius Residential Care Limited (“Radius Care”), for informational purposes. This disclaimer
applies to this document and the verbal or written comments of any person presenting it.
This presentation sets out information relating to Radius Care’s full year result for the period to 31 March 2021. As such, it should
be read in conjunction with the audited consolidated financial statements for Radius Care and its subsidiaries for the period ended
31 March 2021 (“Financial Statements”) and other material that Radius Care has released to NZX along with this presentation. That
material is also available at www.radiuscare.co.nz.
In certain sections of this presentation, Radius Care has chosen to present certain financial information exclusive of the impact of
significant items. A number of non‐GAAP financial measures are used in this presentation which are used by management to assess
the performance of the business and have been derived from the Financial Statements. You should not consider any of these
financial measures in isolation from, or as a substitute for the information provided in the Financial Statements.
This presentation may contain forward‐looking statements and projections. Such forward‐looking statements are based on current
expectations, estimates and assumptions and are subject to a number of risks and uncertainties, including material adverse events,
significant one‐off expenses and other unforeseeable circumstances. There is no assurance that results contemplated in any of
these projections and forward‐looking statements will be realised. Actual results may differ materially from those projected. Except
as required by law, or the NZX Listing Rules, no person is under any obligation to update this presentation at any time after its
release or to provide further information about Radius Care.
The information in this presentation has been prepared in good faith by Radius Care. Neither Radius Care nor any of its directors,
employees, shareholders nor any other person given any representations or warranties (either express or implied) as to the
accuracy or completeness of the information in this presentation and to the maximum extent permitted by law, no such person
shall have any liability whatsoever to any person for any loss (including, without limitation, arising from any fault or negligence)
arising from this presentation or any information supplied in connection with it.
This presentation is not a product disclosure statement or other disclosure document, or an offer of shares for subscription, or sale,
in any jurisdiction. The information in this presentation does not constitute financial product, legal, financial, investment, tax or any
other advice or a recommendation.
Radius Care
3
Radius Care
4
Presenting Today
Brien Cree
Executive Chairman / Managing Director
•Founded Radius Care in 2003, then part of
Radius Health Group
•Moved into Executive Chairman role in
June 2020 focusing on growth
opportunities through development and
acquisition
•Majority shareholder since undertaking
management buy out in 2010 and currently
holds 54.0% through Wave Rider Trust
•Board member of the New Zealand
Aged
Care Association for more than 10 years
•Over 30 years’ experience in the Aged Care
sector
Stuart Bilbrough
Chief Executive Officer
•Appointed Chief Executive Officer in
June 2020
•Formerly Radius Care Chief Financial
Officer from 2010 to 2017
•Over 30 years’ experience in finance
roles in industries including
healthcare, FMCG, logistics, telecoms
and financial services
•New Zealand Chartered Accountant
and holds an MBA with distinction
from Massey University.
•Joined Radius Care in 2016
•Has nearly 25 years’ experience in
finance roles in various
•Industries worked in include
healthcare and financial services
•Michelle trained with
PricewaterhouseCoopers in South
Africa
•She is a New Zealand Chartered
Accountant.
Michelle Slabber
General Manager, Finance
Radius Care
5
Radius Care
at a Glance
HIGH ACUITY AND
SPECIALIST AGED
CARE PROVIDER
Radius Care operates 22 aged
care facilities nationally,
comprising more than 1,700
aged care beds.
We own three of these facilities
and lease 19 from 3rd party
property investors.
We also own two retirement
villages comprising of 76 units.
Radius Care OwnedLeased from 3
rd
Parties*
Total
Existing Portfolio
Sites51924
Aged Care Beds1781,5371,715
Retirement Village Units
1
76-76
Total Places2541,5371,791
Existing Facility - Landbank
Aged Care Beds4460104
Retirement Village Units202040
Belfast, Christchurch194-194
Total Existing + Landbank5121,6172,129
* All leases are triple net lease and long term in nature ‐with an average term to next renewal of 9.1 years but 27.7 years after
accounting for all renewals.
Portfolio summary as at 31 March 2021Portfolio summary as at 31 March 2021
Radius Care
announced on 7 April
2021 the exercise of
its option to acquire
4.3 hectares of
development land in
Christchurch
Note: As part of its December 2020 listing Radius Care prepared:
•A Listing Profile (which contains similar information to a Product Disclosure Statement) providing an overview of the business, the industry, risks and financial performance.
•Supplementary Financial Information providing more granular financial and operational information.
This information is contained on the
Radius Care website https://www.radiuscare.co.nz/investors‐centre/listing‐documents
Radius Care
6
4.2% 95.8%
UnitsCare Beds
Radius Care
at a Glance
National aged care focused portfolio with strong regional presenceNational aged care focused portfolio with strong regional presence
Residents and EmployeesResidents and Employees
1,500+
employees
1,700+
beds
Denotes leasehold sitesDenotes freehold sites
AUCKLAND
SitesBedsILUsTotal
Leased3248‐248
WAIKATO
SitesBedsILUsTotal
Leased4334‐334
Owned1‐2222
NEW PLYMOUTH
SitesBedsILUsTotal
Leased155‐55
Owned163‐63
NORTHLAND
SitesBedsILUsTotal
Leased3155‐155
BAY OF PLENTY
SitesBedsILUsTotal
Leased2266‐266
Owned163‐63
NAPIER
SitesBedsILUsTotal
Leased145‐45
PALMERSTON NORTH
SitesBedsILUsTotal
Leased162‐62
CANTERBURY
SitesBedsILUsTotal
Leased3279‐279
Owned25254106
Units vs Care BedsUnits vs Care Beds
OTAGO
SitesBedsILUsTotal
Leased193‐93
1/06/2021
2
Radius Care
7
Agenda
Appendix
—Key operational and
financial metrics
—Summary P&L, Balance
Sheet, Cash Flow
44
Overview
of FY21 financial
performance
First year as a listed
company
22
Analysis of result
Continuation of strong track
record
33
Positioning Radius Care
for Growth phase,
strategy update and
FY22 guidance
11
Radius Care
8
Overview of
FY21 Financial
Performance
FIRST YEAR AS A LISTED
COMPANY
Radius Care
9
FY21 Highlights
and Key Events
FY21 Guidance provided at
the time of listing met or
exceeded across all metrics.
Progress on Strategy
‐Option exercised to purchase 4.3 hectares of Greenfield
Development land in Belfast, Christchurch post balance date
1
‐Increases Greenfield Development pipeline by 70 Care Beds,
30 Care Suites and 94 Retirement Village Units
‐Work progressing on final design, building consents and
construction discussions
‐Multi‐stage development approach provides funding
flexibility
Progress on Strategy
‐Option exercised to purchase 4.3 hectares of Greenfield
Development land in Belfast, Christchurch post balance date
1
‐Increases Greenfield Development pipeline by 70 Care Beds,
30 Care Suites and 94 Retirement Village Units
‐Work progressing on final design, building consents and
construction discussions
‐Multi‐stage development approach provides funding
flexibility
Financial Performance
‐Record result ‐all guidance metrics met or exceeded
‐Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m
to $23.8m)
‐Underlying EBITDA per bed up 13% to $19.5k
‐Continued strong occupancy, private accommodation
supplements and cost control
Financial Performance
‐Record result ‐all guidance metrics met or exceeded
‐Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m
to $23.8m)
‐Underlying EBITDA per bed up 13% to $19.5k
‐Continued strong occupancy, private accommodation
supplements and cost control
1
See NZX release dated 7 April 2021
Radius Care
10
Enhanced management
and governance for listing
‐Brien Cree transitioned in
Executive Chairman role focused
on growth opportunities through
development and acquisition
‐Stuart Bilbrough returned as CEO
‐Hamish Stevens and Mary
Gardiner appointed as
independent directors
‐Direct listing undertaken on 10
December 2020
Enhanced management
and governance for listing
‐Brien Cree transitioned in
Executive Chairman role focused
on growth opportunities through
development and acquisition
‐Stuart Bilbrough returned as CEO
‐Hamish Stevens and Mary
Gardiner appointed as
independent directors
‐Direct listing undertaken on 10
December 2020
COVID‐19 resilience
‐Processes and procedures
introduced in mid‐2000s for
Bird Flu performed well
through COVID‐19 period
‐Locked down facilities early
with industry following
‐No COVID‐19 cases amongst
residents or staff
1
COVID‐19 resilience
‐Processes and procedures
introduced in mid‐2000s for
Bird Flu performed well
through COVID‐19 period
‐Locked down facilities early
with industry following
‐No COVID‐19 cases amongst
residents or staff
1
Balance Sheet Position
‐Net debt of $24.5m down $4.7m
from pcp (31 March 20)
‐Lease liabilities of $184.3m down
from $185.3m for pcp
Balance Sheet Position
‐Net debt of $24.5m down $4.7m
from pcp (31 March 20)
‐Lease liabilities of $184.3m down
from $185.3m for pcp
Balance Sheet Position
‐Net debt of $24.5m down $4.7m
from pcp (31 March 20)
‐Lease liabilities of $184.3m down
from $185.3m for pcp
FY21 highlights
and key events
FY21 Guidance provided at
the time of listing met or
exceeded across all metrics.
1
As at the date of this presentation
Radius Care
11
7.7
8.0
5.8
10.5
0.0
2.0
4.0
6.0
8.0
10.0
12.0
$m
FY18FY19FY20FY21
Financial performance overview
FY21 Underlying EBITDA and Pre‐NZ IFRS 16 Underlying EBITDA within Guidance range provided at time of listing
Pre‐NZ IFRS 16 Underlying EBITDA
‐FY21 Pre‐NZ IFRS 16 Underlying EBITDA
of $10.5m up 82%
FY21 guidance range $10.2m –11.0m
Underlying EBITDA
‐FY21 Underlying EBITDA of $23.4m up
28%
FY21 guidance range $23.0 ‐$23.8m
FY21 Guidance achievedFY21 Guidance achieved
19.7
20.4
18.2
23.4
0.0
5.0
10.0
15.0
20.0
25.0
$m
FY19FY18FY20
FY21
Total Revenue
‐FY21 Revenue of $126m up 11%
$m
100.2
110.1
113.7
126.0
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
FY19FY20FY21FY18
Radius Care
12
Cash Flow and Dividends
AFFO
‐FY21 AFFO of $3.7m
‐Outperformance partly due to lower maintenance capex
Achieved AFFO in excess of FY21 Guidance
Dividends
FY21 Final Dividend
‐Gross fully imputed FY21 final dividend declared of
0.89 cents per share (which includes 0.25 cents per
share of attaching imputation credits)
‐Ex Dividend date Friday 11 June 2021
‐Record date Monday 14 June 2021
‐Payment date Monday 21 June 2021
FY21 Total Dividends
‐Including February dividend of
0.58 cents per share
gives a total gross dividend in relation to the FY21
financial year of 1.46 cents per share (which includes
attaching imputation credits of 0.41 cents per share)
‐The total FY21 cash dividend of 1.05 cents per share is
above the FY21 cash dividend guidance of 0.83 to 1.00
cents per share
FY21 Guidance exceeded
FY21 guidance range $2.9m to $3.5m
1.3
2.0
(0.5)
3.7
(1.0)
0.0
1.0
2.0
3.0
4.0
$m
FY18FY19FY20FY21
Radius Care’s dividend policy is target to pay 50% to 70% of AFFO
1/06/2021
3
Radius Care
13
Summary of Key Drivers of FY21 Financial Performance
Strong growth in Underlying EBITDA driven primary by (1) improving care occupancy (2) increasing
accommodation supplements (3) cost control containment and (4) contributions from new developments
Aged Care: $4.3m
‐Bureau: $1.6 million improvement
through strong cost control focus
‐Brownfield and Greenfield
Developments contribution: $0.8
million from Windsor Court
Brownfield development ($0.6m)
and Glaisdale (Hamilton)
Greenfield development ($0.2m)
‐Other aged care: $1.9 million.
Primarily driven by the increase in
occupancy $0.7m,
accommodation supplements
$0.7m and other $0.4m
Retirement Village: $0.7m
‐Compounding impact of DMF and
additional unit sales
Group Support: $0.2m
‐Reduced travel as a result of
COVID‐19 disruptions
$1.6
$0.8
$0.7
$0.7
$0.4
$0.4
$0.4
$0.2 $(0.1)
$18.2
$23.4
17.0
19.0
21.0
23.0
25.0
FY20 Underlying
EBITDA
Bureau costsBrownfield &
Greenfield
Developments
Occupancy Accommodation
supplements
Other aged care
operations
DMF and weekly
service fees
Realised Gains on
Resales and
Development
Margin
Other village
operations
Support office
expenses
FY21 Underlying
EBITDA
NZ$m
Aged careRetirement village
Group
support
Radius Care
14
Analysis of result
CONTINUATION OF STRONG
TRACK RECORD
Radius Care
15
Strong revenue growth continues with an increasing proportion from direct private (non‐Government) revenue streams
Revenue Growth and Diversification
65.4
70.370.0
76.1
87.0
100.2
110.1
113.7
126.0
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
FY13FY14FY15FY16FY17FY18FY19FY20FY21
Total revenueAged careRetirement villageGroup support
End of Financial
period
FY13FY14FY15FY16FY17FY18FY19FY20FY21
No. of Beds
1,3071,3821,3711,3791,5251,6821,7011,7041,715
No. of Units
222222364855637376
Total revenue Total revenue Direct private (non‐Government) revenue
1
Direct private (non‐Government) revenue
1
1
Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues
2.2
3.0 3.0
4.5
6.2
7.1
10.1
9.2
13.8
3.4%
11.0%
0.0%
2.5%
5.0%
7.5%
10.0%
12.5%
0.0
2.5
5.0
7.5
10.0
12.5
15.0
FY13FY14FY15FY16FY17FY18FY19FY20FY21
Proportion
of
total
revenue
(%)
Direct
Private
Revenue
(NZ$m)
Direct private revenue (LHS)
Direct private proportion of total revenue (RHS)
Radius Care
16
Bed Mix Oriented to High Acuity and Specialist Care
Over FY21, beds certified for high acuity and specialist care have increased from 82% to 86% of the portfolio. Radius Care
continues to provide more care offerings and in particular more specialist care offerings per facility than peers.
Care Beds by use and typeCare Beds by use and type
1 Source: CBRE analysis, September 2020
2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your‐health/certified‐providers/aged‐care/based on data as at 4 May 2021
3 Dementia and Specialist offerings include Dementia, Psychogeriatric, Physical and Intellectual but does not include Rest Home or Hospital – Geriatric or Hospital –Medical care. Average based on simple average of all certified facilities
3.9
3.2 3.2
3.0
3.6
Radius Oceania Arvida Summerset Ryman
0.9
0.5
0.5
0.2
0.8
Radius Oceania Arvida Summerset Ryman
Total and specialist offerings
2
Total and specialist offerings
2
Total offerings aged care
(per Aged Care facility)
Dementia and Specialist offerings
3
(per Aged Care facility)
Care bed
type
Care bed
use
47.1%38.1%11.1%3.6%
Industry
average
1
17.9%
14.4%
34.1%
41.4%
30.3%
26.5%
10.3%
11.1%
6.6%
5.7%
0.8%
0.9%
FY20
FY21
85.6% high acuity and specialist
52.9% high acuity and specialist
34.4%
32.8%
47.9%
49.6%
10.2%
10.8%
6.3%
5.8%
1.2%
1.0%
FY20
FY21
Rest homeSwingHospitalDementiaPsychogeriatricPhysical and intellectual
65.6% high acuity and specialist
67.2% high acuity and specialist
82.1% high acuity and specialist
Radius Care
17
Strong Occupancy Growth
1. Aging New Zealand population
1
1. Aging New Zealand population
1
Growing Occupancy v.s. industry
3
Growing Occupancy v.s. industry
3
3. Increasing years in dependency3. Increasing years in dependency
•Life expectancy is increasing but more years are being spent in dependency
90.1%
89.2%
89.1%
90.4%
90.9%
91.3%
91.0%
92.1%
93.0%
93.7%
93.4% as
at 31
March
2021
87.2%
87.2%
86.9%
86.5%
86.9%
87.0%
86.8%
87.6%
87.9%
87.8%
85.0%
86.0%
87.0%
88.0%
89.0%
90.0%
91.0%
92.0%
93.0%
94.0%
95.0%
Jun‐19Sep‐19Dec‐19Mar‐20Jun‐20Sep‐20Dec‐20Mar‐21
Occupancy
rate
%
Radius Care (monthly)Industry average (quarterly)
0.0%
2.0%
4.0%
6.0%
8.0%
Jan‐03 Jan‐08 Jan‐13 Jan‐18 Jan‐23 Jan‐28 Jan‐33 Jan‐38 Jan‐43 Jan‐48 Jan‐53 Jan‐58
Rolling
5
‐
year
pop.
CAGR
(%)
65 ‐ 85 5‐yr CAGR85+ 5‐yr CAGR
Aged care demand peak growth
from 2023 ‐2043
Occupancy growth underpinned by supportive industry backdrop of (1) aging population (2) increasing bed demand
particularly for high acuity and specialist care and (3) rising years in spent in dependency
Increasing number of high occupancy facilitiesIncreasing number of high occupancy facilities
88
7
11
9
3
7
7
5
4
2
5
6
4
2
0
5
10
15
20
25
FY18FY19FY20FY21
Number
of
Facilities
95.0% to 100%90.0% to 94.9%85.0% to 89.9%<85%
1 Source: Statistics New Zealand
2 Source: EY Aged Residential Care Funding Model Review analysis using ARC model, August 2019. Historical information based on actual demand data per the ARC demand model which EY have extended using the past 5 year trend over the projection period
3 Source: Industry Information based on
NZACA Occupancy –TAS Aged Residential Care Quarterly Reporting Survey as at 31 December 2020. Includes ORA ARRC‐certified beds and residents
2. Increasing high acuity bed demand
2
2. Increasing high acuity bed demand
2
‐
2,000
4,000
6,000
8,000
20062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031
ActualProjection
Bed
days
(000s
of
days)
DementiaHospitalPsychogeriatricResthome
Radius Care
18
Growing Underlying EBITDA per Care Bed
Underlying EBITDA per Care Bed ($000)
Strong Occupancy (see previous page)
Increasing Underlying EBITDA per care bed
1
Increasing Underlying EBITDA per care bed
1
Growing accommodation supplementsGrowing accommodation supplements
Strong wage controlStrong wage control
18.3
17.9
17.2
19.5
0.0
5.0
10.0
15.0
20.0
FY18FY19FY20FY21
51.9
57.6
62.8
64.4
52.9%
54.1%
56.1%
53.9%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
FY18FY19FY20FY21
$m
Direct Employee Costs% of Direct Revenue
$3.03
$4.07
$4.92
$5.61
$1,819
$2,400
$2,902
$3,300
0
500
1,000
1,500
2,000
2,500
3,000
3,500
0.0
1.0
2.0
3.0
4.0
5.0
6.0
FY18FY19FY20FY21
Accommodation
supplement
per
Care
Bed
NZ$
Accommodation
supplements
NZ$m
Accommodation supplements (LHS)Accommodation supplements per available Care Bed (RHS)
1 Underlying EBITDA for aged care segment divided by the average number of care beds occupied during the period
1/06/2021
4
Radius Care
19
Positioning Radius
Care for Growth
Phase, Strategy
Update and FY22
Guidance
Radius Care
20
Senior management and board strengthened
and sized for next phase of growth.
Positioning
Radius Care for
Growth Phase
‐Brien Cree transitioned to Executive Chairman role
focused on growth opportunities through
development and acquisition
‐Stuart Bilbrough returned as CEO (previously CFO
from 2010 to 2017)
‐Hamish Stevens and Mary Gardiner appointed as
independent directors
‐Employee turnover reduced vs. FY20
‐A focus on employees continuing professional
development and ongoing property
investments
that enhances accommodation supplement
revenue is a focus for the coming year
Radius Care
21
GO FORWARD STATERGYHISTORICAL TRACK RECORDCURRENT STATUS
1. Brownfield development
•Windsor Court (FY18) –15 Care Beds
•Waipuna (FY17) –28 Care Beds
•Elloughton Gardens (FY17) –27 Care Beds
Brownfield potential identified at owned sites at:
‐Lexham Park (Katikati)
‐Thornleigh (New Plymouth)
Detailed feasibility studies underway
2. Purchase of strategically
important facilities already
operated by Radius
•Lexham Park
(FY20) –63 Care Beds
•Thornleigh Park (FY14) –63 Care Beds
•St Helenas (FY14) –52 Care Beds
Continuing work to identify strategically important facilities
3. Greenfield development
Greenfield Development on owned facilities undertaken and funded by
Radius Care:
•Elloughton Grange Village (FY21) –54 Units
Greenfield Development on leased facilities undertaken with and funded
by
landlords:
•Glaisdale (FY18) –80 Care Beds
•Millstream (FY18) –80 Care Beds
Purchase of Belfast, Christchurch Greenfield development land
•As announced in April 2021, Radius Care has exercised its right
to acquire c. 4.3 hectares of land
•Settlement of the land ($5.5m) is expected to take place
between December 2021 and March
2022
•Work progressing on final design, building consents and
construction discussions
•Multi‐stage program provides funding flexibility
4. Opportunistic value accretive
acquisition
•Acquired the operations of 26 aged care facilities and retirement
villages comprising 1,998 Residences since 2003
•Continuing to seek and evaluate potential acquisition
opportunities
Strategy Update
Focus continues on the execution of Radius Care’s growth strategy, with the exercise of Radius Care’s option to acquire the
4.3 hectare Belfast, Christchurch site being a key milestone since Listing
‐
Execution of strategy
‐
Growth Strategy as outlined in the Listing Profile
Radius Care
22
Radius Care
23
Aged Care
•Average occupancy expected to increase further in FY22 given current run
rate
•Continued accommodation supplements growth in FY22 expected
•Additional funding from the Government as part of the Equal Pay claim
for Health Care Assistants
•Operating costs will increase with staffing wage growth but wages to
revenue expected to
remain stable
•Conversion of Dementia rooms at Arran Court
Retirement village
•Sale of final 4 units at Elloughton Grange Village expected
•Resale of 5 units expected
Guidance for the
12 months to 31 March 2022
demonstrates expected
continued earnings uplift.
FY22 Outlook
and Guidance
Guidance
FY21Listing Profile FY21FY22
Actual ($m)Guidance ($m)Guidance ($m)
Underlying EBITDA 23.423.0 ‐23.823.5 – 25.5
Pre‐NZ IFRS 16 Underlying
EBITDA
10.510.2 ‐11.010.5 – 12.5
AFFO3.72.9 ‐3.53.7 –4.7
Radius Care
24
Radius Care provides unique exposure to a high acuity, specialised care provider that remains committed to and
focused on delivering compassionate and outstanding clinical care outcomes
1. Demand
2. Portfolio
3.
Systematic
Approach
4. Growing
Non‐
Government
Revenues
5. Growth
Pathway
6. Strong
Founder
Backed
Team
KeyInvestmentHighlights
0.0%
2.0%
4.0%
6.0%
8.0%
2003 2008 2013 2018 2023 2028 2033 2038 2043 2048 2053 2058
Rolling
5
‐
year
pop.
CAGR
(%)
65 ‐ 85 5‐yr CAGR85+ 5‐yr CAGR
1
Demand underpinned by population demographics
1
3.9
3.2 3.2
3.0
3.6
RadiusOceaniaArvidaSummersetRyman
2
Portfolio oriented to high acuity and specialist care
2
Systematic approach to provision of care
1) Centralised head‐office systems and support
2) Leading IT systems
3) Immigration accreditation
4) Early engagement through Radius Online Shop
3
3.4%
11.0%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Direct
private
portion
of
total
revenue
(%)
Growing direct non‐Government revenues
4
5
Clear growth pathway via
1) Purchase of strategically important
facilities’ land and buildings
2) Brownfield and greenfield development
with ownership of land and buildings
3) Opportunistic acquisitions
Strong founder backed team
Brien Cree
Founder and Executive Chairman
Stuart Bilbrough
Chief Executive Officer
6
1 Source: Statistics New Zealand
2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your‐health/certified‐providers/aged‐care/based on data as at 4 May 2021
3 Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues
1/06/2021
5
Radius Care
25
Appendix
Radius Care
26
Financial periodFY18FY19FY20FY21
$m
Aged Care
27.227.226.330.6
Retirement Village
0.30.80.81.4
Group support
(7.8)(7.6)(8.9)(8.7)
Underlying EBITDA
19.720.418.223.4
Key operational and financial metrics
Financial periodFY18FY19FY20FY21
Number of Care Beds (period end)
1
1,6821,7011,7041,715
Average Care Bed Occupancy
2
89.1%89.5%90.092.4%
Underlying EBITDA per Care Bed
3
(000s)$18.3$17.9$17.2$19.5
Number of Units (period end)
4
55637376
Number of new Unit sales 9118 6
Number of existing Unit resales23‐7
Realised gains on resales (m)$0.2$0.1‐$0.5
Realised development margins (m)$0.2$0.5$0.4$0.3
Cash DMF realised upon resale (000s)$67$66‐$525
Average resale price (000s)$323$355‐$407
Average new unit sale price (000s)$395$377$403$408
Operating metricsOperating metrics
1 Comprises Care Beds occupied, available to be occupied or unavailable due to refurbishment
2 Total occupied Care Bed days divided by total Care Bed days available during the period
3 Underlying EBITDA for aged care (as set out in the lower right table) divided by the average number of Care Beds
occupied during the period
4 Comprises Units occupied, available to be occupied or unavailable due to refurbishment
Financial periodFY18FY19FY20FY21
Accommodation Supplements Revenue
$3.0m$4.1m$4.9m$5.6m
Number of Care Beds
1,6821,7011,7041,715
Number of Available Care Beds with Accommodation Supplements
1,0051,1341,1381,146
Percentage of Care Beds with Accommodation Supplements
59.8%66.7%66.8%66.8%
Accommodation supplementsAccommodation supplements
Financial periodFY18FY19FY20FY21
$m
Aged Care
98.8107.3112.6120.3
Retirement Village
1.32.30.54.4
Group support
0.10.50.61.3
Total revenue
100.2110.1113.7126.0
Revenue by segmentRevenue by segment
DMF terms for Retirement Village unitsDMF terms for Retirement Village units
•30% over three years
•FY20 –21 average resident tenure: 4 years
Underlying EBITDA by segmentUnderlying EBITDA by segment
Corporate function growth from FY19 to FY20 and FY21 reflects strengthening of senior management and board for
next phase of growth.
Radius Care
27
Underlying EBITDA to AFFO Reconciliation
($m)FY18FY19FY20FY21
Underlying EBITDA19.720.418.223.4
Include: Pre‐NZ IFRS 16 operating rental lease expense(12.0)(12.4)(12.4)(12.9)
Pre‐NZ IFRS 16 Underlying EBITDA7.78.05.810.5
Include: Depreciation and amortisation (Pre‐NZ IFRS 16)(3.0)(3.6)(3.7)(4.3)
Include: Net interest expense (Pre‐NZ IFRS 16)(0.6)(0.9)(1.2)(0.8)
Include: Current tax expense(0.9)(0.7)(1.0)(2.1)
Include: Income tax impact from Pro forma adjustments0.20.20.3(0.3)
Pre‐NZ IFRS 16 Underlying NPAT3.43.00.23.0
Remove: Depreciation and
amortisation (excl. NZ IFRS 16
related)
3.03.63.74.2
Include: Maintenance capital expenditure(5.1)(4.6)(4.4)(3.5)
AFFO1.32.0(0.5)
1
3.7
AFFO outperformance in part due to maintenance capex below historical levels
Refer to Note 2.1 in the 31 March 2021 Annual Report for reconciliation of Underlying profit to Reported net profit after tax – see Appendix attached
1
The +$4.2m change in AFFO in FY2021 is calculated on AFFO for FY2020 of $(0.5)m, which has been revised from the FY2020 AFFO of $0.8m shown in the 10 December 2020 NZX Listing Profile due to a reclassification of the deferred tax on
the FY2020 revaluation of the three owned properties.
The impact of this reclassification was an increase of $1.339m in FY2020 current tax and a corresponding decrease of $1.339m in FY2020 deferred tax. There is no impact on AFFO in
any other period and there is no impact going forward.
Capex
maintenance
guidance is
$4.0m
Radius Care
28
Statement of Comprehensive Income
($000)FY20FY21
Revenue
Revenue from contracts with customers113,359121,217
Deferred management fees6711,081
Total revenue114,030122,298
Fair value movement of investment properties(649)2,879
Government subsidy received353794
Interest income4971
Total revenue and other income113,783126,042
Expenses
Employee costs(70,852)(74,457)
Depreciation expense(10,911)(11,552)
Finance costs(10,583)(9,706)
Other expenses(24,770)(28,298)
Total expenses(117,116)(124,013)
Profit / (loss) before income tax(3,333)2,029
Income tax (expense) / benefit 500(324)
Profit /
(loss) for the year(2,833)1,705
Other comprehensive income
Items that will not be reclassified subsequently to profit and loss
Revaluation of property, plant and equipment, net of tax5,7081,104
Other comprehensive income for the year5,7081,104
Total comprehensive income 2,8752,809
Radius Care
29
Statement of Financial Position
($000)FY20FY21
Assets
Cash and cash equivalents2,3172,761
Trade and other receivables7,6487,744
Inventories308548
Property, plant and equipment32,30332,896
Right‐of‐use assets181,431177,170
Investment properties27,83131,675
Deferred tax assets2,0063,635
Intangible assets16,99616,996
Total assets270,840273,425
Liabilities
Trade and other payables14,08614,911
Current tax liabilities7231,135
Borrowings31,42727,212
Deferred management fee9621,178
Refundable occupation right agreements17,51820,591
Lease liabilities185,304184,305
Total liabilities250,020249,332
Net assets20,82024,093
Equity
Share capital4,7365,932
Asset revaluation5,7086,812
Retained earnings10,37611,349
Total equity20,82024,093
Radius Care
30
Statement of Cash flows
($000)FY20FY21
Cash flow from operating activities
Receipts from residents for care fees and village fees113,282122,337
Receipts of government subsidy‐1,210
Payments to suppliers and employees(95,436)(101,724)
Proceeds from the sale of Refundable occupation right agreements3,7053,927
Payments for the repurchase of Refundable occupation right agreements‐(464)
Interest received4971
Interest paid – borrowings(1,183)(883)
Interest paid –lease liabilities(9,400)(8,823)
Income tax paid (814)(1,744)
Net cash provided by operating activities10,20313,907
Cash flow from investing activities
Proceeds from the sale of property, plant and equipment11454
Payments for the purchase of plant and equipment(11,305)(3,577)
Payments for village developments(3,723)(965)
Net cash used in investing activities(14,914)(4,488)
Cash flows from financing activities
Proceeds from bank borrowings15,120‐
Repayments
of bank borrowings4,038(4,215)
Repayments of shareholder loans(5,030)‐
Principal repayment of lease liabilities(3,035)(4,028)
Dividends paid(225)(732)
Net cash (used in) / provided by financing activities2,792(8,975)
Reconciliation of cash and cash equivalents
Cash and cash equivalents at beginning of the year4,2362,317
Net increase / (decrease) in cash held(1,919)444
Cash and cash equivalents at
end of year2,3172,761
1/06/2021
6
Radius Care
31
Reconciliation of NZ GAAP financial measures to non‐GAAP financial measures
($000)FY20FY21
Profit/(loss) for the year(2,833)1,705
Adjustments
Non‐recurring or infrequent items
Remove: COVID‐19 related expenses34653
Remove: Government COVID‐19 Subsidy(353)(857)
Remove: One‐off listing costs‐1,227
Remove: Share based payments‐1,464
Structural changes and other
Include: Listed & other company costs(1,084)(714)
Remove: Historical governance costs350417
Include: Income tax impact from adjustments295(270)
Underlying adjustments
Remove: Change
in fair value of investment properties649(2,879)
Include: Realised development margins512343
Include: Realised gains on resales‐480
Remove: Deferred tax expense(1,533)(1,831)
Underlying Net profit before tax(3,963)(262)
Remove: Depreciation10,91111,552
Remove: Net interest expense10,5349,636
Remove: Current tax expense1,0332,155
Remove: Income tax impact from adjustments(295)270
Underlying EBITDA18,22023,351
Include: Pre‐NZ IFRS 16 operating lease expense
(12,435)(12,850)
Pre‐NZ IFRS 16 Underlying EBITDA5,78510,501
Include: Depreciation (Pre‐NZ IFRS 16)(3,700)(4,262)
Include: Net interest expense (Pre‐NZ IFRS 16)(1,134)(812)
Include: Current tax expense(1,033)(2,155)
Include: Income tax impact from adjustments295(270)
Pre‐NZ IFRS 16 Underlying Net profit after tax2133,002
Remove: Depreciation (excl. NZ IFRS 16 related)3,7004,262
Include: Maintenance capital expenditure(4,400)(3,543)
AFFO(487)3,721
Radius Care
32
$0.1
$0.1
$(0.8)
$(0.2)$(0.1)
$(0.6)
$(0.7)
$20.4
$18.2
17.0
19.0
21.0
FY19 Pro forma
Underlying EBITDA
Brownfield &
Greenfield
Developments
BureauOther aged care
operations
DMF and weekly
service fees
Realised Gains on
Resales and
Development
Margin
Support office
personnel costs
Support office
other expenses
FY20 Pro forma
Underlying EBITDA
NZ$m
Aged careRetirement villageGroup support
Historical Pro forma Underlying EBITDA –FY19 to FY20
Note: Extract from the NZX Listing Profile of 10 December 2020
Radius Care
33
Leased facilityLocationCare BedsUnitsCurrent lease term Time to next renewal Rights of renewal Time to final expiry Landlord
HeatherleaNew Plymouth55‐12 yrs5 yrs3 x 12 yrs41.1 yrsA
Taupaki GablesKumeu60‐12 yrs5 yrs3 x 12 yrs41.1 yrsA
Windsor CourtOhaupo76‐12 yrs5 yrs3 x 12 yrs41.1 yrsA
Elloughton GardensTimaru86‐12 yrs5 yrs3 x 12 yrs41.1 yrsA
KensingtonHamilton96‐10 yrs3.2 yrs2 x 10 yrs13.2 yrsB
PeppertreePalmerston North62‐10 yrs3.7 yrs2 x 10 yrs13.7 yrsB
St
JoansHamilton82‐10 yrs4.1 yrs2 x 10 yrs14.1 yrsB
Fulton HomeDunedin93‐10 yrs4.6 yrs2 x 10 yrs14.6 yrsB
Arran CourtAuckland102‐10 yrs8.3 yrs1 x 10 yrs18.3 yrsB
Potter HomeWhangarei55‐20 yrs8.6 yrs2x 15 yrs38.6 yrsC
Rimu ParkWhangarei55‐20 yrs8.6 yrs2x 15 yrs38.6 yrsC
WaipunaAuckland86‐30 yrs25.9 yrs‐25.9 yrsD
Hampton CourtNapier45‐10 yrs7.9 yrs‐
7.9 yrsE
BaycareNorthland45‐12 yrs5 yrs3x 12 yrs41.1 yrsF
MatuaTauranga149‐30 yrs21.7 yrs‐21.7 yrsG
AlthorpTauranga117‐15 yrs7.5 yrs3x 10 yrs37.5 yrsH
MillstreamAshburton80‐35 yrs30.3 yrs‐30.3 yrsI
Millstream ApartmentsAshburton19‐5 yrs3.5 yrs2x 5 yrs13.5 yrsI
GlaisdaleHamilton80‐15 yrs11.2 yrs2x 15 yrs41.2 yrsJ
HawthorneChristchurch94‐10 yrs9.1 yrs2x 10 yrs19.1 yrsK
Total leased1537‐n/an/an/an/a
Simple average
leased77‐15 yrs9.1 yrsn/a27.7 yrs
Owned facility/village
St HelenasChristchurch52‐n/an/an/an/an/a
Thornleigh ParkNew Plymouth63‐n/an/an/an/an/a
Lexham ParkKatikati63‐n/an/an/an/an/a
Windsor Court VillageOhaupo‐22n/an/an/an/an/a
Elloughton Grange VillageTimaru‐54n/an/an/an/an/a
Total owned17876
Total171576
Directory of facilities
Radius Care
34
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.